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 1 Introduction 
1.1 The innate and adaptive immune system 
In order to protect the body against the diverse challenges provoked by a huge array 
of potentially harmful organisms and substances in our environment, vertebrates 
during evolution have developed an elaborate network of cells and tightly regulated 
molecular mechanisms, that are commonly known as the immune system. Principally 
there are two major requirements this specialized system has to fulfill: First there has 
to be a fast reaction against each invader, that keeps the potential infections in 
check. Secondly, a specific and at the same time flexible reaction against the highly 
diverse nature of invaders has to take place in order to rid the body of harmful 
consequences. 
To accomplish this, two different branches of the immune system have evolved which 
act in concert in a highly efficient way. They are referred as the innate and the 
adaptive immune system, respectively. The former represents an early activated, 
rapidly reacting “first line of defense”. It comprises effector cells and molecules that 
respond rather against common molecular patterns than specific structures, for 
instance invariant pattern recognition receptors can recognize bacterial cell wall 
components or double-stranded RNA during infection cycles of viruses (Mogensen 
and Paludan, 2005). The innate immune system is capable to repel most of the 
attacks in daily life so efficiently that we often do not even notice them. However, 
some organisms - therefore called pathogens - have acquired the ability to overcome 
this first barrier and to spread into the tissues or blood system of their hosts. 
Nevertheless, these pathogens are still kept in check by effector mechanisms of the 
innate immune system as mentioned above. At the same time the adaptive immune 
system comes into play. The corresponding cells recognize pathogens by means of 
highly specific receptors. Additionally, this branch of the immune system mediates a 
sometimes lifelong protection against re-infection based on an immunological 
memory. 
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1.2 B and T lymphocytes - players of the adaptive immune 
system 
The defense mechanisms of the adaptive immune system are based on the 
functionality of two cell types: Thymus derived T lymphocytes, and B lymphocytes, 
originally named after the organ their development was discovered first: the Bursa of 
Fabricius in birds. In most vertebrates like mice and man the main site of B-cell 
development is the bone marrow. 
T as well as B lymphocytes, both have the inherent capability to develop highly 
specific surface receptors against antigens (antigens are defined as molecules or 
structures, that induce an immune response). Importantly, individual lymphocytes 
express exclusively one receptor type against one specific antigenic determinant 
(called epitope). Upon antigen encounter of the specific antigen the respective clones 
react by clonal expansion and differentiation. 
Generally T and B lymphocytes differ in their way to mediate protection. T 
lymphocytes which derive from hematopoietic stem cells and develop from 
precursors after their migration to the thymus, mediate so called cellular immunity - 
reflecting the fact, that their effector function is mediated via cell contacts. The major 
group of T cells cannot recognize their respective antigens directly. Instead, they 
have to contact antigen-presenting cells that provide the respective antigens in a 
processed form. For this purpose the latter bear molecules on their surface encoded 
in the major histocompatibility complex (MHC) that accommodate small peptid 
fragments of the antigen processed within these cells. There are two types of MHC 
molecules: class I and class II. MHC class I molecules are found on the surface of 
almost every nucleus containing cell. They present antigens that are derived from the 
cytosol of the cells e.g. during a viral infection (Hofmann et al., 2001). MHC class II 
molecules represent the second class of MHC molecules, solely found on the surface 
of so called professional antigen-presenting cells, i.e. macrophages, dendritic cells 
and B cells (Bryant and Ploegh, 2004). They present fragments from antigens that 
have been taken up from the surrounding environment by pinocytosis or that has 
gained access to intracellular vesicles by phagocytosis. B cells accumulate antigen 
via their specific B cell receptor and thus provide the basis for specific T cell help by 
presenting it via MHC class II (Parker, 1993). 
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For antigen recognition, the T cell receptor (TCR) binds to the antigen:MHC complex. 
However, in order to fully activate the lymphocyte function further co-stimulatory 
signals are needed. This is provided by either the CD4 or the CD8 co-receptor. 
Mature T cells of healthy individuals bear exclusively one of these co-receptors and T 
cells expressing either of them exhibit different effector functions. Thus, their surface 
expression was used to further classify the T cell compartment into two major 
subsets: the CD8+ cytotoxic T cells and the CD4+ T helper cells (Woodland and 
Dutton, 2003). While the former can identify and kill intracellularly infected host cells 
(Wong and Pamer, 2003), the latter are specialized for the activation of other cells of 
the immune system, e.g. macrophages or B cells, leading to stimulation or inhibition 
of immune reactions (summarized in Woodland and Dutton, 2003). 
B lymphocytes (or B cells), as the second column of the adaptive immune system are 
responsible for the humoral immunity with antibodies as effector molecules (see also 
1.4.1). These immunoglobulins (Ig) can occur in two physical forms, a soluble 
(secreted) and a membrane bound. The membrane bound form acts as the antigen-
specific B cell receptor (BCR) on the surface of B cells. 
The BCR is composed of an antibody molecule that is equipped with an membrane 
integral C-terminal peptide. It is associated with the Igα/Igβ heterodimer, which 
functions as a signal transduction unit. This heterodimer connects the BCR to an 
organized complex of cytoplasmic signaling molecules. On mature B cells the BCR 
provides either a maintenance signal, required for the long-term survival of these 
cells (Lam et al., 1997), or an activation signal upon exposure to antigen (Gauld et 
al., 2002). 
If a B cell becomes activated by antigen - either by crosslinking of the BCR or by the 
disturbance of an ordered oligomeric structure of BCR-complexes as recently 
proposed by Reth (Reth, 2001) - it starts to differentiate and might develop into a 
plasma cell. The sole function of plasma cells is the secretion of antibodies thereby 
abolishing the surface expression of the BCR (Calame et al., 2003). In the secreted 
form the membrane integral and cytoplasmic domains of the BCR are replaced by a 
secretory tail due to alternative splicing (Ross et al., 1998). B cells can in addition 
modulate the binding features and effector functions of their immunoglobulins by 
class switch (see 1.4.5) and/or somatic hypermutation (see 1.4.4) before plasma cell 
differentiation (summarized in McHeyzer-Williams, 2003). 
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As mentioned already antibodies are the main effector molecules of the humoral 
immune response. In contrast to the T cell receptor antibodies recognize native 
antigens present in body fluids and cavities. For instance, they can bind bacterial 
toxins or viral particles thus blocking their access to cells (neutralization). 
Additionally, antibody-antigen complexes influence the inflammatory response and 
cell-mediated immunity indirectly by either complement activation or cross-linking of 
Fc-receptors thus promoting phagocytosis (e.g. by macrophages or neutrophils). This 
may lead to further stimulation of the immune system by production of cytokines, 
chemokines and other inflammatory mediators. Finally, there are many examples of 
antibodies which promote direct anti-microbial activities, e.g. by blocking the function 
of physiological relevant molecules of pathogens (Casadevall and Pirofski, 2004). 
 
Taken together B cells and antibodies produced by them provide a huge impact on 
the protective immunity against viral, bacterial and parasitic infections. Their 
presence after a first encounter with antigen by infection or vaccination might 
completely abolish reinfection by the particular pathogen. 
1.3 B cell subsets 
So far B cells have been described as a homogenous group of immune cells. 
However, these lymphocytes are much more heterogeneous to accomplish 
protection at different stages and time points of an infection. On the basis of 
phenotypic, topographic and functional characteristics, two major subsets of mature 
B cells have been described, which have different requirements for their generation 
and maintenance (Herzenberg, 2000). 
The first subset, termed B-1 cells, are enriched in the peritoneal and pleural cavities 
where they persist by self-renewal as their development takes place mainly during 
early ontogeny: B-1 cell progenitors are found within the embryonic splanchnopleura 
as well as later in the fetal omentum and liver. Their development terminates shortly 
after birth (Herzenberg, 2000). 
B-1 cells are believed to be the primary source of natural serum IgM antibodies. 
These antibodies arise in the absence of exogenous antigenic stimulation (Bos et al., 
1988; Haury et al., 1997) and often display polyreactive, weakly autoreactive binding 
capacity as well as reactivity against many common pathogen-associated 
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carbohydrate antigens (Baumgarth et al., 2005). According to the expression 
characteristics concerning the surface expression of CD5, the B-1 cell pool is further 
divided into two subgroups: CD5+ B-1a cells and CD5- B-1b cells. Except for the 
spleen where B-1a cells comprise a 1-5% population of B cells (their absolute 
number is similar to the number of B-1 a cells found in the peritoneum (Kantor et al., 
1992)), B-1 cells are commonly not found in the other peripheral lymphoid organs. 
In contrast, the second group of mature B cells termed B-2 or conventional B cells 
represent the predominating B-cell population in the peripheral lymphoid organs 
including spleen and are the source for monospecific antibodies. B-2 cells are the 
essential players of the adaptive B cell immune response. Although precursors of B-2 
cells can be already detected in the fetal liver their main site of generation is the bone 
marrow (Herzenberg, 2000; Berland and Wortis, 2002). From this source, newly 
formed B-2 cells continuously enter the mature B-cell pool throughout life. Like the 
B-1 population, also the B-2 population shows some degree of heterogeneity and 
therefore can be further divided into subpopulations. Besides the above mentioned 
recirculating follicular B cells (FO B cells) which locate in the B-lymphoid follicles 
within spleen or lymph nodes, marginal zone B cells (MZ B cells) exist as a splenic 
subset of B-2 cells (Lopes-Carvalho and Kearney, 2004). They are named after the 
marginal zone where they locate as resident cells. This specialized microenvironment 
is positioned at the periphery of the periarterial lymphatic sheath (PALS) and the 
follicular area, at the border between the white and the red pulp. Here, arterial blood 
empties into open sinuses. Predestined by their exposed location to the blood 
stream, MZ B cells are adapted to react quickly to blood-borne pathogens (Martin 
and Kearney, 2001; Lopes-Carvalho and Kearney, 2004; Allman et al., 2004). By 
providing fast antibody responses as well as interaction with T cells this B cell subset 
thus helps to bridge the temporal gap between the innate and adaptive immune 
response. 
1.4 Antibodies and their generation 
Antibodies as the effector molecules of B cells contribute in different ways to an 
immune response. Thus, they cannot not only bind specific antigens but also 
stimulate other parts of the immune system to participate in the immune response. 
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These important functions are mediated by different parts of the antibody molecule 
which are the focus of the next chapters. 
1.4.1 Antibody structure 
The antibody molecule is formed by two identical heavy (H) as well as two identical 
light (L) chain polypeptides which are shaped into the antibodies’ particular structure 
by covalent (disulfide-bonds) and non-covalent interactions (Figure 1.1). Both chains 
can be divided into domains on the basis of sequence similarities. The amino-
terminal domain of each chain is variable in sequence when several antibodies are 
compared. The remaining domains are constant. 
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Figure 1.1. Schematic design of the IgG molecule domain structure. According to their constant 
(Fc) region of their heavy chains antibodies can belong to one of five isotype classes named IgM, IgD, 
IgG, IgA and IgE. The light chains can be either of the κ or λ isotype. The hinge region provides steric 
flexibility. It is only found in IgG, IgD and IgA whereas IgM and IgE contain an additional CH domain 
instead. 
The variable region of either chain is based on a structural backbone formed by four 
relatively invariant framework sequences. These are interspersed by three regions 
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termed hypervariable or complementarity determining regions (CDRs). On the three 
dimensional structure the CDRs of the heavy and light chain form the actual antigen 
binding site of an antibody. Accordingly, the CDRs display an extraordinary high 
variability, the highest diversity always found in the CDR3 regions. The V regions of 
the heavy and light chains are C-terminally followed by C-regions. The C-region of 
the heavy chain determines the class or isotype of an antibody. There are five main 
immunoglobulin classes known: IgM, IgD, IgG, IgE and IgA. Moreover, in mice the 
IgG class is further divided into four subclasses termed IgG1, IgG2a, IgG2b and 
IgG3. Corresponding to their class affiliation the heavy chains are designated by the 
according Greek letters: µ,δ,γ,α and ε (γ1, γ2a, γ2b, γ3, respectively). A major difference 
among heavy chains is the number of C domains. While µ and ε consist of four 
domains γ, δ and α chains display only three domains. However, in the latter the C 
domain 1 is linked with C domain 2 by a so called hinge region that provides flexibility 
to the antibody molecule. The more V-distal part of the CH-region, also called Fc-
region, decides about the functional characteristics of an antibody, such as its half-
life in serum, activation of complement and the ability to interact with Fc-receptors 
(summarized in Frazer and Capra, 1999). 
Of all existing classes and subclasses two are secreted as multimers. IgM can be 
found as penta- or hexamers whereas IgA usually forms dimers (Johansen et al., 
2000). The multimers are assembled from monomers involving an additional 
polypeptide J (joining) chain. Because of the multimeric binding sites the overall 
binding strength (avidity) of the antibodies belonging to the multimer forming classes 
is dramatically increased. Therefore, even low affinity antibodies as often found 
among IgM antibodies become effective. 
The two light chain types are termed κ or λ. In contrast to the constant parts of the 
heavy chains no effector properties have been linked to their CL domains. Among 
different species the ratio between antibodies that bear light chains of κ or λ type 
varies considerably, e.g. in mice a ratio of 10:1, while in horse or cattle the opposite 
ratio is found. In humans the κ:λ ratio is 6:4 (Frazer and Capra, 1999). 
Although the particular constant regions of heavy and light chains display very little 
sequence variability, polymorphisms can be found. These allelic variants are called 
allotypes. Antibodies against the allotypes of the heavy chain C-regions of mice from 
different inbred strains are valuable tools. For instance they can be taken to measure 
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antibodies derived of mixtures of B cells from different inbred strains. Thus they 
represent essential reagents for transfer experiments of cells or antibodies. 
Mice of the BALB/c background, mainly used in this work are of the heavy chain 
allotype IgHa, whereas C57BL/6 mice of another widely used lab strain produce IgHb 
allotypic antibodies (Ovary, 1982). The CB20 strain used in this work is a BALB/c 
strain that carries the IgMb allotype. 
Antibodies can also be distinguished by their idiotypes (Id) (summarized in 
Greenspan and Bona, 1993). The idiotype consists of distinct antigenic determinants 
(idiotopes) found on the V regions of an individual antibody. The idiotope is always 
defined by a monoclonal antibody. There are private idiotopes that are associated 
with unique antibodies and public idiotopes (also termed cross-reactive idiotopes) 
that are shared by different antibody molecules. 
Antibodies directed against such idiotopic determinants are termed anti-idiotypic 
antibodies (anti-Id). Some of them recognize conformational determinants dependent 
on combined VH and VL interactions, others are specific for either VH or VL chain 
determinants. 
1.4.2 The immunoglobulin loci 
The genes that encode these immunoglobulin molecules are located on different 
chromosomes. The heavy chain locus of mice resides on chromosome 12, while the 
κ and λ light chain loci are found on chromosomes 6 and 16, respectively. Unique to 
the immunoglobulin loci is that the gene segments that encode the variable regions 
of the BCR or later of the antibodies do not exist in a form that allows their direct 
transcription from DNA in germline configuration. Instead they have to be assembled 
from small gene segments during the ontogeny of a B cell. This is accomplished in a 
process involving the somatic rearrangement of DNA. 
1.4.2.1 The heavy chain locus 
The V-region of immunoglobulin heavy chain (IgH) genes is assembled from three 
different types of gene segments termed VH, DH and JH. They are distributed over an 
estimated length of 1.5 megabases (Mb) (Figure 1.2). The exons encoding the 
constant parts of the heavy chains follow further downstream extending the whole 
locus to approximately 3 Mb (Chowdhury and Sen, 2004). 
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Figure 1.2. Immunoglobulin heavy chain (IgH) locus organization. A schematic representation of 
the murine IgH with approximate distances between the gene segments is shown. Several VH genes 
(black rectangles), the 5’-most (DFL 16.1) and the 3’-most DH gene segments (pink rectangles) are 
indicated along with the different constant region isotypes. Numbers of members belonging to each 
gene family are written in parentheses below the line. Three known cis-regulatory elements, the 
intronic enhancer Eµ, the Dq52 promoter, and the 3’ locus control region are depicted as red ovals 
(Chowdhury and Sen, 2004). 
More than 100 V region segments (V, D, J) have been classified in the mouse so far 
(Chevillard et al., 2002; Chowdhury and Sen, 2004). The VH segments are assigned 
to 15 partially interspersed gene families. Close to half of the murine VH genes 
belong to the J558 family, the majority being located at the 5’ end of the VH cluster. 
The extreme 3’ end of the VH locus comprises the 7183 family. An overview about the 
VH gene family is given in Figure 1.3. 
Besides the functional VH gene segments a number of pseudogenes can be found, 
that are either not able to rearrange or lead to non-functional polypeptide chains due 
to mutations. 
Downstream of the VH gene segments a cluster of 13 D gene segments follows. The 
first 12 D gene segments are relatively evenly distributed over a 60 kb region, 
whereas the thirteenth most 3’ D segment, Dq52, lies in much closer proximity to the 
JH gene segments, separated from the other D members by a 18 kb gap. Its distance 
to the nearest JH gene segment (JH1) of the following J cluster adds up to 1 kb. The J 
cluster consists of 4 functional gene segments. 
The first exons encoding the constant part of the heavy chain follow further 
downstream. Cµ and Cδ are located within the next 12 kb. After a gap of 50 kb the 
exons for the different subclasses of γ chains are found followed by Cε and finally Cα 
(Figure 1.2) (Chowdhury and Sen, 2004). 
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Figure 1.3. Schematic representation of the murine VH locus. The map is shown in chromosomal 
orientation, left is toward the centromer, this is opposite to the transcriptional orientation. The relative 
chromosomal location of respective family members is given as well their total number. Pseudogenes 
have not been included (Graph modified after Chevillard et al., 2002). 
1.4.2.2 The light chain loci 
Both types of light chains, κ and λ, appear to be functionally identical. Only their order 
of expression during ontogeny appears to differ (Engel et al., 1999; Duber et al., 
2003). 
The κ locus 
The murine Vκ-locus (Figure 1.4) consists of 140 localized and sequenced Vκ gene 
segments. They can be classified into 75 functional, 21 potentially functional and 44 
pseudogenes and spread over 3 Mb (Roschenthaler et al., 2000). Like in the case of 
the VH genes, different Vκ gene segments can be assorted due to sequence 
homologies into 18 different families. Particular for this cluster is that Vκ segments 
can be found in different transcriptional orientation. Upon rearrangement this leads 
either to the deletion of intervening Vκ segments or to their inversion (summarized in 
Schlissel, 2004). 
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Further downstream the Vκ cluster is followed by a set of five Jκ segments, one of 
which (Jκ3) is a pseudogene. A single exon for the constant region finally locates 
2.5 kb 3’ of the Jκ cluster. 
 
 
 
L1 Ln
RS
 
Figure 1.4. The murine κ light chain locus. Gene segments are shown in germline configuration (not 
to scale). One peculiarity about the Vκ locus is indicated: Its gene segments are located in both 
transcriptional orientations respective to the C region. Arrows indicate promoters and transcription 
direction. The black ovals represent the intron enhancer iEκ and the 3’ enhancer 3’Eκ, both promoting 
transcription of the rearranged light chains. Pseudogenes are designated by Ψ and RS indicates the 
recombining sequence that can mediate Cκ deletion. (Figure adapted from Düber, 2004). 
The λ locus 
In contrast to the κ locus with its multiple V-region families, the Vλ region (Figure 1.5) 
includes only three V-segments, termed Vλ1, Vλ2 and VλX. Also different from the 
organization of the heavy or κ chain locus, the λ-locus harbors, instead of the 
spatially separated unique J or C regions described earlier, four gene clusters, each 
containing one J and one C segment, respectively (Figure 1.5). From these four 
clusters, however, one (Jλ4-Cλ4) is nonfunctional due to a frame shift in the 
C region, defective recombination signal sequences as well as a defective RNA 
donor splice site (Weiss and Wu, 1987). 
The J-Cλ3 and J-Cλ1 genes are arranged in one cluster about 3 kb apart with the 
Vλ1 gene lying about 16 kb upstream of J-Cλ3. The second Cλ sequence cluster is 
positioned about 130 kb upstream of the Cλ3 locus and contains J-Cλ2 and the 
unexpressed J-Cλ4-combination followed by the two Vλ genes Vλ2 and VλX further 
upstream. VλX however is only rarely used as it has an in-frame termination codon at 
its 3’ end (Gerdes and Wabl, 2002). 
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The gene order (V2-Vx-CJ2-JC4-V1-JC3-JC1) explains why Vλ2 (or sometimes VλX) 
is commonly found in association with Cλ2 whereas Vλ1 combines with Cλ1 or Cλ3. 
In rare cases Vλ2 has also been found in association with the 190 kb distant Cλ1 and 
Cλ3, however backward recombination of Vλ1 with Cλ2 has not been observed so 
far (Weiss et al., 1985). 
The λ1 gene was the first mammalian single copy gene ever to be isolated and 
sequenced (Tonegawa et al., 1978a; Tonegawa et al., 1978b), subsequentially 
followed by the others (Arp et al., 1982; Blomberg and Tonegawa, 1982; Miller et al., 
1982; Selsing et al., 1982; Weiss et al., 1985; Weiss and Wu, 1987; Sanchez et al., 
1990). 
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Figure 1.5. Physical map of the mouse λ light chain locus. Picture of the genomic organization of 
the various λ gene segments. The distances are given in kilobases (kb). Transcriptional orientation is 
from left to right (promoters illustrated by arrows). ψ indicates the pseudogene. (Modified after Gerdes 
and Wabl, 2002). 
1.4.3 The rearrangement process 
The rearrangement process that underlies the assembly of the B cell receptor gene 
segments explains the capability of B cells to recognize a tremendous number of 
different antigenic determinants. Because it involves the genomic relocalization of the 
different types of variable gene segments it is called VDJ rearrangement in the case 
of the heavy chain and VJ rearrangement in the case of the light chains, respectively. 
However, receptor rearrangement is not restricted to B cells. T cells, that have to 
fulfill equal requirements regarding antigen recognition, use the same mechanism 
and - as described later in this chapter - even the same machinery for it (for review 
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see Livak, 2004). The genes encoding the T cell receptor are however different from 
the BCR genes. 
In both B and T cells the assembly of the V regions to functional transcription units is 
a highly ordered process. Nevertheless, it includes some volitional imprecisions that 
contribute to further diversity in addition to the combinatorial diversity that is achieved 
by the combination of different gene segments. 
The assembly of the heavy chain V-region in the mouse starts with the combination 
of one of the D-segments with one of the four J-segments (Figure 1.6). This first step 
is then followed by the connection of one of the V genes to the newly formed D-J 
sequence, leading to a final VDJ-sequence encoding the entire V-domain 
(Chowdhury and Sen, 2004). The connection with the constant part of the 
immunoglobulin is then later on achieved by RNA splicing of the primary transcripts. 
The recombination process is mechanistically very similar for heavy and light chain 
genes (Jung and Alt, 2004). Differences occur mainly due to the lack of D segment 
recombination step in the light chains. 
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Figure 1.6. Schematic illustration of heavy chain rearrangement. A D segment is first combined 
with a J segment followed by addition to a V segment. After the final VDJ recombination step 
transcription can occur. Remaining J segments of the recombination process are removed by splicing 
of the primary transcript thereafter (promoters illustrated by arrows). 
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The correct order of V(D)J assemblies (first V, then (optionally) D followed by J) is 
dependent on short, conserved, non coding DNA sequences flanking each of the 
single gene segments (Jung and Alt, 2004). They are known as recombination signal 
(RS) sequences and serve as recognition sites for the recombinase machinery. RSs 
consist of relatively conserved heptamers and nonamers, with respective consensus 
sequences of CACAGTG and ACAAAAACC. They are separated by a non-
conserved spacer of either 12 or 23 basepairs (Figure 1.7). 
VH and JH segments are both flanked with RSs with 23-bp spacers (here termed as 
23RS), while DH segments are flanked on either side with RSs containing spacers of 
12 bp (12RSs). 
At the light chain loci Vκ segments are followed by 12RSs whereas Jκ segments are 
flanked with 23RSs while for the Igλ locus the reverse is found. Recombination 
occurs only between one RS with a 12-bp spacer and one with a 23-bp spacer thus 
directing recombination between appropriate gene segments. The underlying 
principle is referred to as the “12/23” rule (Early et al., 1980). 
 
 
 
1212
12
12κ
λ
IgH
CACAGTG-
Heptamer
ACAAAAACC-
Nonamer
23
23
23 23
V
V
V D
J
J
J
CACTGTG-
Heptamer
GGTTTTTGT-
Nonamer
 
Figure 1.7. RSs at the different loci. Depending on the locus, V segments may be flanked by 12- or 
23-bp RSs, and similar for J segments. But one of each type of element must be present for 
recombination to occur, a requirement that prevents futile recombination events (e.g. J to J). 
 
The recombination events are mediated by the recombinase machinery, the process 
being started by the gene products of the recombination activating genes Rag1 and 
Rag2. Both are indispensable for V(D)J recombination as Rag1 or Rag2 deficient 
animals exhibit a complete lack of mature B and T cells (Mombaerts et al., 1992; 
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Shinkai et al., 1992). The RAG-proteins form a complex (RAG) providing the 
endonuclease activity for the formation of double strand breaks (DSB) that are 
necessary for the DNA rearrangement. To initiate the cleavage reaction, RAG binds 
first to one (12 or 23) and then to a second (23 or 12) RS introducing a precise nick 
at the very border of each RS and the particular gene segment. 
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Figure 1.8. Summary of the RAG cleavage reaction (Jung and Alt, 2004). 
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After this initiation step the resulting free 3’-OH end on the coding strand generates a 
blunt, 5’-phosphorylated RS end and a closed hairpined coding end through direct 
nucleophilic attack on the opposite phosphodiester bond (Figure 1.8). The four free 
DNA ends remain associated with RAG in a post-cleavage synaptic complex, two 
belonging to the coding strand and two belonging to the ends of the RSs, 
respectively. The postcleavage synaptic complex has basically two functions: to 
protect the DNA ends from inappropriate insertion elsewhere in the genome and to 
recruit DNA repair enzymes that are supposed to catalyze the following DNA 
religation steps (Jung and Alt, 2004; De et al., 2004).  
There are currently six identified repair proteins known to be involved in this step. 
They can be subdivided into two classes. One consists of the proteins Ku70 and 
Ku80, which form a DNA binding heterodimer, and XRCC4 and DNA ligase 4, which 
form an end-ligation complex (Bassing et al., 2002). All members of this group were 
found to be evolutionary conserved with homologues found already in yeast. The 
second class contains the remaining two proteins, DNA-dependent protein kinase 
catalytic subunit (DNA-PKcs) and Artemis, which have evolved more recently 
(Jackson, 2002). All enzymes are ubiquitously expressed in all cell types and ligate 
double strand DNA breaks irrespective of sequence homology. They have also been 
found to generally repair double strand breaks thus representing repair function 
beyond gene rearrangement (Bassing et al., 2002). 
During the DNA religation the coding and signal ends within the postcleavage 
synaptic complex are processed differently. The signal ends are joined precisely with 
each other in a head-to-head fashion thus forming a circular DNA fragment that is 
finally lost when the cell proliferates (Jung and Alt, 2004). However, the religation of 
the residual coding strands can proceed in a much more imprecise way which is 
contributing to further diversity to the joined region and is started by the opening of 
the hairpin loops. This cleavage often occurs asymmetrically resulting in a single-
stranded tail containing a few nucleotides of the coding sequence followed by a 
stretch of nucleotides derived from the respective complementary DNA strand. DNA 
repair enzymes replenish the missing DNA strand by complementary nucleotide 
addition thus generating palindromic DNA regions. The newly introduced nucleotides 
are therefore termed P (palindromic) nucleotides (Lafaille et al., 1989; McCormack et 
al., 1989).  
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A second group of newly introduced nucleotides found in the joined regions are N 
nucleotides (non-templated). These N sequences are the result of the action of 
terminal deoxynucleotidyl transferase (TdT), an enzyme, which catalyzes an addition 
of nucleotides to the 3’ ends of symmetrically cleaved hairpin loops of coding ends 
(Landau et al., 1987; for review see Benedict et al., 2000). N-nucleotide sequences 
at VD and DJ junctions can gain a length of up to 15-20 bp and are often G-rich due 
to preferential usage of dGTP by the enzyme (Max, 1999). They are mainly restricted 
to the heavy chain VDJ-junctions, because TdT expression ceases before the 
rearrangement of the immunoglobulin light chain genes. However, exceptions have 
been reported (Hiramatsu et al., 1995; Bentolila et al., 1999). The third mechanism 
generating diversity is rather the opposite of the two described so far. It concerns the 
loss of nucleotides of the J regions. This process known as ‘nibbling’ may be the 
result of exonucleases (Kenter and Tredup, 1991). The specific enzyme responsible 
for this process, has not been identified yet.  
All of the three mechanisms presented here occur either alone or in combination, e.g. 
nibbling preceding N-nucleotide insertion during VDJ arrangement. Their more or 
less random nature gives rise to an enormous number of variant immunoglobulin 
chains, all displaying different antigen binding potential, distinct from the germline 
encoded sequences. However, these diversification mechanisms can also result in 
non-functional rearrangements as frame-shift mutations might be introduced. They 
lead to abortion of translation by encounter of stop-codons in the newly acquired 
reading-frames in the C-region and are therefore termed non-productive (non-
functional) rearrangements.  
1.4.4 Diversification by somatic hypermutation 
The mechanisms contributing to diversification regarded so far take place during the 
formation of the B cell receptors in development and are essentially independent of 
antigen. However, even after the formation of BCR in mature cells its specificity can 
be altered. The underlying process is termed somatic hypermutation (summarized in 
Diaz and Casali, 2002). Its activation leads to the acquisition of point mutations within 
the variable regions of the heavy and light chain genes, thus, achieving further 
diversification. Although, these are distributed over the whole variable region of an 
antibody, distinct regions can be defined that display a high density of mutations, 
therefore known as hotspots. These are mostly found in the CDR regions. 
17 
1. Introduction  
The enzyme regarded to be the causative factor of this process is activation-induced 
cytidine deaminase (AID). The underlying mechanism is not completely understood 
yet, e.g. the question whether the target is RNA or DNA. This is due to the sequence 
homology of AID with the RNA-editing enzyme APOBEC-1 that is known to convert 
cytidine into uracil. However, several studies from the groups of Neuberger and Alt 
demonstrate direct interaction of AID with single stranded DNA (Lee et al., 2004; 
Besmer et al., 2004; Neuberger et al., 2005).  
Somatic hypermutation is activated after a B cell recognizes an antigen via its 
receptor and requires T cell help. In some of these B cells the mutations will result in 
specificities that confer a stronger binding to the encountered antigen. This will allow 
the expansion of successful specificities, i.e. antibodies of higher affinities, a 
phenomenon also known as affinity maturation. It takes place in the germinal centers 
of the peripheral lymphoid organs (Franklin and Blanden, 2004). 
 
Summarizing the diversification mechanisms described in this chapter: there are four 
main mechanisms for generation of diversity, that shape the BCR/antibody V-region. 
Starting with the existence of different V-, D- and J-region gene segments, 
combinatorial diversity is generated by the different combinations of these segments 
during assembly. This is further amplified by integration of additional P or N 
nucleotides or removal of coding sequences by ‘nibbling’. Additionally, the assembly 
of the antibody molecule itself provides further means for diversity - as the antigen 
binding sites are products of heavy and light chain V-region combinations. And 
finally, the diversification process is enhanced by the introduction of point mutations 
within V regions during the response to antigen. 
1.4.5 Class switch recombination 
BCRs and antibodies, respectively, can not only differ within their variable regions but 
also by their constant parts. B cells that after the completion of their development 
have not yet encountered antigen, are termed naïve B cells. These B cells express 
BCRs of two different classes, IgM and IgD, bearing the same variable region. The 
gene segment encoding the δ-chain lies directly 3’ of the µ-chain gene segment. The 
primary Ig transcript contains both C-regions in addition to the variable segments. 
Differential splicing gives rise to both BCRs (Max, 1999; Frazer and Capra, 1999).  
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During an immune response the IgM/IgD H-chain classes initially used can be 
substituted by the classes located further downstream in the locus. The underlying 
mechanism is called class switch recombination (CSR, see Chaudhuri and Alt, 2004). 
Class switch is started upon antigen-encounter and appropriate T cell help. It is 
mediated by special DNA sequences, so called switch regions, positioned in the 
intron between the rearranged VDJ region and the µ-gene as well as in the 5’ regions 
preceding the respective downstream C-region gene segments except Cδ. CSR 
involves a recombination event between two S regions, with to a different 
downstream CH gene (Figure 1.9). Interestingly the above mentioned enzyme AID is 
essential for CSR. Most likely it acts on the single stranded DNA that is generated 
during the activation of a particular C region for switching (Chaudhuri and Alt, 2004). 
As different antibody classes mediate different effector functions in concert with other 
cells or molecules of the immune system, the class switch mechanism provides the 
means for efficient clearance of a particular antigen i.e. a pathogen from the body.  
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Sµ Sγ3 S α
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S α
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IgG3
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Figure 1.9. Schematic representation of the class switch mechanism. The episomal switch circle 
contains the intervening sequences removed during CSR. The new genomic order in this example 
may give rise to further switch events. 
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1.5 B cell development 
All the processes described above can be assigned to particular stages in B cell 
development. These stages that are characteristic for particular steps during BCR 
assembly are paralleled by the differential expression of a collection of intracellular 
and surface marker proteins (Rolink et al., 1999). 
1.5.1 Early events - B cell lineage commitment 
B cell development is first observed in the fetal liver with early precursors found in the 
omentum and splanchnopleura. After birth B cell development takes place in the 
bone marrow (Herzenberg, 2000; Berland and Wortis, 2002). Starting point for the 
generation of B cells is the commitment of pluripotent, self-renewing hematopoietic 
stem cells (HSCs). HSCs are defined by their ability to give rise to all of the 
hematopoietic lineages in vivo and sustain the production of these cells for the life 
span of the individual. HSCs are discernable by their Thy-1lo, Sca-1hi (Ly6A/E), c-kit+ 
surface expression pattern. Moreover adult HSCs lack all the lineage markers (Lin-) 
of mature cells from the hematopoietic system, i.e. CD3 (T cells), CD45R/B220 
(B cells), Ly6G/Gr-1 (granulocytes), Ter119 (erythrocytes), Mac-1/CD11b 
(macrophages) (Wognum et al., 2003).  
The first differentiation step results in the appearance of multipotent progenitor (MPP) 
types. This differentiation step is accompanied by the loss of long-term self-renewal 
characteristic for HSCs and the expression of the tyrosine kinase receptor Flt3, also 
known as Flk2 (Adolfsson et al., 2001; Christensen and Weissman, 2001). These 
early progenitor cells can on one hand give rise to an IL7 receptor negative (IL7R-) 
common myeloid progenitor (CMP, Akashi et al., 2000) that has the potential to 
differentiate into all myeloid cell types (erythrocytes, megakaryocytes, granulocytes 
and macrophages). On the other hand, MPPs can differentiate into the earliest 
lymphoid progenitors (ELPs) which already initiate Rag1 and Rag2 expression and 
can undergo DHJH rearrangement at the IgH chain locus (Igarashi et al., 2002). ELPs 
still can give rise to the IL7R+ common lymphoid progenitor (CLP) in bone marrow 
and CLPs have residual potential to generate T, B, dendritic and natural killer (NK) 
cells (Kondo et al., 1997;Busslinger, 2004).  
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The entrance into the subsequent CLP-2 stage is marked by the onset CD45R/B220 
expression. Cells at this stage also start to express the complement component C1q 
like receptor C1qRp, a widely used marker in analysis of B cell development 
(Norsworthy et al., 1999; Petrenko et al., 1999, see also Rolink et al., 2002). This 
transmembrane protein can be found on all succeeding stages of immature B cells 
but is lost on mature B cells.  
Correlated with the induction of CD19, the cells finally enter the pro-B cell stage 
during which they complete the first part of the BCR receptor assembly: the 
rearrangement of the DH and JH genes (Hardy et al., 1991; Li et al., 1993; Li et al., 
1996). The absence of mature B cells in Rag-/- mice has been traced to a block of B 
cell development at this stage (Mombaerts et al., 1992; Shinkai et al., 1992). Besides 
this main B220+CD19+ fraction a second B220-CD19+ fraction of cells was identified 
(Montecino-Rodriguez and Dorshkind, 2002). Interestingly, although expressing the 
CD19 molecule, which is usually associated with B cell lineage, these cells show 
nevertheless the potential for the generation of macrophages. However, these cells 
do not display the potential to generate T cells or NK cells. 
1.5.2 B cell receptor formation 
The pro-B cell stage mentioned above is the first in a series of seven defined stages 
that reflect different events during the assembly of the B cell receptor. Like the 
preceding ones these stages have been characterized and defined by means of 
differential surface marker expression. Additionally, the sequential expression of 
components of the BCR as well as a panel of intracellular molecules engaged in BCR 
formation characterize the single steps during the developmental progress. 
 
Two nomenclatures are commonly used to define these stages in the bone marrow 
(Hardy et al., 1991; Rolink and Melchers, 1991). The nomenclature by Rolink and 
Melchers not only takes surface marker expression and the respective 
rearrangement states into account but also considers different cell sizes as indicators 
for proliferation (large cells) or rest (small cells). Based on this nomenclature the 
events during BCR formation will be described (Figure 1.10).  
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Figure 1.10. Cellular stages of B cell development in the bone marrow. H: heavy chain locus. L: 
light chain locus. N.R.: not rearranged, +: detectable. protein: detectable only on protein level, SL: 
surrogate light chain. cytoµ: cytoplasmic µ chain, Iµ0 germline transcripts of the heavy chain locus, κ0, 
λ0: germline transcripts of the respective light chain loci. 
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Initially, DJ rearrangement on both chromosomes takes place in the pro-B cell stage. 
The transition into the following pre-B-I cell stage is marked by the loss of Flt3 but the 
cells remain ckit+IL7R+. The recombinase machinery as well as TdT are expressed at 
the pre-B-I stage (Grawunder et al., 1995a).  
Pre-B-I cells are often used in differentiation models as they can be cultivated and 
maintained in this stage in vitro in the presence of IL7 or IL3 and start to differentiate 
upon removal of the cytokines (Rolink et al., 1991; Winkler et al., 1995). Moreover, 
transferred into lymphocyte deficient mice they can give rise to fully mature B cells 
indicating their exclusive commitment to the B cell lineage.  
The next step in heavy chain formation, the joining of VH to DJH segments occurs at 
the transition from pre-B-I to the pre-B-II stage (Rolink et al., 1999). Whenever the 
VHDJH rearrangement on one allele is productive and leads to a µ-heavy chain that 
potentially can pair with a light chain, a pre-B cell receptor (pre-BCR) is formed and 
exported to the cell membrane. 
The pre-BCR 
The pre-BCR has a structure that is reminiscent of the BCR (Figure 1.11). It consists 
of two newly formed µ-heavy chains associated with two so called surrogate light 
chain (SL) heterodimers that mimic a functional light chain (Hendriks and 
Middendorp, 2004). Surrogate light chains consist of two subunits, the VpreB and the 
λ5 protein, which are non-covalently associated. λ5 is encoded by a single gene and 
two isotypes exist for VpreB-proteins, the VpreB1 protein found to be expressed in all 
cells expressing the λ5 gene, the VpreB2 protein only found to be co-expressed in 
approximately 30% of such cells. However, both can contribute to a functional pre-
BCR (Kudo and Melchers, 1987; Karasuyama et al., 1994; Dul et al., 1996). The 
VpreB and λ5 genes are located on chromosome 16 in mice closely linked to the λ 
locus (Gerdes and Wabl, 2002). 
The pre-BCR is fully capable to initiate signaling mediated via its two accessory 
molecules Igα and Igβ. This step is crucial for further B cell development providing a 
first positive selection step as cells that fail to rearrange a functional heavy chain and 
thus cannot provide a functional pre-BCR complex undergo apoptosis. However, the 
trigger of the signaling events is still unclear. Two different scenarios are discussed. 
The first supports the idea that an extrinsic ligand stimulates the pre-BCR signaling. 
This is based on the finding that galectin-1, a stromal cell derived lectin, is required to 
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induce Igα-Igβ phosphorylation in a human pre-B cell line (Gauthier et al., 2002). 
Furthermore soluble murine or human pre-BCR molecules show specific binding to 
stromal-cell associated heparan sulphate, controlled by the non-Ig-like unique tail of 
λ5 (Bradl and Jack, 2001; Gauthier et al., 2002). 
On the other hand, Ohnishi and Melchers showed that the non-Ig-like unique tail of 
λ5 mediates cell-autonomous pre-BCR signaling (Ohnishi and Melchers, 2003). They 
proposed that either the pre-BCR interacting with neighboring pre-BCRs serves 
intrinsically as its own ligand or that alternatively pre-B cells express a molecule on 
their cell surface that has binding sites for the non-Ig-like unique region of λ5. 
However, in all signaling scenarios λ5 mediates a crucial impact on signaling 
(Hendriks and Middendorp, 2004). 
 
 
 
Figure 1.11. The pre-BCR. Two rearranged µ-chains form a complex with two surrogate light chains 
consisting of the two noncovalently associated chains VpreB and λ5. The two known VpreB proteins 
show homology to Vλ segments, the λ5 gene has homology to the Jλ and Cλ gene segments. 
Signaling initiated through the pre-BCR induces clonal expansion of the Igµ+ pre-B 
cells with IL7 playing a crucial role as pre-B-cell specific proliferation factor (Milne et 
al., 2004). As a result, pro-B cells differentiate to the next developmental stage of 
large, cycling pre-B cells. Recently, GL7 has been described as a novel marker 
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characterizing this stage (Murasawa et al., 2002). In cycling pre-B cells, TdT 
expression is shut down and the Rag1 and Rag2 genes are transiently 
downregulated upon signaling from the pre-BCR. Thus, the recombination machinery 
is turned off (Grawunder et al., 1995a). This happens as soon as one of the two 
heavy chain alleles is functionally rearranged which explains why every single B cell 
expresses only one type of heavy chain, a phenomenon termed allelic exclusion. 
This principle is also valid for rearranged light chain loci. The mechanism appears to 
be very stringent since only occasionally B cells are found that seem to have 
circumvented it (with a frequency of 1 in 104; Barreto and Cumano, 2000). The 
respective molecular events that finally lead to allelic exclusion, have still to be 
unraveled (Mostoslavsky et al., 2004). 
 
After a limited number of cell divisions, during which surrogate light chain expression 
ceases, the large pre-B-II cells stop cycling and differentiate into small, resting 
pre-B-II cells. The transition is associated with reactivation of the rearrangement 
machinery as now the second step of receptor assembly occurs: the light chain 
rearrangements (Rolink et al., 1999). Germline transcripts, i.e. transcripts of 
unarranged Ig gene segments, that indicate an accessibility of the particular Ig loci 
for the recombination machinery are in the case of κ already present in the large pre-
B-II cell stage (Grawunder et al., 1995b, Engel et al., 1999). In contrast germline 
transcripts for the λ-locus become detectable not until the small pre-B-II stage (Engel 
et al., 1999).  
In large pre-B-II cells the rearrangement of κ gene segments is initiated and 
precedes in small pre-B-II cells (Grawunder et al., 1995b; Engel et al., 1999). If this 
results in a functional κ light chain it can bind to the µ chain and is expressed as IgM 
molecule on the cell surface together with Igα and Igβ. If the rearrangement of κ 
genes is non-productive, rearrangement at the λ L-chain loci takes place (Rolink et 
al., 1999). As soon as a successful light chain rearrangement is achieved the 
expression of the BCR on the cell surface results in the inhibition of additional 
rearrangements at all light chain loci. This leads to the expression of either a κ or a λ 
chain. As only one light chain isotype is thus expressed per B cell, the phenomenon 
is called isotype exclusion. In combination with allelic exclusion also found for the 
light chain genes only one species of light chain and thereby only a single type of 
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antibody per cell is produced. Collectively, these limitations are referred to as 
‘haplotype exclusion’ (Nemazee et al., 2002). 
Small pre-B-II cells that produce a functionally rearranged light chain differentiate into 
immature B cells (Rolink et al., 1999). These cells express a functional IgM BCR 
receptor on their surface that is associated with Igα and Igβ and are characterized as 
IgMhiIgDloC1qR+ bone marrow cells. Within the immature stage potential harmful 
anti-self specificities are cleared from the newly generated B cell pool. In contrast to 
previous selection steps that probed the functionality of the receptor complex, 
selection at the immature stage is designed to probe the receptor-ligand interaction, 
since now the BCR is for the first time able to interact with antigens. It has been 
estimated, that 40-60% of all surface IgM positive B cells in the bone marrow may 
have autoreactive specificities (Spanopoulou et al., 1994; Xu et al., 1998), making an 
effective selection in terms of self-protection indispensable. Three main mechanisms 
act at this stage in order to evade autoimmunity: receptor editing, apoptosis and 
anergy. 
Editing 
Although IgM expression induces light chain allelic exclusion, surface IgM expression 
does not necessarily terminate rearrangement. Instead, secondary rearrangements 
can occur, replacing the original specificity with a new, non-autoreactive one (Edry 
and Melamed, 2004). This process is called receptor editing and takes place mainly 
at light chain loci since the required RS configuration may still exist. However, 
receptor editing has also been observed at the H chain loci where a V in the VDJ unit 
is replaced by an upstream germline VH segment (Reth et al., 1986; Kleinfield and 
Weigert, 1989). 
Apoptosis 
If receptor editing fails, escape from autoimmunity is usually assured by apoptosis of 
the cells with anti-self BCR specificities (Nemazee and Burki, 1989; Hartley et al., 
1993; Sandel and Monroe, 1999). Therefore immature B cells from the bone marrow 
undergo apoptosis when stimulated with high levels of anti-Ig mimicking self-antigen 
encounter (Norvell et al., 1995). The process to eliminate self-reactive B cells by 
apoptosis is also known as clonal deletion and is mainly observed when a 
multivalent, often membrane-bound self-antigen is recognized.  
26 
1. Introduction  
Anergy 
Cells that encounter soluble self-antigens during the immature stage might enter a 
state of anergy. Anergic B cells show downmodulation of IgM surface expression and 
impaired BCR signaling in response to antigen. They also fail to provide appropriate 
signaling for the activation of T helper cells. Due to these defects they are not 
activated to secret antibodies. In normal mice anergic B cells show furthermore a 
shorter half-life compared with mature B cells ensuring the rapid elimination of 
autoreactive specificities (summarized in Cornall et al., 1995).  
1.5.3 Peripheral maturation finalizes B cell development 
B cell development in the bone marrow is closely associated with stromal cells. 
During the transition to the immature state, however, the immature B cells become 
independent of stromal factors, migrate inside the central sinus and leave the bone 
marrow via the blood stream (Carsetti et al., 2004). They are then passively 
transported to the spleen, where they locate within the outer periarteriolar lymphoid 
sheat (PALS) (Figure 1.12). They still can be assigned to the immature B cell 
compartment due to their IgMhiIgDloCD21loCD23- CD24hi surface markers and the 
expression of C1qRp. Such B cells are also referred to as transitional B cells 
because they are in transit from the bone marrow and represent a distinct short-lived 
developmental transitional stage from immature to mature B cells. At least two major 
subsets of transitional B cells exist, transitional type 1 (T1), which specifies the 
freshly entered cells from bone marrow and transitional type 2 (T2), that are at a 
IgMhiIgDhiCD21hiCD23hiCD24hi C1qRp+ stage and are already located within the 
follicles (Su et al., 2004). 
After 1-2 days T2 cells develop into IgM+IgDhiCD21+CD23+CD24lo follicular or 
IgMhiIgDloCD21hiCD23lo marginal zone B cells. This final maturation step involves the 
loss of the marker protein C1qRp that marks nascent and immature B cells (Rolink et 
al., 1999; Loder et al., 1999). Now the B cells have finished their maturation and are 
fully capable to exert their respective effector functions in response to antigen.  
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Figure 1.12. Peripheral B cell development. Immature B cells leave the bone marrow as short-lived, 
transitional B cells. T1 cells travel through the bloodstream and enter the spleen where they reside 
within the periarteriolar lymphoid sheath (PALS). T1 cells differentiate into T2 cells that reside within 
the splenic follicle until they differentiate into mature B cells (Su et al., 2004). 
1.5.4 Fetal liver as a different site of B cell development 
The developmental steps shown in the chapters before describe mechanisms mainly 
based on observations made on B cells generated in the adult bone marrow. 
However, B cell development is already initiated during embryonic stages, with the 
fetal liver (FL) as the main site of hematopoiesis. The overall concept of B 
lymphocyte development found in bone marrow holds true also for fetal liver with 
regard to expression of cell surface and intracellular molecules as well as the 
correlated sequential rearrangement of Ig loci. However, also differences can be 
found. 
Concerning the B lymphocyte development in FL many progenitors have been 
identified that show a common myeloid/lymphoid potential. Thus a tripotent 
progenitor, which gives rise to T cells, B cells and macrophages has been described 
(Lacaud et al., 1998). Furthermore bi-potential precursors giving rise to B/myeloid 
progeny (Ohmura et al., 1999; Kawamoto et al., 2000) and a rare population of 
B/macrophage progenitors that have no potential to differentiate into other myeloid 
cells (Cumano et al., 1992) were found. Moreover a CLP population equivalent to the 
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CLP in BM with regard to cell marker expression was identified in FL. In contrast to 
BM CLP these cells are capable to generate also DCs and macrophages in addition 
to T, NK and B cells (Mebius et al., 2001). Interestingly bi-potential T/B progenitors 
which have been found in adult bone marrow (Kondo et al., 1997) have not been 
found in the fetal liver up to now. In summary, these observations indicate that FL 
lymphoid precursors retain the capacity to generate macrophages. In contrast 
lymphoid BM progenitors - with exception of the B/macrophage progenitor population 
mentioned earlier (1.5.1) - do not display this potential (Douagi et al., 2002). 
Other differences between fetal liver and murine bone marrow B cell precursors 
concern the differential expression of particular molecules. Recently performed 
studies in our lab that compared CD19+ckit+ cells from FL and bone marrow of 
BALB/c mice in microarray based experiments revealed a total number of 88 genes 
(70 known and 18 expressed sequence tags (EST)) differentially expressed between 
both sites (Düber, 2004). They also confirmed the previous made observation that 
pre-B cells generated in the fetal liver e.g. lack MHC class II expression whereas in 
the BM this molecule is already expressed on pre-B cell stage (Hayakawa et al., 
1994; Lam and Stall, 1994). Another example is the gene for a regulatory myosin 
light chain (precursor lymphocyte-specific regulatory light chain or PLRLC) (Oltz et 
al., 1992) that is expressed in BM pre-B cells but cannot be found in fetal liver pre-B 
cells. However, the most prominent example of a differentially expressed molecule is 
that of TdT. In contrast to B cell precursors from BM FL precursors express little or no 
TdT during VDJ rearrangement of the heavy chain loci (Li et al., 1993). Accordingly B 
cells from fetal liver contain no or only few N nucleotides in the VDJ junctions of their 
heavy chains in contrast to B cells generated in adult BM (Feeney, 1990; Li et al., 
1993; Gilfillan et al., 1993). Thus the lack of N nucleotide diversification at the heavy 
chain junctions is usually taken as an indicator for fetal origin of a B cell.  
Another difference between fetal and adult B cell development was revealed by the 
analysis of the effect of pre-BCR assembly/signaling on the proliferation of pre-B 
cells in stromal culture. Although the expression of a heavy chain transgene (capable 
of associating well with the SL chains of the pre-BCR) resulted in proliferation of adult 
bone marrow pre-B cells, the same chain inhibited proliferation of pre-B cells derived 
from fetal liver (Wasserman et al., 1998, see also Hardy et al., 2000). In contrast, a 
heavy chain transgene that failed to assemble efficiently with the SL chain had less 
suppressive effect on fetal proliferation. Therefore Wasserman et al. proposed that 
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pre-BCR signaling is important to promote B cell development in bone marrow but 
induces exit from cell cycle in fetal liver derived pre-B cells which are the main source 
for B-1 cells. 
1.6 B-1 cells 
The identification of B-1 cells as additional population besides B-2 cells some 30 
years ago was followed by many observations that addressed the different nature of 
both populations. Upon growing data, the question after the origin of both mature 
subsets became a controversial issue resulting in two hypotheses to explain their 
occurrence. The linchpin concerning both consist in the question if B-1 and B-2 cells 
originate from one or two different lineages. 
1.6.1 Origin of B-1 cells 
The initial hypothesis concerning B-1 cell development came from Herzenberg and 
coworkers (reviewed in Herzenberg, 2000). It was based on cell transfer studies in 
which fetal liver cells transferred into irradiated mice could reconstitute both, B-1 and 
B-2 cell populations, whereas transferred adult bone marrow only led to the 
generation of B-2 cells. Therefore, they proposed a model that suggested 
development from different, committed precursors, hence, B-1 and B-2 cells being 
descendants of two different lineages. Later, the fetal omentum and paraaortic 
splanchnopleura were shown to give rise exclusively to B-1 cells (Solvason et al., 
1991; Godin et al., 1993). In addition, when all B cells were depleted in mice after 
birth the newly formed B cells showed a fast recovery of B-2 cells in contrast to an 
impaired generation of B-1 cells (Lalor et al., 1989a; Lalor et al., 1989b; Hamilton and 
Kearney, 1994). This was taken as further indication that B-1 and B-2 cells derive 
from different lineages with their progenitors present at particular sites and time 
periods during ontogeny. 
In contrast, the second hypothesis suggests an ‘induced differentiation’ for B-1 cell 
generation (Cong et al., 1991; Haughton et al., 1993; Clarke and Arnold, 1998). It 
proposes that the B cell fate is determined by the nature and quality of the signaling 
mediated via its BCR. Based on their specificity, cells are thus selected either into the 
B-1 or B-2 compartment. Since the BCR is randomly assembled this hypothesis 
predicts one common progenitor for both B cell populations. The signaling events 
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upon (self) antigen encounter by slightly autoreactive or polyreactive specificities, 
possibly in addition of inappropriate T cell help, would select the cells into the B-1 
compartment (Berland and Wortis, 2002). 
Several observations have led to this proposal: in vitro experiments on splenic B-2 
cells manipulating BCR signaling by anti-Ig treatment resulted in the conversion from 
splenic B-2 cells into cells with B-1 characteristic in terms of marker expression and 
responses to mitogenic stimuli (Rothstein et al., 1991; Cong et al., 1991; Wortis et al., 
1995; Murasawa et al., 2002). Furthermore the fetal/neonatal repertoire is skewed 
towards the expression of immunoglobulins that bind TI-2 antigens (as for example 
found in the microbial flora of the gut). The adult repertoire generates these 
specificities rarely (e.g. due to N nucleotide insertion upon TdT expression). Thus, 
only few B-1 cells originate from adult bone marrow.  
Table 1.1. Extract of genetic alterations that affect B-1 cell numbers (Berland and Wortis, 2002). 
Alterations that decrease B-1 cell numbers References 
Mutations of positive regulators of BCR signaling  
Btk-/- or point mutation of btk Khan et al., 1995; Hendriks et al., 1996 
PKCβ-/- Leitges et al., 1996 
PLCγ-/- Hashimoto et al., 2000; Wang et al., 2000 
Deletion of P85α of PI-3 kinase Fruman et al., 1999; Suzuki et al., 1999 
CD19-/- Engel et al., 1995; Rickert et al., 1995 
SLP65-/- Jumaa et al., 1999; Pappu et al., 1999 
CD21/35-/- Ahearn et al., 1996; but see Molina et al., 1996 
Vav-/- Tarakhovsky et al., 1995; Doody et al., 2001; Tedford et al., 2001 
Mutation of B cell transcription factors  
Oct2-/- Humbert and Corcoran, 1997 
Aiolos-/- Wang et al., 1998 
NFATc-/- Berland and Wortis, 2002 
Alterations that increase B-1 cell numbers  
Mutations of negative regulators of BCR signaling  
SHP-1-/- Schmidt et al., 1998 
CD22-/- 
O'Keefe et al., 1996; Sato et al., 1996a ; but 
see Otipoby et al., 1996; Nitschke et al., 
1997 
Lyn-/- Chan et al., 1997 
CD72-/- Pan et al., 1999 
Overexpression of positive regulators of BCR signaling  
CD19 transgenic Sato et al., 1996b 
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In addition, many transgenic and gene targeted mouse models seem to provide 
evidence for the signaling based model. Mutations that weaken BCR signaling by 
alteration or deletion of positive regulators in the signaling pathways lead to 
decreased B-1 cell numbers. In contrast diminished or absent function of negative 
regulators leads to increased B-1 cell numbers (Table 1.1). 
Moreover transgenic mouse models expressing a B-1 specificity develop mainly B 
cells belonging to the B-1 compartment, most of them expressing CD5. Conversely, 
in mice carrying B-2 derived transgenes, transgene expressing B cells belong almost 
exclusively to the B-2 compartment (Table 1.2). 
However, supporters of the two-lineage model nevertheless argue, that the 
phenotypes observed in these transgenic mice could as well be attributed to different 
selection processes that B1 and B2 progenitors have to undergo (Herzenberg, 2000). 
 
Table 1.2. Effect of Ig-transgene expression on B cell development (Berland and Wortis, 2002) 
Transgene Specificity Source Phenotypea References 
3-83 H-2KkDk adult spleen B-2 Nemazee and Burki, 1989 
HyHEL-10 Hen Egg Lysozyme adult spleen B-2 Goodnow et al., 1988 
VH12/ Vκ4 
Phosphatidyl 
choline (PtC) 
CD5+ 
Lymphoma B-1a Arnold et al., 1994 
VH11/ Vκ9 
Phosphatidyl 
choline (PtC) B-1 cell B-1a Chumley et al., 2000 
SM6C10 Thy-1 B-1 cell B-1a Hayakawa et al., 1999; Hayakawa et al., 2003 
4C8 Mouse red blood cells NZB spleen B-1 Okamoto et al., 1992 
2-12H sM snRNP MRL/lpr mouse B-1a Qian et al., 2001 
a Predominant phenotype of B cells expressing the transgene 
1.6.2 Features 
B-1 cells are not defined by a single specific marker. In flow cytometry they can be 
distinguished from other B cells by differential expression using several cell surface 
markers. B-1 cells are IgMhiIgDloCD23-CD43+B220lo and constitutively express the 
IL5 receptor (Wetzel, 1989; Berland and Wortis, 2002). This is in contrast to B-2 cells 
that are IgMloIgDhiCD23+CD43-B220+. In addition, peritoneal B-1 cells are classified 
into CD5+ B-1a and CD5- B-1b sister populations.  
In contrast to the generally small resting follicular B-2 cells, B-1 cells are large 
granular cells and exhibit more side scatter in flow cytometry (Berland and Wortis, 
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2002). Furthermore, B-1 and B-2 cells differ also physiologically. Peritoneal B-1 cells 
have been shown to respond readily to phorbol esters without additional stimuli 
whereas cell cycle entry of B-2 cells requires ionomycin in addition to phorbol esters 
(Rothstein and Kolber, 1988b). Moreover, B-1 cells fail to enter cell cycle in response 
to anti-Ig stimulation and undergo apoptosis whereas the same stimulus leads to 
proliferation of B-2 cells (Rothstein and Kolber, 1988a; Morris and Rothstein, 1993; 
Bikah et al., 1996). According to their constitutive expression of IL5R, peritoneal B-1 
cells elicit stronger proliferation upon IL5 stimulation then splenic B-2 cells (Wetzel, 
1989; Baumgarth et al., 2005). 
Several studies showed differences between B-1 cell populations of the peritoneum 
and the spleen. The longest known example is the differential expression of Mac-1 
(CD11b/CD18) between peritoneal and splenic B-1 cells, the former expressing the 
molecule whereas the latter lacking it (Kantor et al., 1992). Moreover, CCR2 and 
CCR3 transcripts have been found in splenic but not in peritoneal B-1a cells 
(Rothstein et al., 2000). Splenic B-1 cells furthermore express much less IL-10 
mRNA than peritoneal B-1 cells and peritoneal B-1 cells express constitutively 
phosphotyrosinylated STAT3 which localizes in their nuclei whereas splenic B-1 cells 
do not (Fischer et al., 2001). Furthermore splenic B-1 cells have recently been 
reported to express the Notch family members Notch-1 and Notch-2 and other Notch-
related genes at significantly higher levels then peritoneal B-1 cells (Tumang et al., 
2004). Another difference between peritoneal and splenic B-1 cells concerns a more 
functional aspect. In contrast to peritoneal B-1 cells splenic B-1 cells fail to respond 
upon phorbol ester stimulation (Fischer et al., 2001).  
1.6.3 Function 
B-1 cells have been shown to be the major source of natural serum IgM (Herzenberg 
et al., 1986; Lalor et al., 1989a; Baumgarth et al., 1999; Baumgarth et al., 2005). 
These antibodies are produced in the absence of exogenous antigenic stimulation 
and provide a first line of defense against the infection by pathogens (Ochsenbein et 
al., 1999; Baumgarth et al., 2000). Accordingly, many antibody specificities against 
discrete microbial or viral components can be found in the natural antibody repertoire 
(Baumgarth et al., 2005). Furthermore many of these antibodies are poly- and weakly 
autoreactive and bind specific antigen with low-affinity (Baumgarth et al., 2005). 
Several studies characterized these particular features of B-1 cell derived antibodies 
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and provided evidence for the importance of B-1 specificities in the defense against 
pathogens.  
Antibodies of the B-1 cell derived T15 idiotype that consist of VH1/Vκ22 family 
member associations, have been shown to play an important role in protection from 
infection by Streptococcus pneumoniae (Briles et al., 1981; Yother et al., 1982). 
Furthermore antibodies with this idiotype can bind to oxidized low-density lipoprotein 
(LDL), which may contribute to its clearance from blood thus suggesting a role in 
prevention of atherosclerosis (Shaw et al., 2000). Similarly, such antibodies could 
have an impact during the course of this vascular disease as they may bind to 
atherosclerotic plaques and initiate an inflammatory response.  
Other prominent specificities found in 5-15% of peritoneal B-1 cells are those for 
phosphatidyl choline (PtC) (Mercolino et al., 1988; Wang and Clarke, 2004a). PtC is 
a glycolipid component of common plasma membranes and is exposed on senescent 
erythrocytes and on many other cell types that have been treated proteolytically 
(Kawaguchi, 1988). Thus anti-PtC specificities are examples for the many 
autoreactive specificities found in the B-1 cell pool (see 1.6.6). Anti-PtC antibodies in 
normal mice are encoded by either VH11/Vκ9 or VH12/Vκ4/5H heavy light chain 
combinations and show restrictions in the heavy and light chain CDR3 regions (Wang 
and Clarke, 2004a). The PtC specificity of VH11/Vκ9 and VH12/Vκ4/5H antibodies was 
revealed in studies that investigated their binding to mouse red blood cells (MRBCs) 
after treatment with the proteolytic enzyme bromelain (Br) (Kawaguchi, 1988). 
Therefore, they are also termed anti-BrMRBC antibodies. Besides their potential to 
bind senescent cells, anti-BrMRBC have been also shown to recognize thrombin-
treated mouse platelets (Kawaguchi, 1989). Therefore, it has been proposed that 
these antibodies may overtake a kind of physiological “housekeeping” function by 
removal of senescent cells (Hardy et al., 2004). 
Another prominent B-1 cell derived specificity is directed against LPS (Su et al., 
1991). Almost all natural antibodies that react against this bacterial cell wall 
component can be traced back to B-1 origin. These antibodies are important for the 
clearing of LPS. This was indicated by studies that used antibody deficient mice. 
They showed increased susceptibility to death after LPS injection but the phenotype 
could be rescued by administration of normal mouse serum containing natural 
antibodies prior to LPS injection (Reid et al., 1997).  
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Natural antibodies have also been shown to control early stages of the immune 
reaction against influenza viruses (Baumgarth et al., 2000). In the absence of natural 
IgM mice infected with influenza virus showed markedly decreased survival and an 
increased viral replication in the lung (Baumgarth et al., 2000). B-1 cells were 
identified as the source for the virus binding antibody whereas B-2 cells contributed 
only minimally to the anti-viral IgM antibodies. However, seven days after the 
infection with virus increased titers of B-2 derived IgM were observed whereas the 
titer of natural anti-virus IgM stayed constant. Thus B-1 cells do not respond to the 
infection with increased IgM production (Baumgarth et al., 2000). However, they 
provided a stable titer of IgM keeping the infection in check until the adaptive immune 
response mediated by B-2 cells could take place.  
1.6.4 B-1 cell contribution to immune responses 
It is possible to distinguish antigens upon the requirements of the elicited immune 
response. Responses to some antigens require the presence of mature T cells, 
therefore classified as T cell dependent (TD) antigens whereas others do not and are 
therefore called T cell independent (TI) antigens. The T cell independent antigens 
moreover can be further subdivided into TI-1 and TI-2 antigens. TI-1 antigens, often 
also referred as innate antigens, are polyclonal activators of B cells leading to their 
differentiation into antibody-secreting cells irrespective of their specificity. Antigens 
that belong to this class are LPS, peptidoglycans, lipoproteins. However, bacterial 
cell walls also contain TI-2 antigens which are typically repetitive polymers such as 
capsular polysaccharides from bacteria. They lack an intrinsic polyclonal B cell-
activating property. Prominent members of this second class are pneumococcal cell 
walls and dextrans but also synthetic haptenized derivatives such as TNP-Ficoll or 
NP-Ficoll (summarized in DeFranco, 1999). 
B-1 cells have been shown to participate in TI-2 responses (Claflin et al., 1974; 
Forster and Rajewsky, 1987; Martin et al., 2001). Transfers of B-1 cells into allotype-
congenic mice revealed their in vivo responsiveness towards the TI-2 antigen α-1-3 
dextran (Forster and Rajewsky, 1987). Furthermore, the above mentioned T15 
idiotype has been shown not only to contribute to natural serum IgM but also to the 
response during S. pneumoniae infection (Claflin et al., 1974; Masmoudi et al., 1990; 
Martin et al., 2001). The T15 antibodies were produced in addition to the already 
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existing idiotypes in the sera. Infection of mice devoid of T cells demonstrated the T 
cell independency of this process (Martin et al., 2001). 
However, some TI-2 antigens like TNP-Ficoll or NP-Ficoll do not lead to a B-1 cell 
driven TI-2 immune response which is instead provided by the second group of TI-2 
responsive cells - the marginal zone B cells (MZ) of the spleen (Hayakawa et al., 
1984; Berland and Wortis, 2002). Because B-1 and MZ B cells are positively 
selected, indicated by their skewed repertoire, and can respond rapidly to pathogens 
they are believed to provide a “natural memory” to the immune system. 
1.6.5 Natural memory 
The term ‘natural memory’ has been developed in analogy to the term immunological 
memory which reflects the fact that e.g. B cells that have once responded to a certain 
antigen can in case of a second encounter with the antigen respond faster and more 
efficiently. Thus memory B cells provide already appropriate antibody classes and an 
affinity matured repertoire (Mc Heyzer-Williams L.J., 2005). The immunological 
memory therefore reflects adapted skills for every individual gained during the course 
of its life.  
In contrast the ‘natural memory’ is suggested as a phenomenon adapted during 
evolution. The repertoire and reactivity pattern of natural antibodies and B-1 and MZ 
BCRs, respectively, is remarkably stable within each species and moreover even 
between species. This is in part explained by the frequent usage of germline V-genes 
that lack N nucleotide insertions. However, it is argued as well that the stability also 
reflects the innate usage of a series of V genes that by evolutionary pressures have 
been selected in the genome to provide an inherent legacy of specificities suitable for 
protection against pathogens (Martin and Kearney, 2001; Baumgarth et al., 2005). 
1.6.6 Autoreactivity 
In contrast to B-2 cells a large fraction of B-1 cells express self-reactive antibodies 
(Baumgarth et al., 2005). The anti-BrMRBC/PtC antibodies mentioned above are one 
example for such a B-1 cell derived autoreactive specificity (see 1.6.3). Other 
autoreactivities are directed against the cell membrane component 
phosphorylcholine (PC) (Masmoudi et al., 1990), immunoglobulins (rheumatoid 
factor) (Casali et al., 1987), carbohydrate epitopes, single stranded DNA (Casali et 
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al., 1987) and cell surface molecules such as Thy-1 (CD90), an antigen expressed 
on most thymocytes and peripheral T cells (Schlesinger, 1965; Martin and Martin, 
1975; Hayakawa et al., 1999).  
In general, low affinity antibodies are not pathogenic in normal animals. Only when 
these self- and polyreactive antibodies undergo affinity maturation and isotype 
switching and thus become high-affinity IgG antibodies, they might become 
pathogenic. Although somatic mutations are usually not seen in peritoneal B-1a cells 
(Forster et al., 1988; Berland and Wortis, 2002), it could be demonstrated that B-1 
cells have the potential to undergo somatic hypermutation as well as class switch 
(Taki et al., 1992). Thus B-1 cells might have the potential to contribute to 
pathological situations (Rothstein, 2002; Viau and Zouali, 2005). Accordingly, there 
are a number of autoimmune diseases in mouse and human where an association 
between disease and B-1 cells is discussed. Among these are the autoimmune 
hemolytic anemia (AHA) observed in NZB mice as a result of anti-red blood cell 
antibody production (Howie and Helyer, 1968) and murine lupus erythematosus 
(SLE) observed in F1 hybrids of NZB and NZW mice (Hayakawa et al., 1983). In 
addition, a B-1 cell contribution has been suggested in rheumatoid arthritis (Youinou 
et al., 1990) and Sjogren's syndrome (Dauphinee et al., 1988). All of these diseases 
are associated with elevated numbers of CD5+ B cells  
 
To provide a pool of autoreactive specificities, seems on the first glance more risky 
than beneficial. However, the observation that monoclonal antibodies reactive with 
self antigens also react with pathogens sheds a new light on this situation (Mercolino 
et al., 1986; Kearney et al., 1987; Claflin and Berry, 1988; Pecquet et al., 1992). The 
assumption is that the natural antibody repertoire may indeed be composed entirely 
of autoantibodies that also react with pathogens (Baumgarth et al., 2005). The pool 
of such reactivities thus would provide immediate immune protection that controls an 
infection until the adaptive immune system can fill in. This explanation is moreover 
perfectly in line with the observation that B-1 cells are positively selected by 
autoantigen (Hayakawa et al., 1999).  
1.6.7 Positive selection of B-1 cells by autoantigen 
The important impact of autoantigen upon B-1 cell selection has been shown by work 
from Hayakawa and colleagues using an anti-thymocyte autoantibody (ATA), a self-
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specificity found amongst CD5+ B cells. This antibody is encoded by VH3609 and 
Vκ21C germline genes and binds to a carbohydrate epitope on the Thy-1/CD90 
glycoprotein. The expression of the VH3609µ chain as a transgene in mice resulted in 
the generation of both B-1 and B-2 cells. However, the frequency of CD5+ B cells 
was increased. Moreover, the B-1 cells produced high titers of serum ATA - 
generated through pairing of the transgene with endogenous Vκ21C light chains. In 
contrast, B-2 cells in the spleen expressing the same heavy chain were found to be 
associated with a diverse repertoire of light chains and did not contribute to the high 
serum ATA levels. In the absence of the autoantigen (i.e. in Thy-1 deficient mice) no 
ATA-expressing B-1 cells were detected and in accordance no high ATA serum titer 
was observed. Thus both the accumulation of ATA CD5+ B cells and elevated level of 
serum ATA were dependent on the presence of the autoantigen (Hayakawa et al., 
1999; Hardy and Hayakawa, 2004). 
1.7 The L2 mouse model 
Although an extensive amount of knowledge about B-1 cells has been accumulated 
since their discovery, many important aspects are still poorly understood. This is in 
part due to the low numbers of such cells found in normal mice. To avoid such 
problems in the present work, a transgenic mouse strain (L2) was used that has been 
extensively characterized before (Engel et al., 1998; Kretschmer et al., 2002; 
Kretschmer et al., 2003a; Kretschmer et al., 2003b; Kretschmer et al., 2004). These 
mice express a transgenic λ light chain obtained from the plasmacytoma MOPC315 
(λ2315). Their major lymphoid organs contain almost exclusively B-1 cells while the 
development of conventional B-2 cells is inhibited in the bone marrow (Engel et al., 
1998). In the spleen of L2 mice 5-10% CD5+ B-1 cells are found which makes these 
mice extremely useful for the investigation of such cells. The only additional splenic B 
cell population are MZ B cells (Kretschmer et al., 2003a).  
Studies carried out on the antibody repertoire of B-1 cells in L2 mice revealed a 
striking phenotype (Kretschmer et al., 2002; Kretschmer et al., 2003b). Since the 
heavy chain loci in L2 mice could theoretically rearrange randomly during B cell 
development they could give rise to a very heterogeneous pool of different µ-chain 
specificities. However, the sequencing of transcribed heavy chains from the B-1 cell 
pool of L2 mice showed pronounced oligoclonality. In addition some sequences could 
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be found repeatedly by single cell RT-PCR and dominated the repertoire. These 
particular specificities could be shown to be derived from independent cells that had 
undergone also independent rearrangements of their receptor genes (Kretschmer et 
al., 2002; Kretschmer et al., 2003b). 
These dominant sequences could repeatedly be even found at the same frequency in 
the peritoneum of different individual mice. Thus, a substantial fraction of the B-1a 
cells expresses the same BCR on their surface providing an excellent molecular 
marker for these B-1 cells. The most dominant sequence was found in 15% of the 
peritoneal B-1a cells, a second in 13% and a third in 7,4 %. These data suggest a 
strong positive selection of such specificities probably by autoantigen (Kretschmer et 
al., 2002; Kretschmer et al., 2003b).  
Only some of these specificities could be found at a reasonable frequency in the 
spleen. This suggested that there is little exchange between these two anatomical 
compartments. This was confirmed by migration studies in L2 mice. When peritoneal 
cells were transferred into the peritoneum of L2 mice very few transferred B-1 cells 
could be recovered from the spleen (Kretschmer et al., 2003b). In accordance, gene 
chip analysis revealed significant differences between these two cell populations 
(Kretschmer et al., 2003b). 
Subsequent work furthermore demonstrated an impact of the spleen on the 
maintenance of the dominant clones. The dominant specificities found in the 
peritoneal cavity were lost after splenectomy. This, suggests a dependency of 
peritoneal B-1 subpopulations on a splenic survival factor, which in accordance with 
the previous observations was speculated to be a splenic autoantigen (Kretschmer et 
al., 2004).  
1.8 Aims of this work 
The results of the gene chip analysis on B-1a cells from spleen and peritoneal cavity 
of L2 mice could be explained in two ways. Splenic and peritoneal B-1 cells are 
descendants of two different cell lineages or the microenvironment imprints a 
particular gene expression pattern onto B-1 cells that arise from the same 
precursors. To decide this question diagnostic genes should be defined for the two 
populations from the gene chip analysis. Their expression should then be analyzed in 
cells that were recovered after transfer of peritoneal cells from spleen and 
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peritoneum of lymphopenic mice in which transferred peritoneal B-1 cell are known to 
home to the spleen and the peritoneum. Along these experiments novel, so far 
unknown, markers should be defined for B-1 cell by using the gene chip results. 
The dominant specificities could be regarded as unique B-1 cell specific markers. 
Therefore, antibodies with these specificities should be further analyzed. To this end 
hybridomas had to be established to obtain monoclonal antibodies representing 
these specificities. Using such antibodies, first anti-idiotypic antibodies should be 
generated that would greatly simplify the analysis of the dominating specificities. 
Furthermore, these B-1 cell derived antibodies should be used to search for the 
antigen that is recognized by them and it should be investigated how they behaved in 
vivo since they were supposed to be directed against an autoantigen. 
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 2 Material and methods 
2.1 Mice 
The L2 mouse line (IgHa) has been described previously. (Engel et al., 1998). 
Transgenic and non-transgenic mice were used at the age of 6-15 week old mice. 
Transgenic mice were crossed to BALB/c background for more than 20 generations 
and kept as heterozygotes. L2 mice of the IgHb allotype were obtained crossing L2 
mice to CB20 mice that are congenic with BALB/c mice but carry the IgHb haplotype.  
To obtain mice with the B cell specific deletion of the VCAM-1 gene mice 
homozygous for the loxP flanked (floxed) VCAM-1 gene (Terry et al., 1997) were 
crossed with CD19cre mice (Rickert et al., 1995). Rag1-/- mice on BALB/c 
background were obtained from The Jackson Laboratory (Bar Harbor, USA). Igα-/- 
mice on BALB/c background were obtained from Michael Reth (Freiburg) (Pelanda et 
al., 2002). 
2.2 Flow cytometry and cell sorting 
Single cell suspensions were obtained by flushing lymphoid organs or the peritoneum 
of mice with ice-cold IMDM (Iscove’s modified Dulbecco’s medium, 
GibcoBRL/Invitrogen). Erythrocytes in splenic, thymic or bone marrow preparations 
were lysed by incubation with ACK buffer (0.15 M NH4Cl, 10 mM KHCO3, 0.1 mM 
Na2EDTA, pH 7.2) for 2-5 min on ice.  
 
Blocking: 5x105-106 cells per 100 µl were incubated in FACS-buffer (2% FCS and 
2mM EDTA in PBS (8 g NaCl; 0.2 g KCl, 1.44 g Na2HPO4 x 2H2O, 0.2 g KH2PO4 in 
1 l H2O; pH 7.0)) containing Fc-block (clone 2.4G2, protein G purified from 
concentrated hybridoma supernatants or obtained from Pharmingen), mouse serum 
and/or Endobulin (human IgG, Baxter). The blocking was carried out on ice for 15-20 
min. 
 
Staining: Cells were stained for 10-15 minutes on ice using antibodies coupled to 
FITC, PE, APC or Biotin from the list below. Samples were washed twice with 
FACS-buffer afterwards. Biotinylated antibodies were counterstained in a second 
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step with streptavidin-APC (Pharmingen) or streptavidin-R-PE conjugates (Southern 
Biotechnology Associates) for 10 min on ice followed by a washing step with FACS-
buffer. Flow cytometry was carried out using a FACSCalibur® (Becton Dickinson). 
Cell sorting was carried out on a MOFLO (Cytomation), or a FACSVantage® (Becton 
Dickinson). Data were analyzed using Summit® v3.1 software (Cytomation) or 
CellQuest software (Becton Dickinson). 
 
Antibodies 
Monoclonal antibodies  
IgMa (DS-1) Pharmingen 
IgMb (AF6-78) Pharmingen 
IgDa (AMS9.1) Pharmingen 
IgDb (217-170) Pharmingen 
CD5 (53-7.3) Pharmingen 
VCAM-1 (429(MVCAM.A)) Pharmingen 
CD19 (1D3) 
Pharmingen or protein G purified 
from concentrated hybridoma 
supernatants* 
CD3 (500A2) 
Pharmingen or protein G purified 
from concentrated hybridoma 
supernatants* 
CD23 (B3B4) Pharmingen 
CD21(7G6) Pharmingen 
Polyclonal antibodies  
goat anti-mouse JAM-1 (Lot #: GJO01) R&D Systems 
 
*Antibodies obtained from hybridoma supernatants were conjugated to FITC 
(FLUOS, Roche Diagnostics) or Biotin (Biotinamidohexanoic acid N-
hydroxysuccinimide ester, Sigma) according to standard protocols . 
 
8H10 stainings were performed using supernatants from 8H10 hybridoma (rat-anti 
mouse L2P3, isotype IgG2b) culture and revealed by an mouse anti-rat IgG (H+L) 
Cy5-conjugated F(ab’)2 fragment (Jackson ImmunoResearch). L2P3, L2M15 and 
MOPC104E stainings were detected using the IgMa-FITC coupled antibody 
(Pharmingen) as secondary reagent.  
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2.3 Transfers 
Cells obtained from peritoneal lavages of L2 mice were washed twice with PBS prior 
to transfer.  
 
Intravenous transfer: 1.6x107 cells per mouse were transferred into the tail vein of 
Rag1-/- mice. After 2.5 weeks mice were sacrificed and cells from spleen and 
peritoneum were prepared. Cells from both compartments of individual mice were 
analyzed in flow cytometry using antibodies specific for IgMa, CD5 and VCAM-1. 
Residual cells from both organs were pooled, stained with anti-CD5 and anti-IgMa 
antibodies and sorted to obtain samples for RT-PCR. 
 
Intraperitoneal transfer kinetics: 7.8x106 cells per mouse were transferred i.p. into 
Rag1-/- mice. Splenic and peritoneal cell preparations of transferred mice were 
analyzed after 7, 15, 23, 29 and 32 days by flow cytometry using antibodies specific 
for IgMa and CD5 according to standard protocols. Spleen cells were additionally 
stained with anti-VCAM-1 antibody. 
 
Intraperitoneal transfer: 2,6x107 cells were transferred into the peritoneum of Rag1-/- 
mice. After 3 weeks cells from peritoneum and spleen of these mice were prepared 
and cells from both compartments of individual mice were analyzed in flow cytometry. 
To this end, cells were stained with anti-IgMa, anti-CD5 and anti-VCAM-1 antibodies. 
Residual cells from both compartments were pooled, stained with anti-CD5 and anti-
IgMa antibodies and sorted. 
 
Transfer of VCAM-1-CD19+ peritoneal cells: Cells from peritoneal lavages of L2 mice 
were stained with anti-VCAM-1 and anti-CD19 antibodies and sorted. VCAM-1-
CD19+ cells were mixed with cells obtained from peritoneal lavages of Igα-/- mice at a 
ratio of 2:1. From this mixture, 7.2x106 cells per mouse were transferred into the 
peritoneal cavity of Rag1-/- mice. After two weeks mice were sacrificed and spleen 
and peritoneal cavity cells were analyzed by flow cytometry using antibodies against 
IgMa, CD5 and VCAM-1. 
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2.4 Preparation of RNA 
Total RNA from sorted cells or hybridomas was prepared with TRIzol® Reagent 
(GIBCO BRL®) according to the manufacturer’s protocol. After preparation, RNA was 
solved in 10 µl DEPC treated water (Ambion) and transcribed into cDNA. 
Alternatively, possible DNA contamination in total RNA was eliminated prior to cDNA 
generation, by DNase1 treatment (DNA-freeTM, Ambion) according to the supplied 
protocol. Briefly, extracted RNA was incubated with DNase1 (2 units) at 37°C and 
after 30 min treated with DNase1 Inactivator. Samples were spun down at 10.000x g 
for 1 min and supernatants collected.  
In case of sorted cells, photometrical determination of RNA prior to cDNA synthesis 
was not possible because of low cell numbers available. For these samples the 
amount of cDNA was estimated by PCR with primers for Hprt. 
2.5 cDNA synthesis 
To transcribe cDNA, 3-5 µl RNA in DEPC treated water, 1 µl oligo-d(T)12-18 
(500 µg/ml, Amersham Biosciences), 0.5 µl RNAsin (40 U/µl, Promega) were 
adjusted with RNAse free water to a total volume of 12 µl per sample (Mix1) and 
incubated for 10 min at 70 °C. Samples were cooled on ice for two minutes and 
reaction mix containing 4 µl 5x RT buffer (Invitrogen), 2 µl 0.1 M DTT, 1µl 10 mM 
dNTP and 1µl Superscript II RNaseH- (200 U/µl, Invitrogen) was added. To control for 
genomic DNA contaminations additional samples were included in which the enzyme 
was substituted with water. Samples were incubated for 60 min at 42°C and 2 min at 
95°C thereafter. cDNA was stored at -20°C. 
2.6 PCR 
Oligonucleotides: Primer for PCR (except VCAM A-D primers) were selected by 
DNASTAR, Primer Select software (Lasergene) based on sequences obtained from 
the Ensembl Genome Browser (www.ensembl.org). All primer pairs, except Ccr3 and 
Fpr1, were designed as intron spanning primer pairs to control for genomic DNA 
contamination. Ccr3 and Fpr1 PCRs were conducted including control samples in 
which Superscript II enzyme was omitted during cDNA preparation. Primers for 
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VCAM A-D were selected according to Araki et al., 1993. All primers were purchased 
from Invitrogen. 
 
Primer 5’        3’ 
Adamdec1 for CATACAGCTGGAAGGGACAAGAC 
Adamdec1 rev ACTGAGAAGCTGGGCGTGGTTAT 
Adml for AGAACACAACTGGCCCCCTACAA 
Adml rev CACCCGCACCTATATCCTAAAGAG 
Api6 for GACTGCAACGGAACGGAAGACACG 
Api6 rev CCAAACGACTCAAAAGGCAAGACC 
Ccr3 for CTCGCTATCCAGAAGGTGAAGAAG 
Ccr3 rev GTGGAAAAAGAGCCGAAGGTGTT 
Cd5 for AGAAAAAGCAGCGTCAGTGGATTG 
Cd5 rev TCAGGATGGAGGGGATGC 
F11r for ACCCGGAAGGACAATGGAGAGTAT 
F11r rev TGGGCCTGGCAGTAGTATTCAC 
Fpr1 for GAACTTGGCCATTGCTGACTTTTG 
Fpr1 rev GACGGCCACCTTCCTCTTCTCTAC 
Hpgd for GCAGGCGTGAACAATGAGAAAAAC 
Hpgd rev CACAAAGCCTGGGCAAATGACA 
Lpl for CGAGAGGATCCGAGTGAAAG 
Lpl rev CTAATGCTGGAAGACCTGCTATG 
Mrc2 for TTTTACGAGAAGTTGGGGTCAGG 
Mrc2 rev TTTGGTCAGCTTTGGTTGTAATGG 
Spic for CAGAGGCAACGCTAACTACTATGG 
Spic rev CAGCTTTCTCCGGATTTTTATGAT 
Vcam1 (=Vcam7/8) for TCCCTAATGTGTATCCCTTTGACC 
Vcam1 (=Vcam7/8) rev AGGCTGCAGTTCCCCATTATTTAG 
VCAM A for CAACGATCTCTGTACATCCC 
VCAM B rev AGAGGCTGTACACTCTGCCT 
VCAM C for AAGGATCCGGTACCAAGCAGAGACTTGAAATGCC 
VCAM D rev CCCTTGAACAGATCAATCTCC 
Wee1 for TTTGCTCTTGCTCTCACAGTCGTA 
Wee1 rev CCATTTGGGCTTTCTTGAGTTCT 
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PCR: PCR reactions were conducted in a reaction volume of 20 µl per sample using 
the HotStarTaq® DNA polymerase kit from Quiagen. 
 
Reaction mix: 
1.2 µl  primer mix (containing 10 pmol/µl forward and 10 pmol/µl reverse 
primer) 
2.0 µl  10x PCR buffer containing 15 mM MgCl2 (Quiagen) 
1.6 µl  2.5 mM nucleotide mix (Bioline) 
0.2 µl  HotStarTaq DNA polymerase (5U/µl; Quiagen) 
13.6 µl Ampuwa® water (Fresenius Kabi) 
19 µl in each tube 
 
1µl cDNA was used as template in each PCR reaction. For PCR reactions 
polymerase was activated at 95°C for 15 min. Optimized conditions for each primer 
pair were used (20 s 94°C, 40 s 50-60°C, and 20 s 72°C, final extension 72°C 
10 min). Depending on the redundancy of each cDNA, 30-40 cycles were performed.  
 
Fifteen microliters were analyzed in gel electrophoresis.  
 
Threefold serial dilutions of the cDNA were used for semiquantitative RT-PCR and 
normalized according to expression of the housekeeping gene Hprt.  
 
Reaction tubes: 0.2 ml Micro-Strips & Caps (Abgene® House) 
2.7 Gel electrophoresis 
PCR products or restricted DNA were analyzed in agarose gel electrophoresis on 
0.8 % or 2% gels, respectively (SeaKeM® LE Agarose, Cambrex) in TBE-buffer 
(90 mM Tris-Borate, 2 mM EDTA, 0.11% (v/v) acetic acid). Ethidium bromide was 
added to the gels to reveal DNA bands under UV light. The size of DNA fragments 
was determined by comparison with DNA fragments of known size. 
 
DNA-markers: SmartLadder SF, 100 bp- 1kb (Eurogenetec); peQ gold 1 kb DNA-
Leiter (PeqLab) (used for gel electrophoresis during Southern experiments). 
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Documentation was performed using the E.A.S.Y Win32 gel documentation system 
and software (Herolab).  
2.8 Southern blotting 
CD19+ or CD3+ cells from flox/flox; cre/+ mice were sorted according to standard 
protocols. Yield for CD3+ and CD19+ splenic cells were between 4-5x106 cells. The 
pooled peritoneal fraction yielded 6.4x105 CD19+ cells. 
 
Preparation of genomic DNA: For the preparation of genomic DNA, 720 µl tail buffer 
(100 mM Tris HCl (pH 8.5), 5 mM EDTA (pH 8.0), 200 mM NaCl, 0.2% SDS) and 
30 µl proteinase K (Sigma) of a 10 mg/ml stock solution in H2O was added to the cell 
samples and shaken over night at 54°C. The next day, samples were spun down at 
room temperature (10 min, 20000 x g) and supernatants were transferred into a new 
tube containing 600µl 2-propanol. Tubes were gently inverted to promote DNA 
precipitation. Then samples were spun down for 5 min at 10000 x g. Supernatants 
were removed, the pellets washed with 500 µl 70% ethanol and subsequently dried 
at room temperature. Pellets were resuspended in 50 µl TE 10/1 (10 mM Tris (pH 
7.6), 1mM EDTA) and incubated overnight in a thermomixer at 54°C to properly 
dissolve the DNA. 
 
DNA digestion and blotting procedure: For Southern blot analysis, DNA was digested 
overnight at 37°C with BamHI (New England BioLabs) in a 60 µl reaction volume 
containing BamHI restriction buffer (New England BioLabs), 1 mM spermidine 
(Sigma), 1 mM DTT (Sigma), 100 µg/ml BSA (New England BioLabs), 50 µg/ml 
Rnase A (Serva), and 15U BamHI per reaction. Subsequently, the total volume of 
each sample was loaded to an agarose gel (0.8%) and separated by electrophoresis. 
DNA was then transferred to a nylon membrane (Gene Screen plus, NENTMLife 
Science Products) by capillary force under alkaline conditions. After the transfer, the 
membrane was washed with excess 2x SSC for 1-2 minutes (20x SSC: 3 M NaCl, 
0.3 M Tri-sodiumcitrate, pH 7.2). Finally, the DNA was fixed to the membrane by 
drying it for 2 h at 80°C. 
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Labelling of the probes: BgllI/SpeI restriction fragments used as probes for Vcam1 
were as described by Terry et al., 1997 and kindly provided by Dr. Angela Schippers, 
EI, GBF. The probe was labeled by incorporation of [α-32P] dCTP (Amersham 
Biosciences) using the “LaddermanTMLabelling Kit” (TaKaRa) according to the 
manufacturer’s protocol. Non-incorporated nucleotides were removed using 
ProbeQuantTM G-50 Micro Columns (Amersham Biosciences). After addition of 35 µl 
sonicated salmon sperm DNA (10 mg/ml) the probe was heated at 95°C for 5 min 
and was used for the hybridization of the blot. 
 
Hybridization and detection: To wet the membrane and to remove excess salt, the 
blot membrane was briefly dipped into deionized water before prehybridization. Then 
it was prehybridized in a rotating hybridization oven for 45 min at 65 °C using 
QuickHyb® Hybridization Solution (Stratagene). Subsequently the labeled and 
denatured probe was added to the solution and hybridized for one hour. 
After hybridization the following washing steps were carried out: 
1) two times shortly with 2x SSC/0.1% (w/v) SDS at room temperature 
2) two times for 15 min with 0.1x SSC/0.1% (w/v) SDS at 58°C 
Afterwards the membrane was wrapped in plastic wrap. Autoradiography was carried 
out using a BIOMAX MS film (Kodak) and an intensifying screen at -80 °C. Exposure 
was performed over night and developed using the Curix 60 automatic developer 
machine (Agfa). 
2.9 Generation of hybridomas 
Pooled cells from either spleen or peritoneum of two L2 mice were sorted for 
expression of CD5 and IgM (purities: spleen 91%, peritoneum 93%) and stimulated in 
vitro for 48h with 20 µg/ml LPS (Bacto Difco) in OptiMEM medium (GibcoBRL) 
containing 5% heat inactivated FCS (Integro), 100 µg/ml penicillin/streptomycin 
(Biochrom AG), 100 µg/ml gentamycin (Biochrom AG) and 250 µM 
ß-mercaptoethanol (Serva). Cells were then fused to non secreting P3X63Ag8.653 
mouse myeloma cells (Kearney et al., 1979).  
Cell fusion: For fusion, myeloma cells and activated lymphocytes were washed with 
serum-free IMDM (GibcoBRL) and mixed at ratio of myeloma:lymphocyte of 20:1. 
The mixture was spun down (5 min, 180 x g) and the supernatants discarded. After 
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loosening the pellet, the cells were incubated for 5 min at 37°C using a water bath. 
While gently shaking the tubes in the water bath, 500 µl polyethyleneglycole solution 
(PEG 1500; 50% (w/v) in 75 mM HEPES buffer (Boehringer)) were slowly added to 
the pellet over 60 seconds and tubes were agitated for an additional minute. 9 ml 
serum-free IMDM (GibcoBRL) were then added dropwise (3 ml/30 sec) followed by 
an additional incubation at 37°C (water bath) for 5 min. Cells were spun down (5 min, 
180 x g) and the pellet was resuspended in HAz medium followed by an 30 min 
incubation at 37°C in the incubator. Hybridomas were then plated under limiting 
dilutions in HAz medium and only wells bearing single colonies were expanded for 
further analysis. 
 
HAz-Medium: 0,5 mg Azaserine/6,8 mg Hypoxanthin (Hybri-Max, Sigma) were 
dissolved in OptiMEM medium (GibcoBRL) containing 5% heat inactivated FCS 
(Integro), 100 µg/ml penicillin/streptamycin (Biochrom AG), 100 µg/ml gentamycin 
(Biochrom AG) and 250 µM ß-mercaptoethanol (Serva). 
 
Culture conditions: Hybridomas were cultivated at 37°C and 5.0% CO2 in a 
humidified atmosphere. 
2.10 Amplification and sequencing of IgM chain transcripts 
from hybridomas 
Total RNA was prepared from 1-3 x 106 cells of the hybridomas. Reverse 
transcription and PCR were carried out sequentially in the same tube with primers for 
the amplification of the IgM V region (VHcons: 5’-
GAGGTGCAGCTGCAGGAGTCTGG-3’; Cµ1: 5’-ATGGCCACCAGATTCTTATCAGA-
3’) using the QIAGEN® One Step RT-PCR Kit according to the manufacturer’s 
protocols. Reverse transcription was performed at 50°C for 30 min in 25 µl reaction 
mix. PCR conditions were 95°C 30s, 50°C 30s, 72°C 30s using 30 cycles. The PCR 
was completed by a final extension step for 10 min at 72°C. 
PCR products were run on 2% agarose gels and extracted using QIAquick gel 
extraction kit (Qiagen). Purified products were directly sequenced. For sequencing 
the Cµ1 primer described above was employed. The sequencing reaction was carried 
out in a 11 µl reaction volume using the ABI PRISMTM BigDye Terminator Cycle 
Sequencing Kit (PE Biosystems) applying the following programme: 96°C for 60 s, 
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25 cycles at 96°C for 60s, 55°C for 15s and 60°C for 4 min. After the reaction the 
DNA was precipitated. Briefly, 100 µl 2-propanol were added to the samples and 
mixed. After 15 min incubation at room temperature, the precipitate was spun down 
(45 min, 1420 x g, room temperature). The supernatant was removed by a 
subsequent centrifugation with inverted open tubes (1 min, 180 x g). Residual 
2-propanol was evaporated on a thermocycler by incubation of the open tubes at 
65°C for 2-5 min. Samples were stored at -20 °C until loading on the sequence gel 
and analyzed with an automatic DNA sequencer (ABI PRISM 377, PE Applied 
Biosystems) in the Department of Genome Analysis at the GBF.  
 
Sequences were evaluated with the SequencerTM 3.1.1 program (Gene Codes 
Corporation). To this end they were aligned with the sequences of the four functional 
JH gene segments to determine the J-usage. The VH gene segment family was 
determined submitting the sequences to database search (Advanced BLAST Search 
and IgBLAST, National Center for Biotechnology Information, 
http://www.ncbi.nlm.nih.gov/BLAST/). The longest D element matches were used to 
assign the D element. At least five nucleotides had to match to assign a D segment. 
Nucleotides neighboring nucleotides at the ends of J, D or V gene segments and 
forming palindromic sequences with the neighboring nucleotides were assigned as P 
nucleotides, the remaining nucleotides were considered as N nucleotides.  
2.11 Purification of IgM antibodies from cell culture 
supernatants 
L2P3, L2M15, 2D4 (Young, Jr. et al., 1979) hybridoma cells and MOPC104E 
plasmacytoma cells were cultivated in IMDM (GibcoBRL/Invitrogen), 3% protein G 
adsorbed heat inactivated FCS (Integro), 100 µg/ml penicillin/streptamycin 
(Biochrom AG), and 250 µM ß-mercaptoethanol (Serva). Supernatants were 
collected from roller cultures and concentrated using an Amicon device (Series 8000, 
Millipore) with a 50K ultrafiltration membrane (Pall). After centrifugation of 
concentrated supernatants at 1620 x g (30 min) a pre-precipitation step was carried 
out. To this end a saturated ammonium sulfate solution (4.1M in H2O) was added 
slowly and dropwise to the gently stirring supernatant at 4°C until 20% saturation was 
reached. Samples were then left stirring over night. As mouse antibodies start to 
precipitate at a 45-50% saturation this step was used as a pre-clearence step 
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removing debris that precipitates at lower ammonium sulfate concentrations. The 
solution was spun down at 1620 x g for 30 min and supernatants containing IgM 
molecules were submitted to a second over night precipitation adding saturated 
ammonium sulfate solution until a 45% saturation was reached. The solution was 
spun down thereafter at 1620 x g for 30 min and the pellet was suspended in PBS. 
After dialysis (Dialysis tubing Visking, exclusion limit MWCO 14 000, Roth) against 
PBS at 4°C an additional dialysis step against binding buffer from ImmunoPure® kit 
(Pierce) for the purification of IgM was carried out. IgM was purified using an 
immobilized Mannan-binding protein column according to the kit instructions 
thereafter. After purification IgM was dialyzed against PBS and stored at -80°C. 
2.12 Generation of the 8H10 anti-idiotype antibody 
Generation of the anti-idiotype antibody in rats and subsequent ELISA screenings for 
the identification of L2P3 binding hybridoma supernatants were kindly carried out in 
the lab of Dr. Elisabeth Kremmer at the GSF in Munich. Purified L2P3 IgM and 
L2M15 as well as MOPC104E used for ELISA screenings were provided from IgM 
preparations described above. 
2.13 Analysis of IgM sequences of sorted IgM+ 8H10+ cells 
Peritoneal cells of six L2 mice were pooled and sorted for IgM and 8H10 expression. 
Total RNA was isolated from these cells using TRIzol® Reagent 
(GibcoBRL/Invitrogen). Reverse transcription and amplification of the resultant cDNA 
was done in one step according to the QIAGEN® One Step RT-PCR Kit instructions 
(Qiagen). For the amplication of IgM V region specific cDNA, the VHcons 
(5’-GAGGTGCAGCTGCAGGAGTCTGG-3’) and Cµ1 
(5’-ATGGCCACCAGATTCTTATCAGA-3’) primers were used (program: 50°C for 
30 min followed by 30 cycles of 95°C 30s, 50°C 30s, 72°C 30s and a final extension 
step of 10 min at 72°C). The sample obtained from PCR was run on a 2% agarose 
gel and the PCR products were cut out and purified using the QIAquick gel extraction 
kit (Qiagen). PCR products were then cloned using the “TOPO TA Cloning kit” 
(Invitrogen). Plasmid clones were isolated using the GFXTM Micro Plasmid Prep Kit 
(Amersham Pharmacia Biotech) and the insertion of the cDNA fragments was tested 
by EcoRI restriction digestion of plasmid DNA aliquots prior to sequencing. Plasmid 
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DNA was sequenced using the VHcons primer and sequences were evaluated as 
described in 2.10.  
2.14 Determination of IgM clearence 
10 µg of L2P3, L2M15, MOPC104E or 2D4 antibodies, respectively in PBS were 
injected intravenously into the tail vain of CB20/L2 mice. Groups of 3 mice were used 
except for the injection of L2M15, where only two mice formed one group. Mice were 
bled after 4 h, 1 day, 3 days, 5 days and 7 days and sera were prepared. Sera 
obtained before injection of the antibodies were used as controls for the ELISA (pre-
bleed). 
Sera: To obtain sera from mice, blood derived from the tail vein of mice was placed 
on ice for 2 hours to allow clotting of the blood. The clot was removed with a wooden 
toothpick and samples were spun down at 4 °C with 2700 x g for 10 min. 
Supernatants were transferred into new tubes and stored at -20 °C until usage. 
 
ELISA: The kinetic of the clearence of injected IgM into CB20/L2 mice was 
determined with an allotype specific ELISA using an antibody against IgMa that 
detects the injected IgM molecules and does not bind to IgMb molecules of the 
CB20/L2 mice. 
 
Coating buffer: 0.1M Na2CO3, 0.1M NaHCO3; pH 9.6 in H2O 
Washing buffer: 0.1% Tween 20 in PBS with 5% FCS 
Blocking buffer: 3% BSA in washing buffer 
Dilution buffer:  1% BSA in washing buffer 
OPD substrate: 1 mg/ml o-Phenylendiamin in Substrate Buffer; 0.3% H2O2 
Substrate buffer:  0.2 M NaH2PO4 , 0.1 M Na3-citrate; pH 5.0 
 
Plates (MaxiSorbTM Immunoplates, Nunc) were coated over night at 4 °C with 2 µg/ml 
rat anti-mouse IgM antibody (clone II/41, Pharmingen) diluted in coating buffer. After 
washing, wells were blocked with 200 µl blocking buffer for two hours at RT and 
plates flicked to discard the fluid. The sera from different time points were diluted 
1:100 in blocking buffer and added to the plate for a 2 h incubation at RT. After 
washing, 0.5 µ/ml biotinylated anti-mouse IgMa antibody (DS-1, Pharmingen) in 
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dilution buffer was added and incubated for 1 h at room temperature. Plates were 
washed and horseradish peroxidase (HRP) conjugated streptavidin (Pharmingen) in 
dilution buffer was dispensed into the wells. Plates were incubated for 45 min at room 
temperature and washed. Then the ELISA was developed at RT for 25 min in the 
dark adding o-Phenylendiamin (OPD) as substrate for the peroxidase. Reaction was 
stopped adding 1 M H2SO4. Results were read using an ELISA-reader (BioRad 3550-
UV microplate reader) at a wavelength of 490 nm. 
 
Determination of IgM half-life: For each time point the mean value at OD490 was 
calculated from the data of individual mice of one group representing the IgMa 
fraction in sera. The mean value at 4 h was arbitrarily set to 100% and the remaining 
mean values were correlated to it. Using Microsoft® Excel 2000, these data points 
were plotted in a semi-logarithmic diagram depicting the percentage of the IgMa 
fraction versus time t, where t = 0 corresponds to the first data point at 4 h. To obtain 
the curve of the monophasic 2D4 clearance a trendline was determined by using a 
least-squares fit of the functional form A exp(-bt). A is the IgMa percentage at t = 0 
constrained to equal 100% and b is the elimination rate constant. Thus the half-life 
T1/2 of IgMa equated ln(2)/b. 
Each curve of the biphasic L2P3, L2M15 and MOPC104E kinetics is represented by 
the two-phase functional form C exp(-dt) + D exp(-et). C and D are the extrapolated 
IgMa percentages of the first (fast) and the second (slow) phase at t = 0, and d and e 
are the corresponding elimination rate constants (d > e). Using the built-in 
interpolation of Microsoft® Excel 2000 the approximated runs of these curves were 
obtained and plotted in a semi-logarithmic diagram. In order to determine the half-
lives of the two phases, first, an extrapolated trendline was generated for the second 
phase of each curve applying the least-squares fit of the functional form D exp(-et). 
Subtracting data values of this trendline from values of the interpolated biphasic 
curve yielded data points that were used to determine the trendline representing the 
first phase. This trendline was generated using the least-squares fit of the functional 
form C exp(-dt), where C + D was constrained to equal 100%. The half-lives T1/2 for 
both the first and the second phase thus equated ln(2)/d and ln(2)/e, respectively. 
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B-1 cells have been extensively characterized. Nevertheless, it is often difficult to 
detect such cells in particular tissues or follow their migration. Thus the panel of 
available reagents and markers needs to be increased - an issue that was followed 
up in this work.  
The background of the first part of this work was provided by microarrays that had 
been carried out before. Gene expression profiles from B cell populations located at 
different anatomical sites like peritoneal B-1a and B-1b cells as well as splenic B-1a 
cells from L2 mice had been obtained. Similarly, follicular B-2 cells as well as 
peritoneal and splenic B-1a cells from non-transgenic littermates had been analyzed 
(Kretschmer et al., 2003b). Based on those array data, genes had been classified 
into groups and two of them were further investigated during this work: 
 
1) Genes that were expressed in splenic B-1a cells but revealed only background 
expression levels in peritoneal B-1a cells (Group 1), 
2) Genes that were expressed in peritoneal and splenic B-1 cells but were 
absent in follicular cells (Group 2). 
3.1 Group 1 genes 
First genes expressed in splenic B-1a cells but not in peritoneal B-1a cells of L2 mice 
were analyzed. Differences between B-1 cells from spleen and peritoneum had been 
described before which include phenotypic, biochemical as well as functional aspects 
(Rothstein, 2002). These differences have led to the suggestion that B-1 cells from 
the two different anatomical sites may in fact represent two populations with different 
origin. On the other hand, they might simply reflect differences in B-1 cell function at 
the respective anatomical sites. Therefore, this question was tackled on the basis of 
the following assumptions: If peritoneal B-1 cells and splenic B-1 cells differ in their 
origin, a different developmental program should determine their phenotype. Hence, 
peritoneal B-1 cells brought into the splenic environment should fail to express 
specific genes found in B-1 cells of splenic origin. However, genes that are 
expressed due to functional requirements or environmental influences should also 
become expressed by peritoneal derived B-1 cells when residing in the spleen. 
 
3. Results  
In order to investigate this the following experimental system was used: Peritoneal 
lavage cells obtained from L2 mice were transferred into lymphocyte deficient Rag1-/- 
mice. In these mice migration of intraperitoneally transferred B-1a cells from 
peritoneal lavages into the spleen had been shown before (Kretschmer et al., 2003b). 
Thus such transferred B-1 cells should be reisolated from spleen and peritoneum and 
the changes in expression of marker genes should be analyzed by RT-PCR and flow 
cytometry. 
Microarray data were screened for genes expressed in splenic but absent in 
peritoneal B-1a cells (Figure 3.1). Then B-1a cells from spleen and peritoneum of 
female L2 mice were sorted to high purity (>98.5%) based on the markers IgMhiCD5+ 
and submitted to RT-PCR to confirm the data obtained by expression arrays.  
All of the chosen genes displayed in Figure 3.1A showed the expected expression 
pattern by RT-PCR, i.e. being expressed in the splenic B-1a cells and showing low or 
no expression in the peritoneal B-1a cells.  
To extend this analysis and to base the experiments on more quantitative data 
splenic and peritoneal B-1a cells were sorted again to high purity. Cells from male 
and female L2 mice were pooled to increase the number of cells analyzed. 
Semiquantitative analyses performed on the sorted L2 B-1a cells of two independent 
sorts confirmed the expression pattern found for Vcam1 and Spic (Figure 3.2). 
Furthermore, mRNA for an additional gene, Adamdec1, was also found in splenic 
B-1a cells but not detected in peritoneal B-1a cells. The data for Hpgd varied 
between the two independent cell sorting experiments performed. In the first 
experiment there was also some expression detected in peritoneal B-1a cells (data 
not shown). However, no expression was detected in peritoneal B-1a cells in the 
second sorting experiment (Figure 3.2). Expression patterns for Lpl and Mrc2 differed 
from the results displayed in Figure 3.1. Message from these genes was now also 
detected in peritoneal cavity B-1a cells and expression of Lpl in splenic B-1a cells 
was low in contrast to the preceding RT-PCR experiments. Similarly, expression of 
Fpr1, an additional gene analyzed, differed from the expectations based on array 
data, since it was found in B-1a cells of the peritoneal cavity. 
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A
L2 B-1a  B-1b  
Gene Affy_id SP SD PEC SD PEC SD 
Ccr3 (CCR3) 99412_at 569 90 61 0 61 0 
Vcam1 
(VCAM-1) 92559_at 380 67 61 0 61 0 
Vcam1 
(VCAM-1) 92558_at 16760 1398 61 0 61 0 
Adamdec1 
(Decysin) 98976_at 314 84 61 0 61 0 
Spic (Spi-C) 103454_at 752 86 61 0 61 0 
Lpl 
(lipoprotein lipase 
(LPL)) 
95611_at 2104 400 69 12 482 210 
Hpgd 
(NAD+-dependent 15-
hydroxyprostaglandin 
dehydrogenase) 
93351_at 1117 93 61 0 61 0 
Mrc2 
(mannose receptor,  
C type (CD206)) 
103226_at 2326 191 67 8 463 55 
Fpr1 
(N-formyl peptide 
receptor) 
99387_at 869 125 63 4 61 0 
 
 
Figure 3.1. Differentially expressed genes among 
splenic and peritoneal B-1a cells and peritoneal 
B-1b cells from L2 mice. A) Array data of 
differentially expressed genes from spleen (SP) and 
peritoneum (PEC) as well as B-1b from peritoneum 
of L2 mice. The unique Affymetrix probe set 
identifier (Affy_id), mean average difference values 
are presented in bold letters and standard deviation 
(SD) of three replicate experiments are shown. 
Background values are represented by a mean 
average value of 61. B) Splenic B-1a (Sp B-1a) and 
peritoneal B-1a (Pec B-1a) were sorted according to 
expression of IgMhiCD5+ and analyzed by RT-PCR. 
Intron spanning primers were used to exclude 
genomic DNA. Control is water control.  
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Figure 3.2. Semiquantitative RT-PCR 
analysis of sorted B-1a cells from 
peritoneum and spleen of L2 mice.  
A) Reanalysis of cells sorted from 
respective sites of L2 mice demonstrated a 
purity of 98,1% for peritoneal IgMhiIgDloCD5+ 
cells and 98,8% for splenic IgM+CD5+ cells. 
B) Semiquantitative RT-PCR analysis on 
sorted cells from A. cDNA was diluted 
threefold for each step. Data are 
representative for one of two experiments. 
 
 
 
 
The expression of the respective genes was also tested in the B-1a cell population of 
non-transgenic mice. To this end, B-1a cells from spleen and peritoneum of female 
BALB/c mice were sorted and the same semiquantitative RT-PCR was conducted on 
the sorted samples as described in Figure 3.3. These data confirmed the expression 
data observed for L2 mice. Vcam1, Adamdec1, Spic and Hpgd were expressed in 
splenic but not in peritoneal B-1a cells. Message of Lpl, Mrc2 and Fpr1 was found in 
both peritoneal and splenic B-1a cells.  
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Figure 3.3. RT-PCR analysis of sorted 
B-1a cells from BALB/c mice. Spleen 
cells were sorted by IgM+CD5+ expression 
(purity: 98,4%), peritoneal B-1a cells were 
sorted by IgMhiIgDloCD5+ expression 
(purity: 98,6%). R4 represents gate for B-2 
cells and reanalysis in R4 indicates that no 
B-2 cells were present in peritoneal B-1a 
samples. 
 
 
 
 
 
3.1.1 Flow cytometrical analysis of VCAM-1 expression 
Since for VCAM-1 antibodies are available, its expression was investigated at the 
protein level. Flow cytometrical analyses were performed on spleen and peritoneal 
cells of L2 mice and non-transgenic littermates. VCAM-1 expression was readily 
detected on gated splenic B-1a cells (Figure 3.4). 
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Figure 3.4. Flow cytometrical analysis of VCAM-1 expression on spleen and peritoneal cells 
from L2 mice and non-transgenic littermates. The staining was performed on pooled cells with 3 
mice per group. Dot plots and histograms show cells gated by region 3 (R3). Black lines in histograms 
represent control staining and green lines staining with VCAM-1 antibody. 
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Interestingly, although no VCAM-1 expression was detected by RT-PCR, VCAM-1 
positive cells could be found by flow cytometrical analysis of peritoneal IgM+CD5+ 
cells (Figure 3.4 and Table 3.1). The staining was apparently specific since it could 
be only marginally lowered by blockage of Fc-receptors.  
 
 
Table 3.1. Analysis of VCAM-1 expression on peritoneal and splenic B-1a cells of L2 mice. 
41,84,74
spleenperitoneumMouse
31,24,43
42,1 ± 7,85,3 ± 0,8Mean
48,65,92
46,66,01
VCAM-1 expression on gated 
IgM+CD5+ cells [% of gated]1L2
1 Table shows four independent stainings of individual L2 mice. All samples were treated with mouse 
serum and Fc-block before staining. 
 
3.1.2 Intravenous transfer of peritoneal derived B-1 cells 
First, the question was addressed of whether peritoneal B-1 cells could be influenced 
to express the respective marker genes after migration to the spleen. To this end 
cells obtained from peritoneal lavage of L2 mice were intravenously (i.v.) 
administered into Rag1-/- mice. This administration route ensures that the cells enter 
the spleen as well as the peritoneum. After 2,5 weeks cells from spleen and 
peritoneum of the transferred Rag1-/- mice (L2→Rag1-/-) were sorted and analyzed by 
RT-PCR (Figure 3.5) and flow cytometry (Figure 3.6 and Figure 3.7).  
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Figure 3.5. Cell sorting and semiquantitative RT-PCR analysis of cells from Rag1-/- mice 
transferred i.v. with cells from peritoneal lavages of L2 mice. A) Results of cells sorted for 
IgM+CD5+ from peritoneum and spleen of transferred mice. Non-transferred Rag1-/- mice were 
included as staining controls. B) Semiquantitative RT-PCR analysis of sorted IgM+CD5+ cells from A. 
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Figure 3.6. Flow cytometrical analysis of VCAM-1 expression on spleen cells from Rag1-/- mice 
transferred i.v. with peritoneal cells from L2 mice. A) shows gated regions of splenic cells isolated 
from Rag1-/- recipient mice, an L2 control mouse and a non-transferred Rag1-/- control mouse. B) 
displays VCAM-1 stainings of cells from gate R7 and comparison with controls representing secondary 
reagent staining without addition of primary antibodies. Data shown in A and B represent the results 
from single mice. C) summarizes the results for VCAM-1 staining in IgM+CD5+ cells of six transferred 
individuals as well as an L2 control mouse after subtraction of background staining. 
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Figure 3.7. Flow cytometrical analysis of VCAM-1 expression on peritoneal cells from Rag1-/- 
mice transferred i.v. with peritoneal cells from L2 mice. A) shows gated regions of peritoneal cells 
isolated from Rag1-/- recipient mice, an L2 control mouse and a non-transferred Rag1-/- control mouse. 
B) displays VCAM-1 stainings of cells from gate R7 and comparison with controls representing 
stainings by secondary reagent without addition of primary antibodies. Data shown in A and B 
represent results from single mice. C) summarizes the results for VCAM-1 staining in IgM+CD5+ cells 
of five transferred individuals as well as an L2 control mouse after subtraction of background staining. 
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The spleen of transferred mice (Figure 3.6) contained IgM+CD5+ and low numbers of 
IgM+CD5- cells. CD5+IgM- cells representing T cells were also seen. In RT-PCR 
(Figure 3.5) the marker genes Vcam-1, Spic and Adamdec1 were expressed in the 
splenic CD5+IgM+ cells of the L2→Rag1-/- mice while expression in the peritoneal 
cavity was low or absent. However, Hpgd message could be seen in these cells.  
 
RT-PCR data for Vcam1 were confirmed when expression of the VCAM-1 protein 
was analyzed in flow cytometry. Protein expression was readily detectable in the 
splenic IgM+CD5+ cells of the transferred Rag1-/- mice (Figure 3.6 B and C). In 
comparison to the L2 control mice the expression level in spleen seemed even 
slightly elevated. In peritoneal cavity (Figure 3.7) similar levels of VCAM-1 protein 
expression were observed between transferred mice and control mice. Thus, 
peritoneal B-1 cells change to a splenic B-1 cell phenotype when residing in the 
spleen of the i.v. transferred Rag1-/- mice. 
3.1.3 Peritoneal transfer of B-1 cells - kinetics 
Next the question was addressed of whether peritoneal B cells also switch on the 
expression of the respective genes if administered via the peritoneal cavity, the site 
of their original location, and then enter the spleen. This should resemble more 
closely the situation found in the body when peritoneal B-1 cells migrate via the blood 
stream.  
First, the kinetic of reconstitution was studied in order to find the optimal time point 
for the analysis of IgM+CD5+ cells of the spleen. Cells from peritoneal lavages of L2 
mice were administered i.p. into Rag1-/- mice and single mice were analyzed at 
intervals for IgM+CD5+ cells in the spleen and peritoneum. 
As it can be seen in Figure 3.8, the percentage of IgM+CD5+ cells in the spleen 
increased until 3 weeks after transfer and then remained constant. Similarly, the 
percentage of IgM+CD5+ cells in the peritoneal cavity peaked 3 weeks after transfer. 
After that time point cell numbers remained constant. Since the highest number of 
IgM+CD5+ cells was found in spleen and peritoneum 3 weeks after transfer, this time 
period was chosen for subsequent transfers. 
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Figure 3.8. Kinetics of reconstitution of Rag1-/- mice intraperitoneally transferred with cells from 
peritoneal lavages of L2 mice. Dot plots are gated on lymphoid cells. Region 7 (R7) represents B-1a 
cells, percentage of IgM+CD5+ cells in R7 is given. Additional numbers represent percentage of 
lymphoid cells in the respective quadrants of the dot plot.  
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During the establishment of the kinetics VCAM-1 expression was also followed up at 
the protein level in IgM+CD5+ cells. The splenic cells were positive for VCAM-1 
surface staining at all time points investigated (Figure 3.9). This demonstrated the 
potential of these cells to upregulate VCAM-1 expression in B-1 cells that entered the 
spleen independent of the way of B-1 cell administration. 
 
 
Gate: IgM+CD5+
VCAM-1
day 7 day 15 day 23 day 29 day 32
 
Figure 3.9. VCAM-1 expression on splenic IgM+CD5+ cells from Rag1-/- mice transferred with 
peritoneal cells of L2 mice. Time points of analysis are given in each histogram. Black lines 
represent controls, blue lines represent staining with VCAM-1 antibody.  
 
To follow up whether also the other marker genes are expressed in the transferred 
B-1 cells, transfers were repeated. Peritoneal lavages from L2 mice were transferred 
i.p. into Rag1-/- mice and 3 weeks after transfer cells from spleen and peritoneum of 
these mice were isolated and pooled. Samples were then split. One fraction from 
both organs was sorted for IgM+CD5+ expression and used in RT-PCR. The other 
fraction was used for flow cytometrical analyses concerning VCAM-1 expression.  
As already indicated by the VCAM-1 staining performed during the transfer kinetic 
Vcam1 message was detected in the IgM+CD5+ spleen cells from the transferred 
mice. Also Adamdec1, Spic and Hpgd were expressed (Figure 3.10). In contrast only 
slight expression of Hpgd and Spic could be observed in the peritoneal cavity while 
message of Vcam1 and Adamdec1 was absent. 
Similarly, flow cytometrical analysis of spleen cells from mice transferred with 
peritoneal cells revealed VCAM-1 protein expression on gated splenic IgM+CD5+ 
cells (Figure 3.11). 
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Figure 3.10. Cell sorting and analysis of IgM+CD5+ cells from peritoneum and spleen of Rag1-/- 
deficient mice transferred i.p. with peritoneal cells of L2 mice. A) Sort and reanalysis of sorted 
cells. B) Semiquantitative RT-PCR with samples from A. 
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Figure 3.11. Flow cytometrical analysis of spleen cells of Rag1-/- mice intraperitoneally 
transferred with peritoneal lavages from L2 mice. A) shows gated regions of splenic cells isolated 
from a Rag1-/- recipient, an L2 control mouse and a non-transferred Rag1-/- control mouse. B) displays 
VCAM-1 stainings of cells from gate R7 and comparison with controls representing stainings with 
secondary reagent without addition of primary antibodies. Data shown in A) and B) represent results 
from single mice. C) summarizes the results for VCAM-1 staining in IgM+CD5+ cells of five transferred 
individuals as well as an L2 control mouse after subtraction of background staining. 
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Figure 3.12. Flow cytometrical analysis of peritoneal cells of individual Rag1-/- transfer mice 
transferred i.p. with peritoneal lavages from L2 mice. A) shows gated regions of peritoneal cells 
isolated from a Rag1-/- recipient, an L2 control mouse and a non-transferred Rag1-/- control mouse. B) 
displays VCAM-1 stainings of cells from gate R7 and comparison with controls representing secondary 
reagent without addition of primary antibodies. Data shown in A) and B) represent results from single 
mice. C) summarizes the results for VCAM-1 staining in IgM+CD5+ cells of four transferred individuals 
as well as an L2 control mouse after subtraction of background staining. 
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Flow cytometrical analysis of cells isolated from the peritoneal cavity of the Rag1-/- 
mice transferred with peritoneal cells from L2 mice displayed a low frequency of cells 
expressing VCAM-1 amongst the IgM+CD5+ gated cells while in RT-PCR analysis no 
expression could be observed (e.g. Figure 3.10 and Figure 3.12). This discrepancy of 
protein and mRNA expression of VCAM-1 was observed reproducibly in all transfer 
experiments. Similarly, as shown above, in L2 mice no RT-PCR product could be 
obtained from peritoneal B-1a cells while VCAM-1 expressing cells were detected in 
flow cytometry (Figure 3.4). This discrepancy was now further investigated. Since 
only low numbers of VCAM-1 protein positive cells were present in the IgM+CD5+ B 
cell population it was possible, that the RT-PCR performed was not sensitive enough 
to detect VCAM-1 message within this cell population.  
Therefore, CD19+ peritoneal B-1 cells from L2 mice were sorted for VCAM-1 protein 
expression (Figure 3.13). The reanalysis showed that the sorted sample contained 
more than 90% of cells positive for VCAM-1 surface expression. These cells were 
then subjected to RT-PCR to test for the presence of Vcam1 message. Interestingly, 
no Vcam1 specific cDNA could be observed even at high PCR cycle numbers (Figure 
3.13). This was true for two independent primer pairs used. Thus, in peritoneal B-1 
cells VCAM-1 protein expression without expression of mRNA is observed. One 
explanation could be that these cells represent a population of migratory cells which 
have down-regulated Vcam1 expression after entry of the peritoneal cavity but still 
display the protein on the surface. 
3.1.4 Transfer of VCAM-1 negative peritoneal B-1 cells 
The sorted CD19+ cells that were negative for surface VCAM-1 protein were used in 
an additional transfer experiment (for reanalysis see Figure 3.13). To exclude an 
effect due to the absence of T cells in the sorted population the transfers also 
included peritoneal lavage cells of Igα-/- mice. These mice are devoid of B cells due 
to a block of B cell development (Pelanda et al., 2002). Thus, all peritoneal cell 
populations including T cells are found in these mice except B cells. Due to the low 
numbers of sorted cells only two Rag1-/- mice could be transferred. Therefore, sorting 
cells from transferred mice to obtain samples for RT-PCR was not possible since two 
mice would not supply sufficient amounts of cells. Hence, the mice were analyzed by 
flow cytometry. 
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Figure 3.13. Analysis of Vcam1 expression in peritoneal CD19+ cells of L2 mice. A) The left dot 
plot shows peritoneal cells stained for VCAM-1 and CD19 before sorting. The two dot plots on the right 
show reanalyses of VCAM-1+CD19+ cells or VCAM-1-CD19+ cells, respectively. B) cDNA from sorted 
cell samples shown in A was prepared and normalized by semiquantitative RT-PCR according to 
expression of the housekeeping gene HPRT. C) Samples with the respective normalized highest 
amounts of cDNA were tested for Vcam1 expression by PCR using different intron-spanning primer 
pairs (VCAM 7/8 and VCAM A/B) and 38 cycles during PCR. cDNA-Templates: lane 1: 
CD19+VCAM-1+ undiluted sample; lane 2: CD19+VCAM-1+ undiluted control (without reverse 
transcriptase (RT)); lane 3: CD19+VCAM-1- undiluted sample; lane 4: CD19+VCAM-1- undiluted control 
(without RT); lane 5: B-1a cells from spleen of L2 mice (1:3 dilution); lane 6: B-1a cells from peritoneal 
cavity of L2 mice (1:3 dilution); lane 7 positive control (total spleen cells); lane 8: water control. 
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Figure 3.14. Flow cytometrical analysis of cells from peritoneum and spleen of Rag1-/- mice 
transferred with peritoneal CD19+VCAM-1- cells from L2 mice. Transfers included a cotransfer of 
cells from peritoneal lavages of Igα-/- mice to provide T cell help if necessary. Two individual mice 
were analyzed two weeks after transfer. Peritoneal and splenic cells from an L2 mouse were stained 
as control. Rag1-/- control mice showed no IgM positive cells (data not shown). Spleen sample with 
VCAM-1 staining of the second L2 →Rag1-/- mouse was not determined for technical reasons.  
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VCAM-1 expression comparable to that found in L2 control mice could be detected in 
splenic IgM+CD5+ cells of the recipient mice (Figure 3.14). This result confirmed the 
intrinsic potential of peritoneal IgM+CD5+ cells to upregulate the expression of 
VCAM-1. VCAM-1 expression was also found on the IgM+CD5+ cells in the peritoneal 
cavity of the recipient mice. This might further support the idea that these cells 
belong to a population that has gained VCAM-1 protein expression while migrating 
into different sites of the body and after reentry of the peritoneal cavity downregulate 
Vcam1 gene expression.  
3.1.5 Analysis of VCAM-1 deficient mice 
VCAM-1 is an immunoglobulin-like transmembrane adhesion molecule that effects 
lymphocyte function in many ways. Thus it plays a role in lymphocyte migration 
(Cook-Mills, 2002), in rescue of germinal center B cells or thymocytes from apoptosis 
(Lindhout et al., 1993; Koopman et al., 1994; Koopman et al., 1997; Zaitseva et al., 
1998) and might function in maturation and costimulation of T cells (Burkly et al., 
1991; Damle et al., 1992; Schlegel et al., 1995). However, VCAM-1 in these 
examples is expressed by endothelial, epithelial or follicular dendritic cells. The 
impact on lymphocytes is mediated via interaction with integrin VLA-4 (α4β1), the 
major ligand of VCAM-1, which is expressed by the lymphocytes.  
In contrast only few examples for VCAM-1 expression by lymphocytes themselves 
exist. Thus thymocytes and apoptotic T cells were shown to express VCAM-1 
(Ishiyama et al., 1998). In B cells, VCAM-1 protein expression was demonstrated on 
blood derived human peripheral B lymphocytes and in a human plasmacytoma at the 
RNA and protein level (Xia et al., 2001). However, nothing is known so far about the 
function of VCAM-1 expressed by the B cells. In the context with the finding that B-1 
cells in spleen express VCAM-1 the impact of its expression on B cells was further 
investigated in this work. 
For this purpose a mouse model that was supposed to delete VCAM-1 specifically in 
B cells was studied. Mice with loxP-flanked (floxed) conditional Vcam1 null alleles 
were crossed with mice expressing the Cre protein under the control of the B cell 
specific CD19 promoter. Homozygous mice for the floxed Vcam1 alleles and 
heterozygous for CD19cre were termed flox/flox; cre/+. Non-transgenic littermates 
with respect to Cre-expression were termed flox/flox; +/+.  
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First, the deletion of Vcam1 alleles in B cells of flox/flox; cre/+ mice was tested. To 
this end CD19+ B cells were sorted from spleen and peritoneum of these mice and 
analyzed by Southern blot. Additionally, CD3+ T cells were isolated from the same 
samples by cell sorting and included as negative controls (Figure 3.15). Most of the 
CD19+ B cells showed a deletion of the functional alleles whereas CD3+ T cells kept 
the floxed alleles in an undeleted state. However, faint bands for the non-deleted 
alleles were detected in the CD19+ fraction of the Southern blot.  
 
Next, flow cytometrical analyses of B cell compartments from flox/flox; +/+ control 
mice and flox/flox; cre/+ mice was carried out on pooled cell populations (Figure 
3.16). A twofold reduction of IgMhiIgDlo B-1 cell numbers (Figure 3.16 A, R2) and a 
fourfold reduction of B-1a cell numbers could be observed (Figure 3.16 A, R3) in the 
peritoneal cavity of flox/flox; cre/+ compared to flox/flox; +/+ mice. The proportion of 
the IgD+IgMlo B-2 cells in the peritoneum, however, was nearly the same (Figure 3.16 
A, R1). In the spleen, the follicular B cell compartment was similar in flox/flox; +/+ and 
flox/flox; cre/+ mice and similar proportions of marginal zone B cells were detected 
(Figure 3.16 B; R4 and R5). Furthermore, no differences between IgM+CD5+ cells in 
the spleens of both strains could be observed (Figure 3.16 B, R3). 
 
To assess the significance of these data the stainings were repeated with individual 
mice (see Figure 3.17 and Figure 3.18). Control mice bearing wildtype alleles for 
Vcam1 and the CD19 Cre transgene (+/+; cre/+) were included since Sato and 
colleagues had demonstrated that the development of B-1 cells in CD19 deficient 
mice is severely decreased (Sato et al., 1996b). Thus, the observed reduction of B-1 
cells could be due to the CD19 deficiency in one allele of the flox/flox; cre/+ mice. 
However, since only a few of these mice were obtained from the breedings, analysis 
of only three +/+;cre/+ mice could be performed within the given time frame (see 
Figure 3.17 and Figure 3.18). The reduction of peritoneal B-1 and B-1a cells could be 
observed in all flox/flox; cre/+ mice (Figure 3.17 tables B, C). However, this reduction 
was also observed in the +/+;cre/+ control mice. Thus, the reduction is most likely 
due to the lower level of CD19 expression and not due to the lack of VCAM-1 
expression.  
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Figure 3.15. Isolation of CD3+ T cells and CD19+ B cells from flox/flox; cre/+ mice and Southern 
blot on sorted samples. Three mice were analyzed individually. A) Reanalyses of sorted splenic B 
and T cells from mouse #2 and from CD19+ sorted pooled peritoneal cells from mice #1-3 (dot plot on 
the right). B) Summary for all sorted samples. C) Southern blot of sorted samples. DNA isolated from 
the respective samples was digested with BamHI and hybridized with a radiolabeled Vcam1 specific 
probe. It consists of a mixture of two BglII/ SpeI restriction fragments. Floxed alleles yield two 
restriction fragments at 6 kb and 3 kb, deleted alleles yield a 4,5 kb restriction fragment. D) Schematic 
map of the 5’ part of the targeted Vcam1 locus (according to Terry et al., 1997) . LoxP sites are 
displayed as blue ovals, promoter is shown as orange box, exons are indicated by gray boxes and 
roman numbers. Green boxes indicate hybridization sites for the Vcam1 specific probe.  
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Figure 3.16. Flow cytometrical analysis of B cell subsets in flox/flox; +/+ and flox/flox; cre/+ 
mice. A) Peritoneal staining. R1: IgD+IgM+ B-2 cells; R2: IgDlo/negIgMhi B-1 cells; R3: B-1a cells. B) 
Splenic staining. R3: B-1a; R4: follicular B-2; R5: marginal zone B cells. Stainings represent pooled 
populations from 3 mice. 
 
 
 
B-2 cell numbers in the peritoneal cavity were comparable between flox/flox; +/+ and 
flox/flox; cre/+ mice (Figure 3.17). Similarly, in the spleen of these mice no significant 
differences could be detected in the B cell compartments between the different 
mouse types (Figure 3.18). To extend these studies, also VCAM-1 expression on B 
cells was tested in these mice. Surprisingly, no difference in VCAM-1 expression on 
cells from flox/flox; +/+ and flox/flox; cre/+ mice gated for IgM+ could be observed 
(Figure 3.19) in independent experiments. 
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Figure 3.17. Flow cytometrical analysis of peritoneal cells isolated from individual flox/flox; 
cre/+ mice and littermate control mice. Mean values and standard deviations of the mean from 
each set are given at the bottom of each table. Results are derived from two independent 
experiments. Mice 1-3 experiment 1; mice 4-6 experiment 2. 
 
To confirm these results, splenic cells from individual flox/flox; +/+ and flox/flox; cre/+ 
mice were sorted and analyzed by RT-PCR for Vcam1 mRNA (Figure 3.20). For this 
purpose, a forward primer binding in exon 1 and a reverse primer binding in exon 3 of 
the Vcam1 gene were used. Thus, the forward primer lies within the deletable region 
of the floxed Vcam1 alleles (for overview see schematic map Figure 3.15). 
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Figure 3.18. Flow cytometrical analysis of spleen cells isolated from individual flox/flox; cre/+ 
mice and littermate control mice. Mean values and standard deviations of the mean from each set 
are given below the results for individual mice. Results were derived from two independent 
experiments. Mice 1-3 experiment 1; mice 4-6 experiment 2. 
 
 
Vcam1 expression was detectable in both samples. Thus, both mouse types contain 
cells in which the floxed part of the Vcam1 gene was not deleted by CD19 controlled 
Cre. This might explain the lack of a phenotype in the flox/flox; cre/+ mice. 
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Figure 3.19. Dot plots showing VCAM-1 expression on IgM+ gated spleen cells of flox/flox; +/+ 
and flox/flox; cre/+ mice. Dot plots are representative for a VCAM-1 staining of two individual mice 
(total mice analyzed: n=3 per group). Numbers indicate percentage of VCAM-1+ B cells in comparison 
to non-stained controls. On average VCAM-1 was expressed in 14,2% ± 0,8 of splenic IgM+ cells in 
the tested flox/flox; +/+ mice and 15,1% ± 2,5 in flox/flox; cre/+ mice.  
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Figure 3.20. Sort and analysis of spleen cells from flox/flox; +/+ and flox/flox; cre/+ mice. A) 
Reanalysis of CD19+IgM+ sorted samples from spleen of indicated mice from VCAM-1flox/flox/CD19cre 
breedings. B) Semiquantitative RT-PCR on sorted samples from A. The used forward primer (C) for 
Vcam1 PCR binds in exon 1, the reverse primer (D) in exon 3. Samples were normalized upon 
expression of the housekeeping gene Hprt. 
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3.2 Group 2 genes 
The data obtained from the expression arrays were also used in order to find 
molecules specifically expressed in B-1 cells. Candidate genes that were expressed 
in B-1 cell populations in spleen as well as peritoneum but absent in B-2 cells were 
determined and classified into group 2 by these criteria. The expression array data 
were screened strictly for this purpose: First, only genes expressed in B-1 cells of 
both L2 and BALB/c mice were accepted and second, the mean average difference 
values for gene expression in B-2 cells had to be at background level, i.e. at 61, 
indicating the absence of respective gene expression in these cells. 
Four candidate genes were obtained by this stringent selection (Table 3.2) and first 
investigated by RT-PCR in order to confirm the array data.  
 
Table 3.2. Group 2 genes representing candidate genes for B-1 cell specific markers. 
L2 BALB/c 
 
Peritoneum Spleen Peritoneum Spleen 
Gene (Protein) Affy id B-1a SD2 B-1b SD B-1a SD B-1a SD B-1a SD B-2 SD
F11r 
(Junction cell 
adhesion 
molecule 1, 
JAM1) 
 
103816_at 8081 38 1089 107 584 153 1283 291 439 216 61 1 
Adml 
(ADM, 
Adrenomedullin) 
 
102798_at 683 49 491 80 1327 470 986 229 1267 332 61 0 
Api6 
(Apoptosis 
inhibitory 6) 
93445_at 133 31 274 175 733 89 393 109 1024 829 61 1 
Wee1 
(Wee-1 like 
protein kinase) 
101458_at 505 55 266 60 361 79 184 87 503 155 61 1 
1 Number indicates the mean average difference value. 
2 SD = standard deviation of mean average difference value of three replicate experiments. 
 
 
By this analysis only two genes still fulfilled the above criteria (F11r and Adml) while 
Wee1 and Api6 no longer could be classified into group 2 (Figure 3.21 and Figure 
3.22). Wee1, the Affymetrix gene designation for a wee-1 like kinase, showed weak 
expression in peritoneal and splenic B-1a cells of L2 mice (Figure 3.21). However, 
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when B cells from normal BALB/c mice were tested expression was found in 
peritoneal and splenic B-1a cells but at an equal level also in B-2 cells (Figure 3.21). 
Api6, expressing a protein termed CD5 antigen-like precursor, SP-alpha or CT-2, 
was strongly expressed in splenic B-1a cells and weakly in peritoneal B-1a cells from 
L2 mice. In BALB/c mice Api6 was expressed at similar levels in peritoneal and 
splenic B-1a cells as well as in B-2 cells (Figure 3.21).  
 
Adml and F11r fulfilled the criteria for group 2 in RT-PCR analysis. Both genes were 
strongly expressed in peritoneal and splenic B-1a cells from L2 and normal mice 
(Figure 3.22). A weak signal could be detected in the normalized cDNA from splenic 
B-2 cells. However, this was attributed to the extreme sensitivity of the RT-PCR. 
These data were tried to verify by flow cytometry. Unfortunately, in preliminary 
experiments using the commercially available antibody against Adrenomedullin no 
signal could be obtained in intracellular stainings of B-1 cells. 
 
 
Wee1
1 2 3 4
Hprt
B-1a B-2B-1a
Spleen Peritoneum Spleen control
BALB/cWee1
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HPRT
1:3 1:3 1:3
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4 negative control
 
Figure 3.21. RT-PCR for Wee1 and Api6 on B-1a cells from L2 and BALB/c mice. B-1a cells from 
peritoneum and spleen have been sorted IgM+CD5+ and B-2 cells from spleen have been sorted 
IgMloCD5neg. 
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On the other hand, JAM-1, encoded by the F11r gene, could be clearly detected on 
peritoneal B-1a cells from L2 as well as BALB/c mice (Figure 3.23, R1). In addition, 
peritoneal B-1b cells could be stained for JAM-1 in L2 mice (Figure 3.23). All other 
peritoneal populations were negative for JAM-1 expression.  
The splenic IgM+CD5+ B-1a population of L2 mice was also positive for JAM-1 
staining (Figure 3.24) as well as IgM+CD5+ B-1a cells in the spleen of BALB/c mice. 
However, the JAM-1 staining in the splenic B-1a cells of BALB/c mice was apparently 
weak. Although a slight shift between control cells and cells stained for JAM-1 could 
be seen it is not as pronounced as in splenic B-1a cells of L2 mice.  
Taken together these results show, that JAM-1 protein expression in the peritoneal 
cavity is detected on B-1 cells of L2 and normal mice. Thus, at this site it can be used 
as a B-1 cell specific marker for such cells. In the spleen of L2 mice JAM-1 can also 
be used as a marker for the IgM+CD5+ B-1a cells. 
 
peritoneumspleen control
B-1a B-2
spleen
Hprt
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F11r
1:3
peritoneumspleen control
B-1a B-2
spleen
BALB/c
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1:3 1:3
L2
1:31:3 1:3
 
Figure 3.22. Semiquantitative RT-PCR for F11r and Adml on sorted cell populations from L2 
and BALB/c mice. B-1a cells from peritoneum and spleen have been sorted as IgM+CD5+ and B-2 
cells from spleen as IgMloCD5neg. 
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Figure 3.23. Flow cytometrical analysis of peritoneal cells for expression of JAM-1. Histogram 
overlays show JAM-1 expression in the following regions: L2 mice: R1: B-1a cells; R2: B-1b cells; R3: 
double negative cells; R4: T cells. BALB/c: R1: B-1a cells; R2: IgMhiCD5neg containing B-1b cells; R3: 
IgMloCD5- containing B-2 cells; R4 double negative cells, R5: T cells. Black lines indicate control 
staining, colored lines represent JAM-1 staining.  
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Figure 3.24. Flow cytometrical analysis for JAM-1 expression on spleen cells from L2 and 
BALB/c mice. Histogram overlays show JAM-1 expression in the following regions: L2 mice: R1: B-1a 
cells; R2: CD5-IgM+ cells containing also marginal zone B cells; R3: double negative cells; R4: T cells. 
BALB/c: R1: B-1a cells; R2: CD5-IgM+ cells containing also marginal zone B cells, R3: IgMloCD5- 
containing B-2 cells in BALB/c mice; R4 double negative cells; R5: T cells. Black lines indicate control 
staining, colored lines represent JAM-1 staining. 
84 
3. Results  
3.3 Generation of an anti-idiotype antibody 
One of the particular features of L2 mice is that within the population of peritoneal 
B-1 cells three dominating specificities are found. This was observed by the repetitive 
finding of heavy chains with identical amino acid sequences even in different 
individual mice. Such sequences can also be taken as molecular markers for B-1 
cells since so far they were not encountered in B-2 cells. Antibodies that would 
discern such sequences so called anti-idiotypes would represent extremely valuable 
tools to identify and further characterize such cells in the B-1 cell pool and their 
physiology. 
3.3.1 Hybridoma generation 
To be able to generate an anti-idiotype antibody against one of the dominant BCR-
specificities, first idiotype bearing antibodies had to be established. Thus, peritoneal 
and splenic B-1a cells were sorted, stimulated in vitro with LPS and hybridomas were 
generated by fusion of these cells with the myeloma P3X63Ag8.653. 
From the peritoneum 54 hybridomas (designated L2P) and from spleen 21 
hybridomas (designated L2M) were obtained and subcloned. cDNA of the heavy 
chain V regions from these hybridomas was isolated and sequenced to screen for the 
dominant sequences. Sequences from 27 peritoneum derived and 7 spleen derived 
hybridomas were obtained (Figure 3.25 and Figure 3.26). The remaining hybridomas 
either showed no message for IgM in the RT-PCR or ambiguous sequence data were 
encountered that indicated that more than one hybridoma was present within the 
sample.  
The hybridomas L2P3 and L2M6 displayed VH sequences that belonged to the most 
dominating specificity identified before (Figure 3.27). This IgM heavy chain was found 
in high abundance among the B-1 cells of L2 mice, i.e. 15% of peritoneal, 10% of 
splenic and 5% of blood B-1a cells as determined by single cell analysis (Kretschmer 
et al., 2003b). Similar to these studies, different CDR3 region sequences on the 
nucleotide level were detected in L2P3 and L2M6 (Table 3.3). However, both 
sequences encoded the same protein. The V region of these antibodies is assembled 
by gene segments belonging to the VH Q52, DFL16.2 and JH4 families and is shown 
in Figure 3.27. 
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 CDR3 V D J -J V-D
 
gca aga tat gat tcc tgg gct tac     7183 SP2   L2P1 ala arg tyr asp ser trp ala tyr         
 
gcc aaa tac tac tac tac gct atg tac    Q52 FL16.2   L2P3 ala lys tyr tyr tyr tyr ala met tyr        
 
aca aga gag ggg ggt aac cgg ttt tac    J558 SP2 -1 N L2P4 thr arg glu gly gly asn arg phe tyr        
 
gcc aga ggt agt tac tct tac tat atg gac   Q52 FL16.1  N L2P7 
D-J
 
tgt cac ggt ttt    3 N 
cys his gly phe      
 
tgt aat ggc tat gac   4  
cys asn gly tyr asp     
 
tgt aga tat cct gct   3 N,P 
cys arg tyr pro ala     
 
tgt agg agc tat gct tac  4 N 
cys ala arg arg gly ser ser tyr ser tyr tyr tyr ala met asp tyr          
  
tgt acc agg cat tac tac ggc ttt gac tac          J606 FL16.2 2 -2 P  L2P13 cys thr arg his tyr tyr gly phe asp tyr                
  
tgt gcc aga aat tcc ggg att cat tac tac ggc tac gac tac ttt gac tac   Q52 FL16.2 2  N,P N,P L2P16 cys ala arg asn ser gly ile his tyr tyr gly tyr asp tyr phe asp tyr         
  
tgt gcc aga ggg ggg tgg cca acc ccg cgg gag gct atg gac tac     Q52 n.d. 4 -6 n.d. n.d.L2P17 cys ala arg gly gly trp pro thr pro arg glu ala met asp tyr           
  
tgt gca aga tcg gta gta gtt gac tac           J558 FL16.1 2 -4   L2P18 cys ala arg ser val val val asp tyr                 
  
tgt gcc aaa aat tgg ggg gat tac gac tgt gct atg gac tac      Q52 SP2.2 4 -5 P,N N L2P19 cys ala lys asn trp gly asp tyr asp cys ala met asp tyr            
  
tgt gcc aga ctc tac tat agg tac gac ggg tac tat gct atg gac tac    Q52 SP2.10 4  N P,N L2P20 cys ala arg leu tyr tyr arg tyr asp gly tyr tyr ala met asp tyr          
  
tgt gcc aga gtc tac tat agg tac gac gga tac tat gct atg gac tac    Q52 SP2.10 4   N,P L2P22 cys ala arg val tyr tyr arg tyr asp gly tyr tyr ala met asp tyr          
  
tgt gca aga tcg ggt att act acg gta gta gct caa tat tac tat gct atg gac tac 7183 FL16.1 4  N,P N L2P23 cys ala arg ser gly ile thr thr val val ala gln tyr tyr tyr ala met asp tyr       
  
tgt gca aga cac gat gga aac tgg gac tac ttt gac tac       J558 DQ52 2  N,P  L2P25 cys ala arg his asp gly asn trp asp tyr phe asp tyr             
  
tgt gca aga gac tac ggt agt agc tac tat gct atg gac tac      J558 FL16.1 4    L2P28 cys ala arg asp tyr gly ser ser tyr tyr ala met asp tyr            
  
tgt gca aga cac gaa gct aac tgg gac tac ttt gac tac       VNP Q52 2    L2P29 cys ala arg his glu ala asn trp asp tyr phe asp tyr             
  
tgt gca aga ttt act acg gta gta gct gac tac         J558 FL16.1 2 -5   L2P30 cys ala arg phe thr thr val val ala asp tyr               
  
tgt gcg aga gac ttc gat gtc             GAM3-8 n.d. 1 -7 n.d. n.d.L2P31 cys ala arg asp phe asp val                   
  
tgt aca aga ttc tac tac ggt agt agc tac tac ttt gac tac      J558 FL16.1 2  N  L2P33 cys thr arg phe tyr tyr gly ser ser tyr tyr phe asp tyr            
  
tgt gcc aga aag cat ggt aac tac gtt gac          Q52 SP2 2 -4 P P L2P34 cys ala arg lys his gly asn tyr val asp                
  
tgt gca aga act ggg acg ttt gac tac           J558 Q52 2 -3  P L2P36 cys ala arg thr gly thr phe asp tyr                 
  
tgt gca aga gct gac gtt tat gct atg gac tac         GAM3-8 n.d. 4 -3 n.d. n.d.L2P37 cys ala arg ala asp val tyr ala met asp tyr               
  
tgt gcc aaa aac ccc ctc att act acg gca cgg ggg tac tat gct atg gac tac  Q52 FL16.2 4  N N L2P38 cys ala lys asn pro leu ile thr thr ala arg gly tyr tyr ala met asp tyr        
  
tgt gcc aga ctc tac tat agg tac gac ggg tac tat gct atg gac tac    Q52 SP2.10 4  N N,P L2P40 cys ala arg leu tyr tyr arg tyr asp gly tyr tyr ala met asp tyr          
  
tgt gcc aga gat aga ggt tac tac ggt agt agc tat tac gct atg gac tac   Q52 FL16.1 4  N P L2P41 cys ala arg asp arg gly tyr tyr gly ser ser tyr tyr ala met asp tyr         
  
tgt gca agc ttc tat ggt tac tat gct atg gac tac        J558 SP2 4  P,N N L2P42 cys ala ser phe tyr gly tyr tyr ala met asp tyr              
  
tgt gcc aga gat acc tac tat agg tcc ttt gac tac        Q52 SP2 2 -2 N N L2P43 cys ala arg asp thr tyr tyr arg ser phe asp tyr              
  
tgt gca agc cgg gac ggc ttt gct tac           J558 FL16.2 3 -3 P,N  L2P46 cys ala ser arg asp gly phe ala tyr                 
  
Figure 3.25. CDR3 sequences from hybridomas generated from peritoneal B-1a cells of L2 
mice. The CDR3 nucleotide and amino acid sequence is displayed starting with Cys in position 92 of 
the VH 3’ region and including the D gene segment and the JH 5’ region up to position 102. The VH 
gene family, the D segment and the JH segment are indicated (VDJ). In some cases no D segment 
could be determined (n.d.). Numbers in the (-J) column indicate the number of nucleotides that have 
been removed from J sequence due to nibbling. P and N indicate the presence of P-nucleotides and 
N-nucleotides in the V-D and D-J junctions of the respective sequences.  
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 CDR3 V D J -J V-D D-J
  
tgt gcc aaa aat tac tac ggc tat tac tat gct atg gac tac      Q52 FL16.2 4   P L2M6 cys ala lys asn tyr tyr gly tyr tyr tyr ala met asp tyr            
  
tgt gcc aga aat ggg agg act acg gcg tac tat gct atg gac tac     Q52 FL16.2 4  N P L2M8 cys ala arg asn gly arg thr thr ala tyr tyr ala met asp tyr           
  
tgt gca aga cac gaa gta ggc cgg ctc ctc att act acg gcc ccg ttt gct tac  J558 FL16.2 3 -3 N N L2M12 cys ala arg his glu val gly arg leu leu ile thr thr ala pro phe ala tyr        
  
tgt gca aga tac tac ggc gac tac ttt gac tac         J558 FL16.2 2  P P,NL2M14 cys ala arg tyr tyr gly asp tyr phe asp tyr               
  
tgt gcc aga ctc tac tat agg tac gac ggg tac tat gct atg gac tac    Q52 SP2.10 4  N P,NL2M15 cys ala arg leu tyr tyr arg tyr asp gly tyr tyr ala met asp tyr          
  
tgt gtg agc tac tat gat tac gcc tgg ttt gct tta        DNA4 SP2.2 3   P L2M16 cys val ser tyr tyr asp tyr ala trp phe ala tyr              
  
tgt gca aga gag gat ttt act acg gct acg gac tac        J558 FL16.2 2 -6 N P L2M17 cys ala arg glu asp phe thr thr ala thr asp tyr              
  
Figure 3.26. CDR3 sequences of hybridomas from splenic B-1a cells of L2 mice. For further 
explanations see Figure 3.25. 
 
 
 
A second sequence was obtained twice, once from a peritoneal hybridoma (L2P40) 
and second from a splenic hybridoma (L2M15) (Figure 3.28). Both sequences were 
identical on nucleotide and protein level. This sequence had also been found before 
and made up 5% of the sequences found in the blood of L2 mice (Kretschmer et al., 
2003b). It was not found in spleen or peritoneum before. The V region of this 
antibody consists of rearranged family members of VH Q52, DSP and JH4 gene 
segments. 
 
 
 
 
 
Table 3.3. Comparison of CDR3 regions of L2P3 and L2M6. Differences in nucleotide sequence 
are highlighted in green. 
 CDR3 
L2P3 tgt gcc aaa aat tac tac ggc tac tac tat gct atg gac tac
L2M6 tgt gcc aaa aat tac tac ggc tat tac tat gct atg gac tac
Protein cys ala lys asn tyr tyr gly tyr tyr tyr ala met asp tyr
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L2P3 
#1    NNNGTGCAGCTGCAGGAGTCTGGACCTGGCCTAGTGCAGCCCTCACAGAGCCTGTCCATA 
      X ValGlnLeuGlnGluSerGlyProGlyLeuValGlnProSerGlnSerLeuSerIle 
     1  FR-1                                                   20 
#61   ACCTGCACAGTCTCTGGTTTCTCATTAACTAGCTATGGTGTACACTGGGTTCGCCAGTCT 
     ThrCysThrValSerGlyPheSerLeuThrSerTyrGlyValHisTrpValArgGlnSer 
     21                             31 CDR1       36  FR-2     40 
#121  CCAGGAAAGGGTCTGGAGTGGCTGGGAGTGATATGGAGAGGTGGAAGCACAGACTACAAT 
     ProGlyLysGlyLeuGluTrpLeuGlyValIleTrpArgGlyGlySerThrAspTyrAsn 
     41                         50 CDR2                        60 
#181  GCAGCTTTCATGTCCAGACTGAGCATCACCAAGGACAACTCCAAGAGCCAAGTTTTCTTT 
     AlaAlaPheMETSerArgLeuSerIleThrLysAspAsnSerLysSerGlnValPhePhe 
     61             66 FR-3                                    80 
#241  AAAATGAACAGTCTGCAAGCTGATGACACTGCCATATACTACTGTGCCAAAAATTACTAC 
     LysMETAsnSerLeuGlnAlaAspAspThrAlaIleTyrTyrCysAlaLysAsnTyrTyr 
     81    82A      83                         92 CDR3            
#301  GGCTACTACTATGCTATGGACTACTGGGGTCAAGGAACCTCAGTCACCGTCTCCTCA 
     GlyTyrTyrTyrAlaMetAspTyrTrpGlyGlnGlyThrSerValThrValSerSer 
     98                      103 FR-4                      113 
D-segment    JH-segment 
Complementarity determining regions (CDR) 
Framework regions(FR) 
 
Figure 3.27. V-region sequence of L2P3. The nucleotide and amino acid (aa) sequences are shown. 
N indicates nucleotides that could not be determined due to ambiguities in sequence data. The 
resulting gaps on aa level are indicated by an X. CDR1 and CDR2 as well as the frame work regions 
were determined according to Kabat et al. (Kabat et al., 1987) and are highlighted as explained in the 
legend. The CDR3 region is displayed as the region including the conserved cysteine residue in 
position 92 of the VH and the tyrosine in position 102 of the JH. Thus, in contrast to the commonly used 
CDR3 definition three additional aa of the VH are included according to the definition used in preceding 
work (Kretschmer et al., 2002; Kretschmer et al., 2003b). 
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L2M15 
#1     NNNNNNCAGCTGCAGGAGTCTGGACCTGGCCTAGTGCAGCCCTCACAGAGCCTGTCCATC 
        X  X GlnLeuGlnGluSerGlyProGlyLeuValGlnProSerGlnSerLeuSerIle 
        1         FR-1                                           20 
 
#61    ACCTGCACAGTCTCTGGTTTCTCATTAACTAGCTATGGTGTACACTGGGTTCGCCAGTCT 
       ThrCysThrValSerGlyPheSerLeuThrSerTyrGlyValHisTrpValArgGlnSer 
       21                            31 CDR1        36 FR-2      40 
 
#121   CCAGGAAAGGGTCTGGAGTGGCTGGGAGTGATATGGAGTGGTGGAAGCACAGACTATAAT 
       ProGlyLysGlyLeuGluTrpLeuGlyValIleTrpSerGlyGlySerThrAspTyrAsn 
       41                         50        CDR2                 60 
 
#181   GCAGCTTTCATATCCAGACTGAGCATCAGCAAGGACAATTCCAAGAGCCAAGTTTTCTTT 
       AlaAlaPheIleSerArgLeuSerIleSerLysAspAsnSerLysSerGlnValPhePhe 
       61             66 FR-3                                    80 
 
#241   AAAATGAACAGTCTGCAAGCTAATGACACAGCCATATATTACTGTGCCAGACTCTACTAT 
       LysMETAsnSerLeuGlnAlaAsnAspThrAlaIleTyrTyrCysAlaArgLeuTyrTyr 
       81    82A      83                         92 CDR3         97 
 
#301   AGGTACGACGGGTACTATGCTATGGACTACTGGGGTCAAGGAACCTCAGTCACCGTCTCCTCA 
       ArgTyrAspGlyTyrTyrAlaMETAspTyrTrpGlyGlnGlyThrSerValThrValSerSer 
       98    100            100E       103 FR-4                       113 
 
D-segment   JH-segment 
Complementarity determining regions (CDR) 
Framework regions(FR) 
N-Nucleotide   P-Nucleotide 
 
Figure 3.28. V-region sequence of L2M15. The sequence is identical with the sequence obtained 
from L2P40. For further explanations see Figure 3.27. 
The antibodies of L2P3 and L2M15 as well as antibodies secreted by the 
plasmacytoma MOPC104E (IgM/λ1) were purified from cell culture supernatants by 
ammonium sulfate precipitation and affinity chromatography using immobilized 
mannan binding protein (ImmunoPure). L2P3 was then used as an antigen to 
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immunize rats and to generate hybridomas by fusion of spleen cells with 
P3X63Ag8.653 cells. This work was done in cooperation with the lab of Dr. Elisabeth 
Kremmer at the GSF in Munich. Supernatants of the rat hybridomas were screened 
in ELISA for binding to purified antibodies of L2P3, MOPC104E (IgM/λ) as well as an 
IgM/κ antibody. Thus, one could exclude clones producing antibodies against the IgM 
heavy chain, κ or λ light chains. As the antibody from the hybridoma L2M15 (IgM/λ) 
is very similar to L2P3 (Figure 3.29) including usage of VHQ52 and JH4 gene 
segments it was included in the ELISA screenings as control for the anti-idiotypic 
reactivity.  
One clone was identified that produced antibodies that bound only the L2P3 antibody 
when tested in ELISA. This idiotype specific antibody was named 8H10 according to 
the clone number. Supernatants of this clone were used for further analyses. 
 
          1                                                         20 
L2P3      XXXValGlnLeuGlnGluSerGlyProGlyLeuValGlnProSerGlnSerLeuSerIle 
L2M15     XXXXXX -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  
                                                                     
 
          21                                                        40 
L2P3      ThrCysThrValSerGlyPheSerLeuThrSerTyrGlyValHisTrpValArgGlnSer 
L2M15      -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  
 
          41                                                        60 
L2P3      ProGlyLysGlyLeuGluTrpLeuGlyValIleTrpArgGlyGlySerThrAspTyrAsn 
L2M15      -  -  -  -  -  -  -  -  -  -  - Ser -  -  -  -  -  -  -  -  
 
          61                                                        80 
L2P3      AlaAlaPheMETSerArgLeuSerIleThrLysAspAsnSerLysSerGlnValPhePhe 
L2M15      -  -  - Ile -  -  -  -  - Ser -  -  -  -  -  -  -  -  -  -  
 
          81    82A   82C                                           97 
L2P3      LysMETAsnSerLeuGlnAlaAspAspThrAlaIleTyrTyrCysAlaLysAsnTyrTyr 
L2M15      -  -  -  -  -  -  - Asn -  -  -  -  -  -  -  - ArgLeu -  -  
 
          98                                                           
L2P3      GlyTyr ·  · TyrTyrAlaMETAspTyrTrpGlyGlnGlyThrSerValThrValSer 
L2M15     Arg - AspGly -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  
 
          113 
L2P3      Ser 
L2M15      -  
 
Figure 3.29. Comparison of L2P3 and L2M15 protein sequence. Dashes indicate matching amino 
acids, dots indicate gaps necessary for alignment. Triple X indicates amino acids that could not be 
determined due to ambiguities in the nucleotide sequence.  
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Flow cytometrical analyses were performed using the supernatants from the rat 
hybridoma 8H10. First, peritoneal B-1 cells from L2 mice were tested for binding to 
the anti-idiotype antibody (data not shown). As secondary reagent a fluorochrome 
coupled F(ab’)2 fragment of a mouse anti-rat IgG (H+L) was used which produces 
some staining background. Staining of peritoneal cells of L2 mice could indeed be 
observed. Peritoneal cells from L2 mice were then used to optimize the 8H10 
staining for flow cytometry (data not shown).  
 
 
control 8H10
IgM
7,51,0
A
IgM
8H10
L2 controlBALB/c
B
L2
 
Figure 3.30. 8H10 staining on peritoneal cavity cells. A) Staining of pooled peritoneal cavity cells 
from L2 mice. Background by secondary staining reagent is indicated in the left dot plot. Subtraction of 
background staining of 8H10 stained cells reveals a 6,5% population of 8H10+ cells. Pooled cells were 
obtained from 2 male and 1 female L2 mice. B) Staining of peritoneal cells from female BALB/c mice. 
Dotplot from one BALB/c mouse is representative for three individual mice tested. Peritoneal cavity 
cells of one L2 mouse were included as positive control. 
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Initial stainings using the detection system described above showed a 6,5% 
population (background subtracted) of 8H10+IgM+ double positive cells on pooled 
peritoneal cavity cells from L2 mice (Figure 3.30A). This is consistent with an anti-
idiotype that recognizes a major specificity in transgenic L2 mice. However, 
peritoneal cells from BALB/c mice were not positive for 8H10 stainings (Figure 
3.30B). Therefore, further analyses were focused on L2 mice. 
3.3.2 Analysis of 8H10 specificity and flow cytometrical analysis 
Next, the specificity of the 8H10 antibody was analyzed. Therefore, 8H10+IgM+ 
double positive peritoneal cells of L2 mice were sorted. cDNA of IgM heavy chains 
was prepared and amplified by PCR with primers specific for the V region. Then the 
PCR products were subcloned and individual V-region sequences determined. It was 
not possible to reveal the complete V-region with the obtained sequence data. 
However, CDR3 sequences of all clones could be analyzed. 23 of 34 sequences 
showed the same CDR3 region as L2P3 (Figure 3.31). 19 of these were completely 
identical with L2P3 as far as the sequences could be compared. The remaining four 
sequences showed single nucleotide exchanges, that lead to an exchange of amino 
acids. These single changes could be indicative for somatic hypermutation but could 
also be due to errors of the Taq-polymerase used for RT-PCR. However, their CDR3 
region matched with the L2P3 CDR3. Four sequences of the 34 analyzed sequences 
differed in their CDR3 regions from that of L2P3 (Figure 3.31 B and C, #37, 40, 44, 
45). Of the seven remaining sequences analyzed none encoded a functional heavy 
chain. Most likely these sequences are derived from rearrangements that did not 
yield a correct reading frame. Therefore, these sequences are not translated into 
protein. Thus, of 34 sequences analyzed only 27 encode a functional BCR. Of these, 
23 were identical with L2P3 representing 85% of the functional sequences.  
The analysis of idiotype bearing cells from L2 mice was extended to single L2 mice. 
On average 6% of IgM+ cells were detected by the 8H10+ antibody in the peritoneal 
cavities in male L2 mice (Figure 3.32) which confirmed the data obtained by analysis 
of pooled cells before. However, this result differed from the original expectations 
since 15% the L2P3 idiotype were predicted for the peritoneal cavity using single cell 
RT-PCR and results obtained from analyses of hybridoma sequences (Kretschmer et 
al., 2002; Kretschmer et al., 2003b).  
92 
3. Results  
A B
8H10
IgM
98,4 %
C
 CDR3 V J D 
  
tgt gcc aaa aat tac tac ggc tac tac tat gct atg gac tac      Q52 FL16.2 4L2P3 cys ala lys asn tyr tyr gly tyr tyr tyr ala met asp tyr         
  
tgt gcc aga aat ttc cca ccg cat tac tat gct atg gac tac      Q52 FL16.2 437 - - arg - phe pro pro his - - - - - -         
  
tgt gcc aga aat cgt ccc tta tat tac tat gct atg gac tac      Q52 FL16.1 440 - - arg - arg pro leu tyr - - - - - -         
  
tgt gca aga cat gaa ctt gac tac            7183 n.d. 244 - - arg his glu leu asp tyr               
  
tgt gcc aga gat tat agg   tac tat gct atg gac tac      Q52 SP2.10 445 - - arg asp - arg   - - - - - -         
  
 
Designation 
Sequence 
readable from 
amino acid 
position 
Comparison with 
L2P3 protein 
sequence  
13 27 nf 
14 25 - 
15 30 nf 
16 32 - 
17 44 nf 
18 25 - 
19 33 - 
20 43 - 
21 25 - 
22 28 - 
23 26 - 
24 23 - 
25 19 Ser 19→ Cys 
26 49 nf 
27 12 Ser 19 → Cys 
28 43 - 
29 30 - 
31 44 nf 
32 49 - 
34 25 Gly 44 → Phe 
35 49 - 
36 49 - 
37 26 CDR3 differs from P3 
38 26 - 
39 14 nf 
40 26 CDR3 differs from P3 
41 15 - 
42 28 nf 
43 26 Val 34→ Phe 
44 18 CDR3 differs from P3 
45 15 CDR3 differs from P3 
46 14 - 
47 15 - 
48 30 - 
 
Figure 3.31. Sequences of sorted peritoneal 8H10+IgM+ cells from L2 mice. A) Reanalysis of 
8H10+IgM+ sorted cells. B) Summary of sequence data. The designation of the individual sequences is 
given and the amino acid (aa) position from which sequence data could be analyzed and compared 
with L2P3 sequence. Dash indicates identical aa sequence with L2P3; nf: no functional reading frame 
assignable. Ser 19 → Cys indicates that serine found at position 19 in L2P3 is exchanged by cysteine 
in the compared sequence. C) CDR3 sequences from clones that differed from L2P3 CDR3 sequence. 
Amino acids matching with L2P3 CDR3 aa are indicated by dashes; n.d. indicates that no D segment 
was assignable. 
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1,37,45
0,93,93
1,44,44
1,5 ± 0,56,1 ± 2,2Mean expression
1,85,92
2,09,21
SpleenPeritoneumL2 individuals
% of 8H10 positive cells on gated IgM+ cells
[background substracted]
 
Figure 3.32. Analysis of 8H10 stainings performed on cells from spleen and peritoneal cavity of 
male L2 mice. Dotplots represent stainings of one mouse. The table summarizes staining results of 
individual mice. Background by detection antibody is subtracted in the table.  
Similarly, in the spleens of these mice also lower amounts of 8H10+ IgM+ cells were 
detected than expected from single cell analysis. Results obtained by this method 
predicted 10% of 8H10+ IgM+ cells in the spleen whereas only 1,3% on average 
could be detected in the flow cytometrical stainings from individual mice.
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IgM
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Figure 3.33. Flow cytometrical analysis of peritoneal cells from female mice raised under SPF 
and conventional conditions. The staining was performed on pooled peritoneal cells from four 
female mice from SPF conditions and one female mouse obtained from our normal mouse colony. 
 
Interestingly, when pooled peritoneal cells from female L2 mice bred under SPF 
conditions were analyzed, such mice showed a low percentage of 8H10+ cells 
(Figure 3.33). A female mouse that was housed under conventional conditions and 
was included as a control showed 15% 8H10+ cells, the number expected from single 
cell RT-PCR. As mainly male mice were used in the preceding stainings a difference 
in idiotype expression due to the gender of the mouse was possible. This idea was 
supported by the notion that the single cell studies were also performed with cells 
from female mice. Therefore, the stainings using the 8H10 antibody were repeated in 
male and female L2 mice (Figure 3.34).  
The percentage of 8H10+ cells detected in the peritoneal cavity was lower in male 
mice compared to the stainings in Figure 3.32. Similarly, in spleens lower 
percentages of these cells were found. Female mice in contrast showed a higher 
percentage of 8H10+ cells in the peritoneal cavity than male mice. In the spleen a 
similar finding was observed. There was an average 1,3% population of 8H10+ cells 
detectable in female mice whereas in male mice 0,4% of 8H10+ cells where found. 
These results indicate, that there could be an impact of gender on the expression of 
the L2P3 specificity. However, also the hygienic conditions might play an important 
role as indicated by the differences observed between mice housed under 
conventional and SPF (specific pathogen free) conditions. 
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spleen
female
male
male
female
8H10
control
IgM
8H10
control
peritoneum
4,84,43
12,53,12
8,3 ± 3,93,42 ± 1,2mean
7,62,41
femalemale#
[%] of 8H10 on IgM+ gated cells
1,30,73
1,70,12
1,3 ± 0,30,4 ± 0,3mean
1,10,41
femalemale#
[%] of 8H10 on IgM+ gated cells
IgM
0,50, 8
3,2 8,1
0,33 0,75
0,7 2,07
 
Figure 3.34. Comparison of anti-idiotype stainings on L2 mice. Dotplots show representative 
stainings of a female and a male L2 mouse. A) Staining of peritoneal cells. Background by secondary 
antibody is subtracted in the table. B) Staining of splenic cells. Table summarizes results from three 
individual mice. Significance of gender difference was determined using the one sided Wilcoxon’s two 
sample test. Peritoneum: p< 0,05, Spleen: p<0,01. 
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3.4 Analysis of L2P3 binding 
The B-1 cell derived antibody pool is highly enriched for autoreactive specificities that 
bind to intra- and extracellular autoantigens like single-stranded DNA or carbohydrate 
epitopes of glycolipids and –proteins (Baumgarth et al., 2005). For instance the work 
of Hayakawa and colleagues demonstrated the important role of autoantigen for the 
selection and maintenance of B-1 cells (Hayakawa et al., 1999). They used a 
transgenic mouse expressing a B-1 cell derived anti-Thy-1 IgM antibody (ATA; 
VH3609-DHQ52-JH2, Vκ21C-Jκ2). The presence of the Thy-1 autoantigen yielded an 
increased frequency of CD5+ transgenic B-1 cells. They also observed an age-
dependent accumulation of CD5+ transgenic B cells suggesting cellular selection 
even after the generation of these cells. 
Similarly, the clones dominating in the B-1 cell pool of L2 mice might be the result of 
autoantigen-dependent selection mechanisms (Kretschmer et al., 2002). Thus, L2P3, 
representing one of the dominating specificities and L2M15, that was also repeatedly 
found in blood of L2 mice were tested for their potential to detect autoantigens in L2 
mice. As a first and simple approach L2P3 and L2M15 were tested in flow 
cytometrical analysis using cells from various organs of CB20/L2 mice. These mice 
are congenic BALB/c mice that carry the immunoglobulin locus of C57BL/6 and 
therefore express the IgMb allotype. Since L2P3 and L2M15 antibodies are derived 
from BALB/c L2 mice the IgMa allotype could be distinguished from endogenous IgMb 
by a fluorochrome coupled anti-IgMa detection antibody. Therefore, cells from 
peritoneum, spleen, bone marrow and thymus were isolated and stained with L2P3 
and L2M15, respectively. MOPC104E was included as a possible negative control.  
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L2M15
MOPC104E
Thymus
 
Figure 3.35. Flow cytometrical studies of L2P3 and L2M15 binding. Cells derived from the 
peritoneum (PEC), spleen, bone marrow (BM) and thymus of CB20/L2 mice were gated on lymphoid 
cells in flow cytometry and stained with L2P3, L2M15 and the control IgM/λ antibody MOPC104E. 
Samples consisted of pooled cells obtained from the indicated anatomical sites of two female and one 
male CB20/L2 mouse. Black line represents controls stained with the IgMa detection antibody omitting 
the primary antibody. Colored lines represent staining with the antibodies L2P3, L2M15 and 
MOPC104E as indicated. 
As seen in the histograms of Figure 3.35, L2P3 generated a shift in staining intensity 
in the lymphoid cell population derived from the peritoneal cavity but not on cells 
obtained from spleen, bone marrow or thymus. The second B-1a cell derived 
antibody, L2M15, as well as the control antibody MOPC104E, however, showed no 
reactivity with any of the tested populations. Thus, the staining obtained with L2P3 
indicates a specific staining. Therefore, L2P3 might detect an autoantigenic 
determinant exposed on lymphoid cells in the peritoneal cavity.  
The staining was repeated with a second pool of cells obtained from the peritoneal 
cavity or the spleen of CB20/L2 mice and cells in the lymphoid gate were analyzed in 
flow cytometry. A similar shift inflicted by L2P3 (Figure 3.36) was observed in this 
experiment. No shift was seen with splenic cells stained using this antibody. The 
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stainings with L2M15 and MOPC104E were negative. Thus the binding of L2P3 
observed on cells found within in the peritoneal lymphoid gate was confirmed. 
 
 
 
PEC Spleen
L2P3
L2M15
MOPC104E  
Figure 3.36. Flow cytometrical studies of L2P3 and L2M15 binding. Cells derived from the 
peritoneum (PEC) and spleen of CB20/L2 mice were gated on lymphoid cells in flow cytometry and 
stained with L2P3, L2M15 and the control IgM/λ antibody MOPC104E. Samples consisted of pooled 
cells obtained from the indicated anatomical sites of three male CB20/L2 mice. 
 
Surprisingly, when non-transgenic mice were tested no staining with L2P3 was 
observed (data not shown). This seems to indicate that for unknown reasons this 
autoantigen is found only in the transgenic situation on lymphoid cells of the 
peritoneal cavity. 
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3.4.1 Half-lives of B-1 cell derived antibodies 
The fact that B-1 cell derived antibodies might recognize autoantigens should be 
reflected in their in vivo persistence, i.e. such antibodies should exhibit a short half 
life compared to B-2 cell derived antibodies. Therefore L2P3 and L2M15 were 
injected intravenously into CB20/L2 mice and sera from these mice were collected at 
different time points to determine the rate of clearance of such antibodies from the 
sera. As controls two additional antibodies, MOPC104E (IgM, λ1) and 2D4 (IgM, κ), 
were included in these studies. MOPC104E is derived from a plasmacytoma that was 
induced in BALB/c mice by intraperitoneal injection of mineral oil. This myeloma 
might have arisen from B-1 cells. 2D4 is a hybridoma the antibody of which is 
directed against ganglio-N-triosylceramide (asialo GM2) (Young, Jr. et al., 1979) and 
was obtained after immunization, thus, should be of B-2 origin although autoreactivity 
can not be excluded for the moment. Serum samples of individual mice were 
obtained at variant time points after injection and submitted to a IgMa specific ELISA. 
The optical density value at the first experimental time point was arbitrarily set as 
100% and the following values correlated to it. 
Interestingly, L2P3, L2M15 and MOPC104E showed two rates of clearance (Figure 
3.37A). The first phase showed a rapid decrease of the antibodies in sera, the 
second phase displayed a slower clearance. In contrast, the clearance rate of 2D4 
from sera did not seem to underlie a biphasic mechanism. It could be described by a 
trendline based on an exponential function (Figure 3.37B) which is represented by a 
straight line in a semi-logarithmic diagram. Therefore the kinetic of 2D4 showed only 
one phase. The results showed that all B-1 derived antibodies behaved similar, i.e. in 
the first phase the half life (t1/2) was around 10 hours and in the second phase around 
35-40 hours while t1/2 of the B-2 derived antibody was 22 hours. This might be due to 
the different nature of the antigens recognized by the B-1 versus B-2 cell derived 
antibodies, i.e. reaction with an autoantigen or not. 
 
 
Together the studies using antibodies of B-1 cells from L2 mice added several 
important aspects to the study of B-1 cells and their antibodies. The generation of the 
8H10 anti-idiotype antibody extends the results obtained by sequencing so far and 
will in future allow simplified experiments on the repertoire and selection of these 
cells. 
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Figure 3.37 Clearance of L2P3, L2M15, MOPC104E and 2D4 of sera from CB20/L2 mice. A) 
Clearance curves for L2P3 (orange), L2M15 (green) and MOPC104E (pink) and 2D4 (grey) are 
displayed. B-E) Graphical evaluation the kinetics of the indicated antibodies. Trendlines for the first 
and second phases are indicated by black dashed or black solid lines, respectively. Red dashed and 
solid lines indicate the determination of antibody half-life from the diagrams. Half-life of the antibodies 
in the two phases are shown in the diagrams (T1/2). Data points for all curves represent mean values 
from three individual mice except the curve for L2M15 which is based on data of two mice. 
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In the present work novel features of murine B-1 cells were studied in order to better 
characterize physiological peculiarities of this B cell population. To this end, first, 
marker genes were identified that were differentially expressed between splenic and 
peritoneal B-1a cells. By transfer experiments the question of whether this differential 
expression is due to the microenvironment or intrinsic to the particular cell population 
should be solved. Along this line novel markers for B-1 cells were intended to be 
defined. Secondly, a dominant antibody specificity that was repeatedly found 
amongst B-1 cells in a transgenic mouse was taken as specific marker for B-1 cells in 
order to better understand selective forces that act on such B-1 cells. 
Analysis of gene expression in B-1 cells 
Differentially expressed markers of B-1 cells: Several differences have been reported 
between peritoneal and splenic B-1 cells already (Rothstein, 2002). These results 
indicate that splenic and peritoneal B-1 cells differ phenotypically, biochemically and 
functionally. Two explanations can account for these differences: Either B-1 cells that 
reside in the spleen display an altered phenotype and function that is imprinted by 
the microenvironment of the spleen or splenic B-1 cells are of different 
developmental origin compared to peritoneal B-1 cells thus representing two 
alternative cell lineages. Genes expressed in peritoneal and splenic B-1 cells would 
therefore represent diagnostic patterns of independent developmental programs. In 
the first case, the gene expression pattern would depend on the location of the cells 
independent of their origin while in the second expression patterns would not be 
influenced by the microenvironment. Clearly, the first situation is true for genes 
analyzed in this work. 
To achieve this conclusion, genes were identified on the microarrays that are strongly 
expressed in splenic B-1a cells but showed no or extremely low expression in 
peritoneal B-1a cells. Confirmation of the expression data obtained by arrays 
however yielded conflicting results in RT-PCR analysis. While Vcam1, Adamdec1 
and Spic could be shown to fulfill the original criteria, data for Hpgd in peritoneal cells 
were contradictory. In three experiments using L2 or non-transgenic mice no Hpgd 
expression was observed while in another independent experiment with L2 mice 
expression was observed. Similarly, expression could be observed in peritoneal B-1 
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cells after cell transfer independent of the route of transfer. Hpgd encodes the NAD+-
dependent 15-hydroxyprostaglandin dehydrogenase an enzyme that is catalyzing the 
inactivation of prostaglandins and known to be downregulated during inflammation 
(Hahn et al., 1998; Ivanov et al., 2003). Therefore, expression of this gene might 
represent the inflammation status of the mouse rather than the influence of the 
microenvironment. The expression pattern of this gene was therefore excluded from 
the conclusions. 
The expression pattern of two other genes (Mrc2, Lpl) also showed discrepancies 
between earlier and later RT-PCR experiments. Mrc2 encodes the mannose receptor 
(MR, CD206) which is involved in the clearance of endogenous glycoproteins as well 
as pathogen recognition (Taylor et al., 2005). Lpl encodes lipoprotein lipase (LPL) 
which promotes the hydrolysis of triacylglycerol and is involved in monocyte 
adhesion, induction of the gene for the inflammatory cytokine TNF-α and the 
promotion of cell proliferation (Mead et al., 2002).  
Consistently, in splenic B-1a cells Mrc2 and Lpl expression was detectable in all 
experiments. In contrast, the initial RT-PCR of Mrc2 and Lpl indicated no or low 
expression in the peritoneal B-1a cells while in later experiments Mrc2 and Lpl were 
reproducibly detectable in such cells. The reason for this discrepancy is unclear. 
Possibly, the B-1a cells from peritoneum were contaminated by B-1b cells in which 
expression of these two genes could be detected on microarrays. On the other hand, 
a similar explanation as discussed for Hgpd might hold true also for Mrc2 and Lpl, 
expression simply reflecting the inflammatory status of the mice. Independent of the 
reason these two genes were excluded from the analysis. 
 
Analysis of transferred B-1 cells: Cells from the peritoneal cavity of L2 mice were 
transferred into lymphocyte deficient Rag 1-/- mice either by the i.v. or i.p. route. 
Unsorted cells were used since on one hand only B-1 cells are found in the 
peritoneum of such mice and on the other hand they contained T cells which might 
be essential for the migration of such B cells. Rag1-/- mice were used because no 
migration of B-1 cells to the spleen could be observed when normal or L2 mice were 
used as recipients for i.p. transfers (Kretschmer et al., 2003b). The lack of 
lymphocytes in the spleen of Rag1-/- mice obviously allows i.p. transferred B-1 cells to 
home to the spleen. 
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Independent of the route of transfer peritoneum derived B-1 cells could be found in 
the peritoneum as well as the spleen of recipient mice. In the case of i.p. transfer the 
course of colonization was followed. In both locations the number of B cells 
increased until three weeks after transfer and then remained roughly constant. A 
similar increase is found for T cells. This indicates that the transferred lymphocytes 
expand due to homeostatic proliferation (Woodland and Schmidt, 2005) until the 
compartments are filled at three weeks after transfer. The intrinsic feedback 
regulation then stops expansion and leaves the cells at a steady state number in both 
compartments. 
Transferred cells were isolated and semiquantitative RT-PCR analysis performed for 
the expression of the selected diagnostic genes. Although only three appropriate 
genes could be included in this analysis (Vcam1, Adamdec1, Spic) unambiguous 
results were obtained. Low to no expression was observed in transferred B-1 cells in 
the peritoneum in accordance with expression before transfer. Such genes were 
found to be upregulated when the B-1 cells resided in the spleen after transfer. This 
suggests that the differential gene expression pattern observed for B-1 cells from 
spleen and peritoneum is largely influenced by the microenvironment. This finding 
however does not yet exclude the possibility that splenic and peritoneal B-1 are 
derived from two independent lineages but only indicates that peritoneal B-1 cells 
have the plasticity to express particular genes when migrating to the spleen of 
lymphopenic mice. 
Clearly, this analysis needs to be extended to additional diagnostic genes for 
validation. In the present study only genes with known products were included while 
ESTs (expressed sequence tags) were ignored. Therefore, a follow up study should 
be extended to such gene products. In addition it would be important to analyze gene 
expression patterns of B-1 cells from spleen and peritoneum after transfer of splenic 
B-1 cells. This should give further hints on the plasticity of B-1 cells. 
 
VCAM-1 expression on peritoneal B-1 cells: Particularly interesting results were 
obtained when the expression pattern of VCAM-1 was analyzed during the above 
experiments. Surprisingly, although no RNA expression of VCAM-1 was detectable in 
peritoneal B-1a cells on average 5% could be stained with an anti-VCAM-1 antibody. 
This staining has to be considered real since blockage of Fc-receptors by various 
means did not abolish or significantly lower the staining. Different hypotheses could 
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explain this finding: First, these cells could be migratory cells that have acquired 
VCAM-1 expression outside the peritoneal cavity and downregulated the gene 
expression upon entry into the peritoneum. Surface expression of the protein 
however would remain detectable for some time. Alternatively, shed VCAM-1 might 
have been absorbed passively by a fraction of B-1 cells. Shed VCAM-1 from stromal 
and stimulated endothelial cells has been observed (Kinashi et al., 1995) and is also 
found in serum under a broad range of disease conditions like atherosclerosis, 
rheumatoid arthritis or systemic lupus erythematosus (Gearing and Newman, 1993; 
Wellicome et al., 1993; Blankenberg et al., 2003). Nevertheless, even then one would 
expect that the VCAM-1 carrying peritoneal B-1 cells are migratory and recent 
immigrants into the peritoneum since otherwise all peritoneal B-1 cells should bear 
VCAM-1 on their surface. 
To further investigate this phenomenon additional transfer experiments are indicated. 
So far only VCAM-1 negative B-1 cells from the peritoneum were transferred i.p and 
tested two weeks after. In further experiments earlier time point should be tested 
since at two weeks already steady state with regard to colonization and VCAM-1 
expression might be reached. In addition, VCAM-1 positive cells should be 
transferred and followed in a similar way. If VCAM-1 is involved in the migration and 
homing of B-1 cells one would expect to find effects already early after transfer. 
Under these condition one would also expect that independent of the route of transfer 
and the phenotype of the transferred cells the ratio originally observed for 
VCAM-1+/VCAM-1- should be obtained when steady state is reached. These 
experiments should further support the idea that the microenvironment is defining the 
gene expression pattern of B-1 cells. 
 
Effect of conditional Vcam1 deficiency on the B cell compartment: VCAM-1 is known 
to be constitutively expressed on bone marrow stromal/endothelial cells and classes 
of hematopoietic cells, like dendritic cells and macrophages (Freedman et al., 1990; 
Miyake et al., 1991; Koopman et al., 1991; Jacobsen et al., 1996; Schweitzer et al., 
1996). Xia et al. furthermore showed constitutive VCAM-1 expression on human B 
lymphocytes from peripheral blood and plasmacytomas (Xia et al., 2001). The 
existence of VCAM-1 on B-1a cells described here is novel and its functional role on 
B cells is not known. VCAM-1 is thought to be involved in lymphocyte homing 
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(Papayannopoulou and Craddock, 1997) and is supposed to be a costimulatory 
molecule for T cells (Burkly et al., 1991). 
To address which function VCAM-1 might have on B-1 cells, mice with a supposedly 
B cell specific Vcam1 deletion were investigated. Therefore, mice with floxed Vcam1 
alleles were mated with CD19cre recombinant mice that express the Cre protein 
under the control of the CD19 promoter B cell specifically. No differences within the B 
cell compartment of such mice could be observed in comparison to control mice. 
However, flow cytometrical analysis of such mice revealed that VCAM-1 was still 
expressed on B cells. This is obviously due to a low efficiency of the CD19 driven Cre 
that has been observed also by other investigators (Rickert et al., 1997). In 
agreement, Southern blots of B cells from VCAM-1flox/flox/CD19cre mice revealed 
bands of undeleted VCAM-1 genes. This suggests an incomplete deletion. 
Interestingly, in both VCAM-1flox/flox/CD19cre and control mice on average 15% of the 
IgM+ cells in the spleen were positive for VCAM-1 expression. This suggests for 
unknown reasons a strong selection of B cells with undeleted VCAM-1 into the 
VCAM-1 positive B cell fraction. In future, such incomplete deletions might be 
possible to be circumvented by employing a mouse line in which Cre is driven by the 
mb-1 promoter (the mb1 gene encodes the Igα protein). In such mice Cre efficiency 
is apparently 100% (Elias Hobeika, personal communication). 
 
B-1 cell specific molecules: In flow cytometry B-1 cells are identified by a combination 
of surface markers that allows the distinction from other B cell subsets. For instance 
B-1 cells can be distinguished from follicular B-2 cells by their expression levels of 
IgM and IgD. B-1 cells display a IgMhiIgDlo expression pattern whereas B-2 cells are 
IgM+IgDhi. The expression of the CD5 molecule in combination with IgM defines B-1a 
cells and distinguishes them from CD5- B-2 cells but also from B-1b cells. Other 
markers that characterize B-1 cells, in contrast to B-2 cells, are CD43 or Mac-1. 
However, the example of Mac-1 also shows the restrictions of such B-1 cell markers 
since Mac-1 defines well peritoneal B-1 cells but is not detected on splenic B-1 cells. 
Similarly, expression level of IgM and IgD can be used for the characterization of 
peritoneal cavity B-1 cells but is insufficient in the spleen because of the presence of 
other cell populations with an IgMhiIgDlo phenotype like marginal zone B cells or 
fractions of immature B cells. Thus, in the spleen only CD5 represents a reliable 
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marker for B-1a cells. A unique pan B-1 cell marker would therefore be a valuable 
tool for studies of B-1 cells. 
In this work it could be shown by RT-PCR that the F11r gene, encoding JAM-1, is 
expressed in B-1a cells in spleen and peritoneum of L2 mice. The expression of 
JAM-1 was confirmed by flow cytometrical analyses that were restricted to the 
lymphoid gate. Peritoneal B-1a cells of L2 mice were positive for JAM-1 staining. 
Similarly IgMhiCD5- cells showed JAM-1 expression indicating that also B-1b cells 
express this marker. No expression could be detected on T cells or cells that were 
negative for IgM and CD5 staining. Thus, in the peritoneal cavity of L2 mice JAM-1 
expression is only found on B-1 cells. Similarly, in non-transgenic mice, peritoneal 
cavity IgM+CD5+ B-1a cells were positive for JAM-1 and T cells and IgM-CD5- cells 
were negative. B-1b and B-2 cells could be distinguished by the IgM+CD5lo (B-2) and 
IgMhiCD5- (B-1b) expression pattern and it could be shown, that JAM-1 was only 
expressed in the B-1b population.  
In the spleen, T cells and IgM-CD5- cells were negative for JAM-1 staining in both 
transgenic and control mice. Similarly, splenic B-2 cells in non-transgenic mice 
showed no JAM-1 expression. In contrast, B-1a cells in the spleen of L2 mice were 
clearly JAM-1+. However, the staining was weaker compared to peritoneal cavity 
B-1a cells. The same was true for splenic B-1a cells of BALB/c mice.  
Taken together, JAM-1 expression is detectable on all B-1 cells in transgenic and 
non-transgenic mice and not found on any other of the cell populations present in the 
lymphoid gate of spleen and peritoneal cavity. Thus, at these sites it can be 
considered a marker for B-1 cells in flow cytometry. It will be interesting to extend this 
analysis to other compartments like blood or gut associated tissue. 
JAM-1 was originally characterized on platelets and was later found to be 
predominantly expressed in endothelial and epithelial intercellular junctions. The 
human orthologue of JAM-1 is expressed on a variety of circulating leukocytes in 
peripheral blood, including monocytes, neutrophils, B and T lymphocytes (Ebnet et 
al., 2004). On endothelia the interaction of JAM-1 with LFA-1 on leukocytes supports 
the adhesion and transendothelial migration (Ostermann et al., 2002). However, the 
role of JAM-1 expressed on leukocytes is not known and its function in B-1 cells has 
to be investigated.  
A second gene, Adml, also qualified by RT-PCR as a potential B-1 cell marker. It was 
expressed in splenic and peritoneal B-1a cells of transgenic and non-transgenic L2 
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mice and showed only traces in B-2 cells. Adml encodes Adrenomedullin, which in 
the mouse is a small regulatory peptide 50 aa in length. It is expressed in a variety of 
cells and tissues e.g. heart, brain, kidney as well as in leukocytes in the blood like 
monocytes, mast cells but also in B and T cells. Initially it was characterized as a 
vasodilator but in the meantime many other functions have been reported, e.g. an 
impact on cell proliferation, hormone regulation and antimicrobial activity. A role as 
anti-apoptotic survival factor was also described (Ostermann et al., 2002). 
Preliminary experiments using a commercial anti-Adrenomedullin antibody did not 
reveal any intracellular staining of B-1 cells (data not shown). Therefore, it is not clear 
at the moment whether this molecule can be of use for B-1 cell studies. Clearly more 
systematic investigations need to be carried out in order to validate Adrenomedullin 
as a marker for B-1 cells especially in the light of a potential expression in non-B 
cells. 
In summary, several novel markers have been identified so far which should in future 
either facilitate studies on B-1 cells or shed further light on the function of different 
subpopulations of B-1 cells. 
The L2P3 antibody 
The most important marker of a B cell and of a B-1 cell for that matter is its B cell 
receptor. According to the current hypothesis the BCR might imprint the B-1 
phenotype onto a B cell (Lam and Rajewsky, 1999; Wang and Clarke, 2004b). 
Therefore, the study of the behavior of particular B-1 cell clones under various 
conditions should shed some light on the selective forces that act on this B cell. So 
far analysis of the BCRs of B-1 cells from L2 mice was restricted to sequence 
analysis. This has led to extremely interesting results already. A pronounced 
oligoclonality was observed among their BCR specificities with a few specificities 
dominating. Amongst those one was found in 15% of all peritoneal cavity B-1 cells 
and represented 10% of splenic B-1 cell specificities (Kretschmer et al., 2002; 
Kretschmer et al., 2003b). Two others represent 13% and 7,4% of the specificities in 
the peritoneal cavity. These specificities were B-1 cell specific as they could not be 
detected in B-2 cells so far. Thus they represent the appropriate invariant marker to 
further study such B-1 cells. 
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The 8H10 anti-idiotype antibody: By cell fusion using cells from spleen and peritoneal 
cavity of L2 mice a hybridoma could be established which secreted a monoclonal IgM 
- L2P3 - representing the specificity that was found at a 15% frequency in the 
peritoneum. This IgM was first used to establish a reagent - the anti-idiotypic 
antibody 8H10 – that to a large extend recognizes only antibodies with the 
dominating sequence. This was established by isolating B-1 cells that were 
recognized by the 8H10 antibody and analyzing their heavy chain sequence. 19 of 
such sequences were identical to L2P3. Four additional sequences displayed an 
identical CDR3 region but contained single aa exchanges. Such exchanges are 
characteristic for somatic hypermutation although B-1 cell derived antibodies usually 
lack somatic mutations (Berland and Wortis, 2002). Thus, such aa exchanges might 
be due to Taq-polymerase errors. Besides these sequences, four sequences were 
found that were deviating from the sequence of L2P3. Possibly the secondary 
antibody employed for sorting might be responsible for a contamination with B-1 cells 
not directly recognized by the anti-idiotypic antibody. Alternatively, although the sort 
was highly pure (98,4%) some residual non-L2P3 type of B-1 cells were present in 
the sample which might have contributed the non-L2P3 sequences. However, one 
also cannot exclude that the anti-idiotypic antibody recognizes these BCRs 
specifically via an idiotope that is shared but is not apparent from sequence 
comparison. A second sort and analysis should clarify this question. Independent of 
this, the 8H10+ antibody can be considered a highly specific anti-idiotypic antibody for 
the detection of the L2P3 specificity and should represent an extremely useful 
reagent. 
The use of the 8H10 antibody in flow cytometrical analysis of the L2 mice revealed 
very interesting results. An obvious difference was observed when splenic and 
peritoneal B-1 cells from male and female mice were compared. Female mice 
contained significantly more B-1 cell of this specificity when directly compared with 
male mice. A discrepancy between the frequencies described originally for female L2 
mice concerning this dominating specificity (Kretschmer et al., 2003b) and the 
present data was observed. This could be due to alterations in the hygienic 
conditions. However, since the size of the samples in the present work is still very 
small and pools of mice were used in the original work no importance was given to 
this discrepancy for the moment.  
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Differences in immune reactions between males and females are well established. 
Women are more prone to develop autoimmune diseases than men (Verthelyi, 2001; 
Bouman et al., 2005). Strong differences are also observed in the resistance of 
males and females mice towards Listeria monocytogenes infection (Lengeling 
personal communication). Therefore, the selective forces acting on B-1 cells from 
males and females might be different due to differences in resistance against the 
natural microbial environment. In addition, estrogen receptors are expressed in B 
cells (Grimaldi et al., 2005). Therefore, even a direct influence of the hormonal milieu 
on the selection of B-1 specificities can be envisioned. 
Additional influences on the selection of the L2P3 specificity were observed when 
female mice from different housing conditions – SPF versus conventional - were 
compared. Lower numbers of B-1 cells stained with 8H10 were found in SPF mice 
that contain a defined commensal microbial flora in their intestine and are free of 
known bacterial, viral, and parasitic pathogens. The most obvious explanation for this 
observation is that microbes of the gut contribute significantly to the selection of B-1 
specificities in the lymphoid compartments even when they are not associated with 
this organ.  
Further experiments should now carefully extend the data on the impact of gender 
and housing. Defined pathogens with an intestinal port of entry should be tested in 
this context for their impact on the repertoire of B-1 derived antibodies in the various 
deep lymphoid compartments. 
An influence of the age of the mice on the selection of the L2P3 specificity should 
also be tested since it is most likely not only driven by microbial antigens but also by 
autoantigen. For instance, Carmack et al. have reported a time-dependent 
accumulation of B-1 cells specific for a determinant on senescent erythrocytes (anti-
BrMRBC, anti-PtC) (Carmack et al., 1990). Similarly, Hayakawa et al. observed a 
time-dependent increase of B-1 cells specific for the Thy-1 self-antigen (Hayakawa et 
al., 1999). The finding that L2P3 apparently binds to lymphoid cells in the peritoneum 
of L2 mice is in accordance with this. Although only a weak signal was observed the 
staining appeared to be specific as neither the second B-1 cell derived antibody 
L2M15 nor MOPC104E reacted with these cells and no binding of L2P3 was 
observed in other organs. This might indicate the existence of an self-antigenic 
determinant recognized by L2P3. So far the cells bound by L2P3 have not been 
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characterized. As most (~80%) of the cells in the lymphoid gate of the peritoneal 
cavity are B cells, they mainly contribute to the observed staining.  
Unexplained is still why this antigen is only detected in L2 mice but different 
possibilities exist concerning its nature. Either it is expressed endogenously i.e. by 
the cells themselves like in the case of the autoantigen Thy-1 (Hayakawa et al., 
1999) which is expressed on T cells. Alternatively, it could be a soluble antigen 
attached to receptors on the surface of these cells. An example that even a BCR can 
be involved was provided by Carmack et al. (Carmack et al., 1990). When a B-1 cell 
derived antibody (anti-BrMRBC) was used to stain peritoneal cavity cells, a fraction of 
B-1 cells bound the antibody. More then half of the BCRs of these B-1 cells were 
specific for BrMRBC. This suggests that the self-antigen was bound by the BCR of 
these particular B-1 cells and was then detected by the antibody used in the analysis 
in a sandwich kind of staining. Thus, one could envision that L2P3 detects a 
determinant on an antibody that is bound to an self antigen on peritoneal cells of L2 
mice. However, more likely is that L2P3 is specific for an intracellular antigen as it is 
known for other natural antibodies (Baumgarth et al., 2005). The physiology of the L2 
mice, for instance apoptosis or necrosis of particular cells, might solubilize this 
antigen and render it detectable on the peritoneal lymphocytes of such mice. This 
needs to be further worked out in a systematic way. Intracellular staining will have to 
be carried out using the L2P3 antibody. As samples, cytological and histological 
preparations of cells and tissues from L2 and control mice should be used. Apoptotic 
cells should be included in this analysis.  
Consistent with the detection of a self antigen was the in vivo behavior of the IgM 
antibody L2P3 when injected into L2 mice and compared with two other B-1 cell 
derived IgM – L2M15 and MOPC104E as well as one B-2 cell derived antibody 2D4. 
The 2D4 antibody showed a half-live of 22 h similar to the half-life of IgM described 
by others (Vieira and Rajewsky, 1988). In contrast L2P3, L2M15 and MOPC104E 
showed a pronounced bi-phasic behavior in their clearance rates. During the first 
phase of clearance the half-live of these antibodies was around 10 h which is short 
compared to 2D4. In the second phase the half-life was increased to 35-43 h. The 
monophasic kinetic of 2D4 is compatible with the expected short half-live of an IgM 
antibody which is rather short compared to IgG antibodies (Vieira and Rajewsky, 
1988) and probably reflects the natural degradation rate of this class of antibodies. In 
contrast the B-1 cell derived antibodies are most likely submitted to two processes. 
111 
4. Discussion  
The first process indicated by a short-half life might reflect the binding of these 
antibodies to self antigen leading to their rapid clearance from sera. This binding 
might result in the clearance or sequestration of the antigen thus denying further 
access to the anybodies. With the loss of the antigen the antibody will be cleared at 
its natural rate which is reflected by a extended half-live in serum. 
It is interesting that all B-1 cell derived antibodies in this experiments behaved 
similarly indicating that they all might bind to self-antigenic determinants although 
only for L2P3 a weak self-reactivity could be demonstrated in flow cytometrical 
analysis. Analyses of these antibodies so far only tested a fraction of the putative 
autoantigen presenting cells, as only cells from spleen, thymus, bone marrow and 
peritoneum were analyzed. Therefore, self-reactivity as an explanation for the 
biphasic clearance rates of the B-1 derived antibodies is consistent with the data. 
However, there is one technical draw back at the moment. Only few time points were 
taken for analysis thus a similar curve for 2D4 might have been missed due to the 
limited data available for calculation. Thus, clearly these experiments need to be 
repeated with a more detailed analysis at the early phase of the clearance. In 
addition, non transgenic mice should be included in this analysis. Furthermore, 
histological analysis of various tissues shortly after administration of the antibody 
should be carried out since it should be possible to find cells with bound antibody if a 
self-reactivity exists. This might also help to identify the self-antigen itself. 
 
Taken together, several novel aspects of the physiology of B-1 cells were addressed 
during this work. It became clear during the course of the experiments that this B cell 
population is dynamically reacting to environmental changes. This was most clearly 
demonstrated by the difference in the frequency of L2P3 idiotype bearing B-1 cells in 
mice from different housing conditions. Therefore, some of the analyses were 
aggravated by such changes that could not be controlled but on the other hand might 
reflect the natural situation that should be further analyzed. Nevertheless, interesting 
information on the difference between splenic and peritoneal B-1 cell as well as on 
the selective forces acting on them could be obtained which shed further light on this 
still enigmatic B cell population. 
112 
 5 Summary 
In the present work the transgenic mouse L2 was used in which almost exclusively 
B-1 cells are found in the spleen and peritoneum. Several features of B-1 cells were 
investigated in such mice. First, the question was addressed if differential gene 
expression observed between splenic and peritoneal derived B-1a cells is due to the 
distinct localization or due to different developmental origin of these cells. Based on 
microarray data genes were established by RT-PCR analyses, that were expressed 
in splenic B-1a cells and low or absent in peritoneal B-1a cells. These genes were 
used as diagnostic markers in transfer experiments. In these experiments peritoneal 
derived B-1a cells were injected into lymphopenic mice and reisolated from the 
spleen as well as the peritoneal cavity. Then the gene expression pattern of such 
cells was analyzed. All of the diagnostic marker genes were upregulated in peritoneal 
derived B-1 cells that resided in the spleen. Thus it could be demonstrated that the 
microenvironment is imprinting the gene expression pattern in such B-1 cells. 
 
In line with the gene expression analysis of B-1 cells JAM-1 was identified as a novel 
marker for B-1 cells located in spleen and peritoneum of mice. This protein was not 
expressed in B-2 cells, T cells or any other population at these sites and therefore 
specifically defines B-1 cells in flow cytometrical analysis in spleen and peritoneum. 
 
In the last part of this work an anti-idiotypic antibody directed against a dominant B-1 
cell specificity that had been identified on B-1 cells of L2 mice before, was generated. 
To achieve this, hybridomas of splenic and peritoneal B-1a cells from L2 mice were 
established that produced monoclonal IgM antibodies. Sequence analysis of cDNA of 
VH regions from the individual clones was carried out. One antibody, L2P3, was of 
particular interest because it represented one of the dominant specificities in the B-1 
cell pool of L2 mice. A second antibody, L2M15, represented a specificity only 
occasionally found in blood derived B-1 cells of L2 mice before and was used as 
control antibody for the experiments. L2P3 was used to generate an anti-idiotypic 
antibody in rats which was termed 8H10. Stainings performed with this anti-idiotype 
indicate that the generation and maintenance of L2P3 positive cells might be 
subjected to different selectional forces. Higher numbers of L2P3+ cells were 
detected in female mice compared to male mice. Furthermore, the microbial 
environment might have an impact on the selection as fewer L2P3+ cells were 
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observed in SPF mice than in mice housed under conventional conditions. The anti-
idiotype generated during this work is therefore a valuable tool for the investigation of 
selectional forces B-1 cells are submitted to. Further work with this antibody will help 
to unravel the impact of individual selectional influences shaping the B-1 cell pool in 
L2 mice. 
Finally, the purified antibodies L2P3 and L2M15 were further characterized. The 
binding of L2P3 on cells in the lymphoid gate of the peritoneal cavity revealed binding 
to an autoantigenic determinant whereas such binding was not observed for L2M15. 
An analysis of antibody clearance rates from sera of L2 mice extended the 
characterization of these antibodies. Biphasic clearance rates were found for the B-1 
cell derived antibodies which is consistent with the idea that they bind to an 
autoantigen in L2 mice. 
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 7 Abbreviations 
AID activation-induced cytidine deaminase 
Ab antibody 
Ag antigen 
AHA autoimmune hemolytic anemia 
ATA anti-thymocyte antibody 
BCR B cell receptor 
BM bone marrow 
bp base pairs 
BrMRBC bromelain treated mouse red blood cells 
C constant region 
CD cluster of differentiation 
cDNA complementary DNA 
CDR complementarity determining region 
CLP common lymphoid precursor 
CMP common myeloid precursor 
CSR class switch recombination 
D diversity 
DC dendritic cell 
DNA deoxyribonucleic acid 
DSB double strand break 
DTT dithiothreitol 
ELISA enzyme-linked immunosorbent assay 
EST expressed sequence tag 
FACS fluorescence-activated cell sorter 
FCS fetal calf serum 
FL fetal liver 
FO follicular 
FR framework 
h hour(s) 
H chain heavy chain 
 
7. Abbreviations  
HSC hematopoietic stem cell 
Ig immunoglobulin 
IgH immunoglobulin heavy chain 
IL Interleukin 
IL7R Interleukin 7 receptor 
J joining 
kb kilobases 
L chain light chain 
LDL low-density lipoprotein 
LPS lipopolysaccharide 
Mb megabases 
MHC major histocompatibility complex 
MPP mulitpotent progenitor 
MRBC mouse red blood cell 
MZ marginal zone 
N nucleotide non-templated nucleotide 
NK cell natural killer cell 
NP Nitrophenol 
P nucleotide palindromic nucleotide 
PALS periarterial lymphatic sheet 
PC phosphorylcholine 
PCR polymerase chain reaction 
Pec peritoneal cavity or peritoneum 
PtC phosphatidyl choline 
Rag recombination activating gene 
RNA ribonucleic acid 
RS sequence recombination signal sequence 
RT reverse transcription  
RT room temperature 
SL surrogate light chain 
SLE systemic lupus erythematousus 
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7. Abbreviations  
Sp spleen or splenic 
SPF specific pathogen free 
TCR T cell receptor 
TD T cell dependent 
TdT terminal deoxynucleotidyl transferase 
TI T cell independent 
TNP Trinitrophenol 
V variable 
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